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Abstract
In radiological protection, models are used to assess radiation risk by means of 
extrapolation from high dose and dose rate to low dose and dose rate. In this thesis 
five main biophysical models of radiation action have been evaluated, appraised and 
inter-compared. The five models are lethal and potentially lethal (LPL) by Curtis, 
pairwise lesion interaction (PLI) by Harder, cellular track structure (CTS) by Katz, 
hit size effectiveness (HSE) by Bond and Varma and track core (TC) by Watt. Each 
model has been developed based on certain underlying mechanisms or phenomena, 
to permit interpretation and prediction on the induction o f a specified biological end­
point such as cell reproductive death, chromosome aberrations and mutations. 
Biological systems of interest are, for example, mammalian cells containing 
deoxyribonucleic acid (DNA). Evidence is mounting that double strand breaks in the 
DNA are the critical lesions for various biological end points. To proceed with this 
work the TC model has been chosen.
Cancer induction by ionising radiation is the stochastic effect o f prime concern in 
radiological protection. Cancer induction cannot be avoided entirely but its 
frequency o f occurrence may be reduced to acceptable level by lowering the amount 
of radiation received. The methods of assessment developed by ICRP, in terms of 
the cancer risk coefficients, are presented in this thesis.
In the conventional (legal) system o f dosimetry, radiation is quantified by the 
amount of energy absorbed per unit mass of tissue. Quality factors, superseded by 
radiation weighting factors, are needed to account for the quality dependence on 
radiation type. As an alternative, a new dosimetry system is proposed here which 
is based on the mean free path for primary ionisation along particle tracks and the 
integral fluence generated by the radiation field, whether directly or indirectly 
ionising radiation. From the study of cellular data, the mean free path for primary 
ionisation along particle tracks (A.) emerges as a parameter which best unifies 
biological damage data. Radiation effect is found to depend, not on the energy 
transferred but to depend mainly on the frequency and spatial correlation of 
interactions. Maximum effect occurs when X is equal to X^  (2 nanometre, mii). The
Vll
term ’Absolute Biological Effectiveness’ (ABE) is introduced as a parameter which 
indicates the probability to induce a specified effect, per unit incident fluence. In 
this endeavour, only direct effects are considered in deriving ABE values for various 
radiations. However other factors such as indirect effects, inter-track action, repair 
processes and radiation rate, can be incorporated later if  required, in the derivation 
of ABE. ABE values for photons up to ^Co i.e 1253 keV and neutrons up to 10  ^
keV, have been calculated and presented in this thesis.
An attempt has been made to re-express the cancer risk coefficients, derived by 
ICRP, in the new dosimetry system, in terms of the ABE (Absolute Biological 
Effectiveness).
The hypothesis put forward in this thesis is that the induction of a specified 
biological end-point in a biological system due to ionising radiations, is determined 
not by the amount of energy absorbed per unit mass (dose), but rather by the 
number o f events (ionizations) spatially correlated, along the primary radiation track. 
Based on this hypothesis, a new unified dosimetry system, independent o f radiation 
type, is proposed. Suggestions are made for possible measuring instruments which 
have the equivalent response characteristics, namely maximum efficiency of 
detection for the mean free path X„. Success in devising such types of instrument 
would ensure the practicability of the new dosimetry system, in operational 
radiological protection.
Vlll
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CHAPTER ONE 
GENERAL INTRODUCTION
1.1. Introduction
In Radiological Protection, the basic objective [1] is to protect individuals, their 
progeny and mankind as a whole from the deleterious effects of ionising radiation, 
while still allowing necessary activities that are advantageous but from which 
radiation exposure might result. Ionizing Radiation is capable of producing 
detrimental effects [2] to the exposed individuals. The effects are called somatic 
if  they become manifest in the exposed individual and hereditaiy (genetic) if they 
affect off-spring.
For radiological protection, radiation effects [3] can be generally categorised into 
deterministic effect (or non-stochastic) and stochastic effect. For deterministic 
effect, the severity of the effect varies with the dose and a threshold may therefore 
occur e.g. cataract (lens), erythema, sterility (temporary or permanent). Deterministic 
effects involve the malfunctioning or loss of function of tissues in organs, mainly 
due to cell loss and there is a threshold value for the effects. It can be avoided by 
limiting the doses received to below the threshold dose levels for the effects. For 
this effect, radiation can damage tissue by killing the cells; or interfering with tissue 
functions such as regulation of the cellular components, inflammatory reactions 
which unveil modifications in permeability of cells, natural migration of cells in 
developing organs, indirect functional effects eg. pituitary gland irradiation, 
influences the endocrine functions in other tissues. After irradiation most cells 
continue to function until they attempt to divide.
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For stochastic effect the probability of the effect occurring, rather than its severity, 
is regarded as a function of dose without threshold e.g. cancer induction, hereditary 
disorders. Stochastic effects express themselves long after the exposure which 
include for example increased risk of cancer and hereditary disorders. Apparently, 
there is no tlueshold dose for the effects. Stochastic effects can not be avoided 
entirely because they are assumed to occur even at low doses with low frequency 
i.e. natural background. The effect can be reduced in frequency i.e. its probability, 
by lowering the dose. There are two types of stochastic effects o f concern in 
radiological protection, namely the induction of cancer in somatic cells; and the 
induction of hereditary disorder due to alteration of cells in the germinal tissue.
Cell killing in rapidly dividing cells, becomes manifest, a few days or hours after 
exposure. In slowly dividing cells, death may not occur after months or even years 
after exposures. The degree of killing increases with dose. In an organ or tissue, if 
enough cells are killed, its function is impaired. However functional disorders can 
also result from direct alteration of cellular processes, such as membrane 
permeability or cell to cell communication. Cell survival curves provide information 
on the survival fraction of the irradiated cells against radiation dose [4].
Modification o f a normal cell, occurs in a process known as neoplastic 
transformation. Most neoplastic cell transformations do not progress to a cancer. 
Various agents, including radiation, tobacco smoke, asbestos and other physical 
agents and chemical carcinogens, can induce the transformation. The effect of the 
combination o f radiation and other agents could be synergistic, additive or 
antagonistic, and depends among other things on the sequence, timing, frequency, 
and total duration of exposure to the agents [5]. The transformed cells are capable 
of unlimited cellular proliferation. However for malignant transformation, namely 
the ability of the cells to multiply and form tumour when injected into recipient 
animals, other phenotypic changes can occur as well. Modification of cells of 
germinal tissue will give rise to hereditary disorder which may manifest in the next 
generation [6].
In radiological protection, ionizing radiation effects, either stochastic or 
deterministic, are quantified in the present system of dosimetry, in units of dose or 
its derivatives such as equivalent dose or effective equivalent dose [7]. Cancer 
risk is quantified in terms of probability per unit equivalent dose (Sievert Sv) i.e. 
lO'-’ S v '. The present system of dosimetry, uses the absorbed dose to quantify 
radiation and the relative biological effectiveness (RBE) and linear energy transfer 
(LET) to take care of the relative effectiveness i.e. quality of different radiation 
types [8]. Since 1977, the International Commission on Radiological Protection 
(ICRP) has used the terms Dose D, Dose Equivalent H (H=NQD where N is a 
modifying factor, taken to be one, and Q is the quality factor) and Effective Dose 
Equivalent Elg ( Hi,=WtH , where w, is the tissue weighting factor). ICRP made 
revisions in 1990 and introduced the terms Dose [9], Equivalent Dose H, in 
tissue T (H-p =w^Dy . w^ is the radiation weighting factor and D j is the average 
absorbed dose in tissue T) and Effective Dose E (E=W(H, where w, is the tissue 
weighting factor). The validity o f dose as a concept to quantify radiation has been 
discussed and debated by many authors which include Watt et-al [10], Katz 
[ 1 1 ] [ 1 2 ] [ 1 3 ] ,  B o n d  e t - a l  [ 1 4 ]  a n d  S i m m o n s  [ 1 5 ] .  T h e  
quantification of the radiation field by using dose based on relative biological 
effectiveness (RBE), quality factor (QF) and linear energy transfer (LET), is 
considered by many to be inappropriate and fundamental changes are required.
In this project an attempt is made to express and quantify the biological 
effectiveness of ionizing radiation in an improved system o f dosimetry which uses 
the term absolute biological effectiveness (ABE). A biophysical model based on 
this concept is used to construct an absolute system of radiation effectiveness. For 
radiological protection purposes the proposed system must be able to quantify the 
appropriate radiation risk.
1.1.1. Dosimetric Quantities and Principles
Ionising radiation can be categorised into indirectly ionising radiation such as photon 
(i.e. X-ray and y-rays) and neutrons; and directly ionising radiations such as 
electrons, protons, alpha particles and other charged particles [16] [17]. 
Photons will interact with matter (i.e. water) through photo-electric, Compton
scattering and pair production [18] [19]. A complex shower o f electrons is 
produced in the matter from these processes. Neutrons will interact with matter 
tillough elastic scattering, inelastic scattering, nonelastic scattering, neutron capture 
or spallation processes. However for interaction between neutrons and water (i.e. 
tissue), the main interaction products are recoil protons and recoil oxygen. The 
spectrum of charged particles [20] [21] produced from these processes 
changes with penetration depth tlnough the build up region, reaches equilibrium and 
falls off under transient equilibrium conditions according to the attenuation of the 
primary incident radiation. The charged particle equilibrium spectrum is commonly 
used in dosimetric calculations [22]. The fundamental quantity used in the 
conventional dosimetry system is the dose which is the amount o f energy absorbed 
per unit mass of the irradiated medium. The radiation field can be described by a 
few basic terms which includes [23] fluence [24], [25] flux density 
(fluence rate), energy fluence and energy flux density (energy fluence rate).
1.1.1.1. Absorbed Dose and Equivalent Dose
The absorbed dose D is the quotient of dE by dm, i.e. D==dE/dm, where dE is the 
mean energy imparted by ionizing radiation to the matter in a volume element and 
dm is the mass of the matter in that volume element [23]. It is an average quantity 
and the unit is Jkg'  and 1 Gray (Gy) is equal to 1 .1kg'. The energy imparted E 
[26], by ionizing radiation to the matter in a volume is: E= Rj„ - R^^ +ZQ 
where
Rjn is the radiant energy incident on the volume. I.e., the sum of the energies 
(excluding rest energies) of all those charged and uncharged ionizing 
particles which enter the volume;
R„^ ,j is the radiant energy emerging from the volume, i.e., the sum of the energies 
(excluding rest energies) o f all those charged and uncharged ionising 
particles which leave the volume; and 
ZQ is the sum of all changes (decreases: positive sign, increases: negative sign) 
o f the rest mass energy of nuclei and elementary particles in any nuclear 
transformations which occur in the volume.
For x-rays and y-rays the absorbed dose D is given by the following relationship: 
D= (j).E,^ . Zj (p^/p)i x 1.6x10"'^ Gy
where
(|) is photon fluence:
E., is photon energy in MeV: and
is the mass energy absorption coefficient (mflcg'').
Radiation weighting factors w^ are used to calculate equivalent dose H, from 
absorbed dose D, by using the following equation:
H= EwR.D
1.1.1.2. Linear Energy Transfer
The concept of linear energy transfer (LET) was introduced by Zirkle et-al in 1952. 
ICRU [27] defines LET as follows:
The linear energy transfer or restricted linear collision stopping power (L J  
o f charged particles in a medium is the quotient of dE by dl, where dl is the 
distance traversed by the particle and dE is the mean energy-loss due to 
collisions with energy transfers less than some specified value A.
L^= (dE/dl)^ and A specifies an energy cut-off and not a range cut-off. The energy- 
loss is sometimes referred to as energy locally imparted.
A medium under irradiation contains a spectrum of charged particle energies, and 
L^ is energy dependent so there is likewise a distribution o f L^ values characterizing 
the radiation field. Average value o f L^ can be determined by using two methods 
namely the track weighted averaging; and dose weighted averaging. It is possible to 
have two different radiations with the same LET, but giving very different survival 
fractions [28]. Quality o f a radiation refers to features of the spatial distribution 
of energy transfers, along and within the tracks of particles, that influence the 
effectiveness of an irradiation in producing change, when other physical factors such 
as rate, total energy dissipated, fractionation are kept constant.
The LET concept is limited in its application and the limitation of L^ in specifying 
radiations include the followings:
i. Range Effect
L^ does not provide information on the range o f the particle which is 
important to determine whether the particle can traverse a given target
volume or stop in it. If the particle crosses the volume and spends 
appreciable amount of energy, value upon entering and leaving the 
volume will change significantly.
ii. Delta-rays Production (or primary ionizations)
describes the rate of energy loss but not the diameter o f the track, along 
the track. If the diameter o f the track depends on the maximum range of 
delta rays produced in the interaction (i.e.primary ionizations) and with the 
assumption that the delta rays carry the energy radially outward, so radiation 
of different types with the same could have different track diameter.
iii. Random Variations (Energy Loss Straggling)
L^ describes the expectation value (average value) o f the rate of energy loss 
by a charged particle o f a given type and energy, but it does not address the 
random nature o f energy losses along the track, which may leave zero energy 
in a small target volume, or give more energy than predicted on the basis of 
0^0'
iv. LET is not single valued for a specified radiation because the same LET can 
occur on both sides o f the Bragg peak.
1.1.1.3. Microdosimetry
Microdosimetry is a science that deals with the spatial, temporal, and energy-spectral 
distributions of energy imparted in cellular and sub-cellular biological structures, and 
the relationship of such distributions to biological effects [29]. Rossi H H
[30] noted that microdosimetry is dealing with the microscopic distribution of 
energy in an irradiated material. The differences in response to equal absorbed dose, 
are assumed to be due to differences in the frequency with which various local 
energy densities occur within the irradiated material. Microdosimetry seeks to 
express the quality of radiation in terms of physical parameters to allow quantitative 
prediction of biological effects for different types of ionising radiations. A few 
definitions relevant to microdosimetry, have been introduced which include
[31][32]:
i. Energy Deposit Sj
Energy Deposit Sj is defined as the energy deposited in a single interaction i and 
given by the following expression:
Gj- Tj„ - +  Qxm
where
Tj„ is the energy of the incident ionizing particle (exclusive o f rest mass);
Tout is the sum of the energies of all ionizing particles leaving the interaction
(exclusive of rest mass); and
ths changes of the rest mass energy of the atom and all particles involved in 
the interaction ( ^  0; decrease of rest mass and ^  0; increase o f rest
mass);
ii. Energy Imparted s
Energy Imparted s is the sum of all energy deposit S; and may be due to more than 
one energy deposition event, that is statistically independent particle track.
iii. Specific Energy (Imparted) z
Specific Energy (imparted) z is the quotient of energy imparted a by mass m i.e. z 
= s/m.
iv. Lineal Energy y
Lineal Energy y is the quotient o f s by I where s is the energy imparted to the 
matter in a volume by a single energy-deposition event, and Î is the mean chord 
length in that volume i.e.y= s/I.
V. Five classes of tracks;
Insider; particles originating in the volume may lose their entire energy in the
volume;
Starter; particles originating in the volume may leave the volume before
losing all their energy;
Stopper; particles originating outside the volume may enter the volume and 
stop within the volume;
Grosser; particles originating outside the volume may cross the volume, 
depositing only part of their energy in the volume; and 
Glancer; particles ’brush' the wall of the volume so that only 6-rays enter it.
In microdosimetry the specific energy imparted z, is a stochastic replacement for 
absorbed dose and the lineal energy as a stochastic quantity also conceptually 
replaces L^.
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1.1.2. International Commission of Radiation Protection (ICRP) and a System 
of Dose Limitation
The International Commission on Radiological Protection (ICRP). which has been 
functioning since 1928. is formulated as an appropriate international body to give 
general guidance in the field of radiological protection. ICRP [33] has 
recommended a system of dose limitation, the main features of which are as follows:
i. no practice shall be adopted unless its introduction produces a positive net 
benefit i.e. justification;
ii. all exposures shall be kept as low as reasonably achievable, economic and 
social factors being taken into account i.e. optimization; and
iii. the dose equivalent to individuals shall not exceed the limits recommended 
for the appropriate circumstances i.e. dose limitation.
The basic framework of the Radiological Protection system, recommended by ICRP 
is intended to prevent the occurrence of deterministic effects, by keeping doses 
below the relevant thresholds, and to ensure that all reasonable steps are taken 
to reduce the induction of stochastic effects [34]. In 1977, ICRP 
recommended a formal dose limit [35] for whole body irradiation of workers, 
equal to 50 mSv per year (refer to table 1.1). This limit corresponded to the 
mortality risk factor for radiation induced cancers (fatal malignancies) o f about 1 O'- 
per Sv as an average for both sexes at all ages. For members of the public, a 
mortality risk factor one order of magnitude smaller was deemed appropriate and 
the recommended dose limit for members of the public was 5 mSv per year. In 
1985, the ICRP reconsidered its recommendation on dose limits for members of the 
public at a meeting in Paris [36] and recommended that the dose limit for 
members o f the public be further reduced to 1 mSv per year. The main reason for 
the reconsideration is to clarify the applicability of the dose limits for members of 
the public which was first recommended in 1977. A subsidiary dose limit of 5 mSv 
per year for some years was permissible provided that the average over a lifetime 
would, when averaged, not exceed the principle limit of 1 mSv per year.
The latest ICRP recommendation on effective dose limit for workers is equal to 20 
mSv per year, averaged over five years (i.e. 100 mSv per 5 years) w ith the further
provision that the effective dose should not exceed 50 mSv in any single year. The 
major reason for changes of the ICRP recommendations is the new risk estimates 
for fatal cancer which are higher than the previous estimates as explained briefly by 
Clarke [37]. These fatal cancer risk estimates are now proposed by ICRP and 
contrasted with those adopted by ICRP in 1977, as shown in table 1.3. The data for 
these estimations are derived mainly from the Japanese survivors. The latest ICRP 
dose limits recommendations are listed in table 1.2.
Table 1.1: Protection Recommendation [35]
Year Exposed NCR? ICRP
Population Limit Amiual
Equivalent
Limit Annual
Equivalent
1931-1934 Occupational 0.1 rad/day ~30 rad 0.2 rad/day -60  rad
1949-1954 Occupational 0.3
rem/week
15 rem 0.3
rem/week
15 rem
1957-1958 Occupational 5(N'-18)
rem
5 rem 
(15 rem 
maximum)
5(N-18)
rem
5 rem (15 
rem
maximum)
Public 10 rem/30 
year
1/3 rem 
average
5 rem/30 
year
170 mrem 
average
1971
Occupational 5 rem (15 
rem
maximum)
- -
Public 500 mrem 
(individual) 
170 mrem 
(average)
1977
Occupational - 50
mSv/year
50 mSv
Public 5 mSv/yr 
maximum
5 mSv 
maximum 
0.5 mSv 
average
1987
Occupational 50 mSv/yr 
Age X 10 
mSv
cumulative
guidance
50 mSv
Public 1 mSv/yr 
(continuous) 
: 5 mSv/yr 
(occasional)
1 mSv 
(continuous)
NIRL,
negligible 
individual 
risk level
l OpSv
/source
5 mSv 
(occasional)
'N is age in year
1 0
Table 1.1: Protection Recommendation [35]
Year Exposed
Population
NCRP ICRP
Limit Annual
Equivalent
Limit Annual
Equivalent
1990
Occupational Under consideration 20 mSv/yr 
over 5 
years
20 mSv
Public Under consideration I mSv/yr 
over 5yr
1 mSv
Table 1.2: The Latest Recommended Dose Limits- by ICRP
Application Dose Limits 
Occupational
Dose Limits 
Public
Effective Dose 20 mSv per year 
averaged over defined 
periods of 5 years^
1 mSv in a year'*
Annual equivalent dose in:
i. the lens o f the eyes 150 mSv 15 mSv
ii. the skim' 500 mSv 50 mSv
iii. the hands and feet 500 mSv -
- The limits apply to the sum of the relevant doses from external exposure in the 
specified period and the 50 year committed dose (to age 70 years for children) from 
intakes in the same period.
 ^ With the further provision that the effective dose should not exceed 50 mSv in any 
single year. Additional restrictions apply to the occupational exposiue of pregnant 
women.
In special circumstances, a higher value of effective dose could be allowed in a 
single year, provided that the average over 5 years does not exceed 1 mSv per year.
The limitation on the effective dose provides sufficient protection for the skin 
against stochastic effects. An additional limit is needed for localised exposures in 
order to prevent deterministic effects.
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At dose levels received occupationally, the induction of malignant disease (cancer) 
is likely to be the only significant stochastic effect, except in the developing embryo 
[38]. The prevention o f deterministic effects would be achieved by setting dose 
limits at sufficiently low values so that no threshold dose would be reached, even 
following exposure for the whole of a lifetime or for the total period of working 
life. Radiation levels near those found in the natural environment are considered to 
be very low level radiation exposure, generally known as a low level exposure 
(LLE) in which according to Booz and Feinendegen [39] the fraction of exposed 
cells in a cell population is very, much less than one. Arbitrary definitions of low, 
intermediate and high doses and dose rates by UNSCEAR are given as in table 1.4 
(refer UNSCEAR 1986 Report [40] and UNSCEAR 1993 Report).
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Table 1.3: Risk Coefficients adopted by ICRP 1990 compared with ICRP 1977.
Organ or Tissue ICRP 1977 ICRP 1990
Fatal Cancer 
(% Sv' )
Fatal Cancer 
(% Sv ')
Lethality (%) Loss of life
( y )
Bladder - 0.30 50 9.8
Bone Surface a o 5 0.05 70 15.0
Breast 0.25 020 50 18.2
Colon - 0.85 55 12.5
Liver - 0H5 95 15.0
Lung 0.20 0.85 95 13.5
Oesophagus - 030 95 11.5
Ovary - 0.10 70 16.8
Skin - &02 0.2 15.0
Stomach - 1.10 90 12.4
Thyroid 0.05 0.08 10 15.0
Red Bone Marrow 0.20 0.50 99 3R9
Remainder 0.50 0 3 0 71 13.7
SUB-TOTAL 1.25 5.0 - -
Hereditary defects 0.4* i.o:i: - 203
Total 1.65 <— 7.2(weighted)
1 All generations.
Table 1.4: Definition of low, intermediate and high dose and dose rates [UNSCEAR 
1993].
Doses Effective Dose Equivalent rates
Low 0.0 - 0.2 Gy below 0.05 mSv/m in
Intermediate 0.2 - 2.0 Gy 0.05 mSv/m in - 0.05 Sv/min
High 2.0 - 10.0 Gy above 0.05 Sv/min
Very or Ultra high above 10 Gy -
1.1.3. Biophysical Models and Induction of Radiation Effects
The basic unit o f the living organism is the cell. When a cell is irradiated with 
ionizing radiation, interactions will take place between the cell and radiation 
[41]. From the physical point o f view, radiation interaction with matter involves 
physical processes such as excitation, ionization, scattering and pair production.
However in a biological system the interactions [57] include physical, chemical, bio­
chemical and biological stages which cover the time range from 10''^ second to 
future generations (refer to figure 1.1). All energetic charged particles will lose 
kinetic energy to their environment through coulombic interactions of the charge on 
the moving particle with the charges on the electrons and nuclei o f the matter 
through which they are passing. Physical processes such as ionizations and 
excitations can occur in less than 10'’^  seconds. At low doses, most atoms are 
unaffected, while a small number are ionised or excited. In about 10*'" seconds, 
physico-chem ical process such as induction of free radicals, is expected to take 
place. In about 10"^  seconds, the free radicals are expected to move rapidly to some 
distance and are expected to be inactivated.
DNA damage can be inflicted by radiation through the following processes:
i. direct ionization ( or excitation); or
ii. indirect process, such as free radical induction, set in motion by the 
transfer of energy to the medium.
Effects of radiation on DNA include the following [127];
i. Single strand (ssb) or double strand breaks (dsb);
ii. Base lesions; and }Iiii. Cross-links between strands of DNA or between DNA and protein. 1
DNA physical structure, according to Alberts et-al [42] is shown schematically |
in figure 1.2. For various radiation-damaged end-points in eukaryotic cells which ]
1include cell reproductive death, chromosome aberrations and mutations, the DNA j
dsb has been implicated as the causative lesion [43][44]. Cell reproductive 
death is the death of cell when they attempt to divide and can no longer multiply.
Repair systems can identify and remove the lesions induced in DNA within a 
timescale o f tens of minutes. Mis-repair events can give rise to point mutations 
(error-prone), resulted from base sequence changes, or gene deletion or
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rearrangements. The important biological structures in the cell namely DNA, can be 
altered either directly by the disruption caused by ionization or indirectly by free 
radicals formed and set in motion by transfer of energy to the cell (medium). 
Damage may occur on the vital parts of the DNA or other important 
macromolecules of the cells. Direct effects due to radiation which may occur in 
DNA include double strand breaks (dsb) and single strand break (ssb) in the double 
stranded-DNA helical structure [45] [46]. Other effects such as a variety of 
recombinational changes as well as cross-links, alteration in sugar and base fractions, 
base substitution, deletion and so on, may also occur. Chromosome aberrations are 
also a result o f DNA damage. Such changes are believed to be precursor to 
oncogenic transformations [47] o f cells leading to the manifestation of cancers.
The effect of low level radiation on living systems (cells) can be derived and 
estimated by means o f Biophysical Models. Many different biophysical models of 
radiation action for various biological end-points have been proposed in the 
literature in an attempt to quantify radiation effects for radiological protection at low 
doses (refer to chapter two). Effects on human beings exposed to low level 
radiation, cannot be obtained directly mainly due to statistical limitation. Information 
or result is obtained from various epidemiological studies such as the atomic bomb 
survivors, ankylosing spondylitis patients undergoing radiation treatment and 
uranium miners, which involve exposures at higher level radiation. Effects at low 
level radiation are estimated by means of biophysical models which guide 
extrapolation the effect observed at higher level to lower level. Models are important 
at least for two purposes:
i. to interpret the damage mechanism and to extrapolate the effects obtained from 
laboratory experiments, normally performed at higher dose in animal studies, to 
human beings; and
ii. to extrapolate effect from high dose to lower dose near environmental levels and 
to interpret the damage mechanism.
1.1.4. Cancer Risk Coefficients (CRC)
Liniecki [48] defines the Cancer Risk Coefficients (CRC) as the number of 
cancer cases per 1000 man-Sv. CRC represents the risk o f cancer induction
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(stochastic effect) of an individual exposed to ionizing radiation [49]. ICRP 
Report 60 uses the term The Nominal Fatality Probability Coefficient to estimate 
cancer risks from exposure to radiation, which is defined as the estimated probability 
of a fatal cancer per unit effective dose. Cancer is the word used to include all 
forms of malignant disease. Malignant is understood to be descriptive of a tumour 
that invades and destroys the tissue in which it originates and which can spread to 
other sites in the body via the bloodstream and lymphatic system. Benign tumour 
does not produce harmful effects. Tumour is defined as any abnormal growth of 
tissue or swelling, in or on a part of the body [50]. Tumours may be benign or 
malignant.
In order to determine the induction of stochastic effects, ICRP has based its 
recommendations on cancer risk coefficients (CRC). The derivation o f CRC is based 
on risk models which incorporate a great deal of data obtained from:
i. the survivors of the atomic bomb attacks on Hiroshima and Nagasaki in 
August 1945:
ii. occupational accidental exposures in industries using ionizing radiation;
iii. medical exposures for therapeutic as well as for diagnostic purposes such
as ankylosing spondylitis patients; and
iv. occupationally exposed workers such as miners exposed to radon .
All the data are obtained from high dose and dose rate exposures. CRC represent the 
probabilities o f carcinogenesis in the exposed population and are deduced by means 
of extrapolation from higher dose and dose rate to lower dose and dose rate by 
using an appropriate risk projection model (chapter tlmee).
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Fig. 1.1: The temporal stages o f radiation action. The reaction steps represented by 
broken lines are affected by metabolic processes [57].
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1.1.5. Present Dosimetr} System for Radiological Protection
Before 1991 ICRP recommended the use of the quantity Dose Equivalent H. and 
Quality Factor Q,which are related by:
H= N.Q.D
where
N=1 for non-physical modifying factors;
Q is the quality factor of the radiation; and 
D is radiation dose.
Absorbed dose D, is used to mean the average dose over a tissue or organ.
Q values are quality weighting factors determined from the LET o f the radiation. 
Values are listed in table 1.5. However in 1991, ICRP [34] considered it necessary 
to introduce a few changes which include:
i. Radiation weighting factor Wr is used as a weighting factor, on the absorbed dose 
averaged over a tissue or organ which is related to the quality of radiation (refer to 
table 1.6 for Wr values). Wr is broadly compatible with Q, which is related to the 
quantity linear energy transfer (LET). Wr is introduced to make the physical 
weighting factor on the same format as the tissue weighting factor Wy. However Wr 
for a specified type and energy of radiation has been selected to be representative 
of values of the relative biological effectiveness of that radiation in inducing 
stochastic effects at low doses. The weighted dose is called Equivalent Dose, which 
is calculated according to the following formula;
Hy ~  E R WrI-^ T.R
where
H j is the equivalent dose (Sv) in tissue or organ T;
Wr is the radiation weighting factor; and
DyR is the absorbed dose averaged over the tissue or organ T due to 
radiation R;
ii. The term Dose Equivalent used in ICRP 26 [33] has been changed to Equivalent 
Dose in ICRP 60 [34];
iii. The equivalent dose is weighted by the tissue weighting factor Wj, to derive the 
effective dose E. w,- represents the relative contribution of that organ or tissue to the 
total detriment resulting from the whole body uniform irradiation (refer to table 1.7,
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for Wj values); and
iv. The effective dose E, is the sum of the weighted equivalent doses in all tissues 
and selected organs of the body and is given by expression:
E = E  r WtI-I j
where
W] is the weighting factor for tissue or organ T; and 
Hj is the equivalent dose in tissue or organ T.
2 0
Table 1.5: Q Relationship
in water (kev/pm) Q Quality Factor Radiations
3.5 (and less) 1 P, X, Y etc.
7 2
23 5
53 10 a
175 (and above) 20 thermal neutrons 
C, K  0
Table 1.6: Radiation weighting factors (Wr)
Type and energy range Radiation weighting factor,
W r
Photon all energies 1
Electrons and muons, all energies 1
Neutrons, energy < 1 0  keV 5
10 keV to 100 keV 10
>100 keV to 2 MeV 20
>2 MeV to 20 MeV 10
>20 MeV 5
Protons, other than recoil protons, energy > 2 MeV 5
Alpha particles, fission fragments, heavy nuclei 20
2 1
Table 1.7: Tissue weighting factors (wQ
Tissue or organ Tissue weighting factor, w,-
ICRP 60 ICRP 26
Gonads 0.2 0.25
Bone marrow (red) 0G2 0.12
Colon 0 0 2 n.a*
Lung 0.12 0.12
Stomach 0.12 n.a
Bladder 0.05 n.a
Breast 0.05 0.15
Liver 0.05 n.a
Oesophagus &05 n.a
Thyroid 0.05 0.03
Skin 0.01 n.a
Bone surface 0.01 0.03
Remainder 0.05 0.30
* n.a indicates not available
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1.2. Statement of Problems.
1.2.1. Problems with Biophysical Models of Radiation Action
The fundamental understanding o f radiation interaction with a biological system to 
provide interpretations of the radiation effects, which can be used to predict effects 
at low doses, has not firmly been established. Radiation effects at low levels of 
radiation cannot be directly measured, mainly due to statistical problems. Therefore 
to cari7 out the assessment o f risk o f radiation effect from low doses, a valid 
biophysical model of radiation action is required. There are many biophysical 
models in the literature most o f which are meant to be applicable to a specific 
biological end-point. None o f the models are entirely satisfactory. Therefore their 
ability to predict radiation effects at low doses has to be evaluated.
1.2.2. Problems in Determining CRC
A significant excess for number of cancers occurs in the absorbed dose range from
0.2 to 0.5 Gy is reported by Liniecki [48]. Determination of CRC is derived by 
means of extrapolation to lower dose, based on certain risk projection models, by 
utilising all data available up to a certain date. Following the carcinogenic effects 
of radiation with time after exposure is known as risk projection, which includes 
extrapolating (projecting) beyond our actual observed experience. The CRC 
evaluation is subject to review, mainly due to the existence o f new or more recent 
epidemiological and experimental data as well as to new developments in 
radiological protection as a whole.
1.2.3. Problems with the Currently Accepted Dosimetry System.
In the present dosimetry system the existing problems include the following:
1. Radiation quantity and quality are characterised in terms of absorbed dose and 
linear energy transfer (LET). Radiation effectiveness is expressed in terms of 
relative biological effectiveness (RBE). In mammalian systems RBE increases with 
respect to LET, reaches a maximum value, then decreases. It is not a single valued 
relationship. It is acknowledged that the LET concept is limited in its application 
and cannot provide a reliable description of a radiation field (refer to page 5). In 
Radiological Protection the Quality Factor Q, which is a conservative estimate
Zj
arbitrarily related to RBE, is used to indicate radiation quality in order to derive 
dose equivalent from the formula;
H= N .Q.D 
where N=1 for other modifying factors;
Q is quality factor; and 
D is radiation dose, 
e.g. The Q for fast neutrons is equal to 20 [51].
In ICRP 60 the Radiation Weighting Factor, Wr is used to derive equivalent dose 
from the equation;
H j  =  E W r D -j- R ;
ii. For the internal dosimetry o f Auger-emitting electron capture radionuclides, there 
are inherent problems in the applications of the concepts of absorbed dose [52]. 
Radionuclides which decay by electron capture and accompanied by Auger electron 
cascades or (3 emission, when incorporated into the molecular structure or 
mammalian cell nuclei, can cause damage which approaches those for heavy 
particles [53]. This fact is consistent with the interpretation that electron damage 
is caused predominantly at the end o f the tracks and incorporation of these 
radionuclides simply ensures that the slowing down fluence o f low energy tracks, 
interacts in the vicinity of the radiosensitive sites. The radiation hazards due to 
incorporation of the radionuclides is not assessable by conventional dosimetry 
mainly due to two main reasons namely (a) the complex decay scheme of the 
radionuclides. For example a single decay of ' “^ I can result in the emission of up to 
56 low energy Auger electrons; and (b) Excessive damage beyond that predicted by 
conventional dosimetry if the radionuclide is incorporated into a sensitive site within 
the cell structure e.g. the DNA molecule;
iii. Dosimetry of alpha particles [54] ingested tlnough radioactive aerosols 
cannot be satisfactorily determined;
iv. The quality factor Q, assigned to neutrons having energy in the range of 100 keV 
to a few MeV is inconsistent with that allocated to heavier ions on the basis of 
observed effects in mammalian cells; and
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V. The present system cannot describe the phenomena of reverse dose rate effects 
as it predicts smaller effects at low dose rates (due to sub-repair) whereas the 
opposite (enlianced effect) is sometimes observed.
A new system o f dosimetry in terms of Absolute Biological Effectiveness (ABE), 
is proposed here. The degree of success in overcoming many of the current 
problems will be explored in chapter four. The concept put forward in the new 
system is not the energy absorbed per unit mass but the frequency and spatial 
correlation o f track interactions with the DNA segments at risk, in the irradiated 
system.
1.3. Objectives and Content
The main objectives o f the research described here are;
a. To carry out a detailed evaluation and critical appraisal o f the main
biophysical models of radiation action with particular reference to the 
primary track model under development at St. Andrews’ University;
b. To re-assess and correlate cancer risk coefficients, utilising all information
available at the present time, in terms of the currently accepted model and 
for the St. Andrews’ primary track model of radiation damage; and
c. To propose a new system o f dosimetry, in terms o f Absolute Biological
Effectiveness (ABE).
Detailed aspects o f the work are discussed in the chapters enlisted. In chapter two, 
five main biophysical models of radiation action will be evaluated and critically 
appraised and the results will be presented. In chapter three the available information 
on cancer risk coefficients will be presented. The currently accepted system of 
dosimetry will be explained. The link between the cancer risk coefficient and dose 
limitation will be indicated. The deficiencies of current system are indicated which 
lead to the proposed new system of dosimetry. In chapter four, the principle and 
derivation o f quantities used in the proposed new system will be described and 
discussed. In chapter five the conclusions, discussion and recommendations for 
future work will be presented.
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1.4. Scope of the project
The topic of this project is An Improved System of Damage Limitation for 
Better Risk Control in Radiological Protection Near Environmental Level.
Argument is presented to justify for an alternative system to the present system of 
dosimetry. The new system utilises biophysical quantities which can specify the 
absolute biological effect o f the radiation field. In this initial investigation, the study 
is constrained to environmental levels of radiation where single track effects prevail.
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CHAPTER TWO
BIOPHYSICAL MODELS, INTERPRETATION AND EVALUATION
2.1. General
A biophysical model of radiation damage is an analytical tool, based on an 
understanding o f radiation interaction with matter and of the biology o f the cell. A 
good model should perm it interpretation of the mechanism of radiation action and 
should be in a mathematical formalism which will enable extrapolation of data 
measured at high doses to predict effects at low doses. The major aim o f 
developing a good model is to predict radiation effect at low doses from 
observations at higher doses. There are many biophysical models found and reported 
in the literature, however only five main biophysical models will be appraised and 
evaluated in this chapter.
The mammalian cell is considered as the basic unit of the biological system. The 
cell consists among other things, of a cytoplasm and the cell nucleus. The cell 
nucleus has a complex structure covered by a nuclear membrane and it contains 
deoxyribonucleic acid (DNA) and other components [55]. DNA is a key 
component (refer to figure 1.2). The time range between the inadiation and the 
manifestation o f effects, varies from 10*'^  second to next generations (refer to figure 
1.1). In biophysical modelling, there has been some convergence o f ideas on a few 
points such as the nature of the biological target, the DNA in the cell nucleus; the 
nature o f important damage, DNA double strand break (dsb); and the requirement 
to create a crucial lesion. However there is no concession yet on the mathematical 
form o f the dose effect and on the nature of the crucial lesion.
The double strand break (dsb), is now considered to be the crucial lesion. It could 
possibly occur due to intra-track o f one radiation track, as well as inter-track of two 
radiation tracks. The single strand break (ssb) is considered only as a sub-effective 
lesion which is easily repaired by the available repair mechanism. Experimental 
evidence shows that the probability of the final radiation effect depends on a number 
of modifying factors such as repair, repopulation and cell cycle stage [46].
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The main objectives in modelling of radiation action, include the following:
i. to assess the risk of biological effect from low doses of radiation.
ii. to link between physics and biology in studying the radiation effect 
in a biological system:
hi. to investigate basic mechanisms o f radiation action; and
iv. to suggest new experiments to test hypotheses predicted by the
biophysical model in various applications such as radiation therapy 
and assessment of risk.
In the assessment of biological effect from low doses of radiation, data are only 
readily available from people exposed to larger doses such as for medical reasons 
or atomic bomb survivors. Statistical limitation prevents us from obtaining actual 
experimental data of radiation effects at lower doses and dose rates, where people 
and radiation workers are exposed. Assessment of biological effect at lower doses 
and dose rates, which is very important for radiation protection, can be extrapolated 
from higher doses and dose rates by means of a biophysical model of radiation 
action.
The study of cell proliferative death, the dependence of survival on radiation 
quantity and quality, remains the principle tool for researchers in radiation biology. 
However the shortcomings of this study applicable to mammalian cells are, for 
example, a wide range of cell sensitivity and a limited division potential of the cell. 
These, to some extent, limits our ability to interpret and understand entirely the 
action of radiation at the organismic level. Clonogenic survival is defined as the 
ability of a single cell to proliferate reproductively to form a colony of cells. This 
method o f colony counting has been widely used for clonogenic survival studies on 
bacteria, virus, yeast and other lower organisms. However it is only since the late 
1950s that the method, pioneered by Puck and Marcus [56] has been applied to 
mammalian cell lines. Among the common mammalian cell lines (mostly are 
immortal or transformed cells) are HeLa cells, derived from a human cervical 
cancer; V79 cells, derived from hamster lung; CHO cells, derived from hamster 
ovary; 9L cells, derived from rat gliosarcoma; and TI cells, derived from a human 
kidney. Due to recent developments in cell culturing methods, it is now possible to
28
undertake survival analysis in vitro from fresh explants of normal and tumour tissue, 
as well as non-immortal lines that divide for only a few tens o f generations. The 
criterion o f clonogenic survivability is usually taken as the production of 50 or more 
cells at the minimum after 10 to 20 days from seeding.
2.2. General Types of Biophysical Models
2.2.1. Hit and Target Model
In this model [57], a biological cell or system is assumed to consist of targets 
which must be hit in order to inactivate the cell or the system. The probability of 
inactivation generally is assumed to follow the Poisson statistical law. Depending 
on the assumed number of hits and targets involved, the model can be further 
categorized into single hit single target, single hit multi-target, multi-hit single target 
and multi-hit multi-target.
2.2.1.1. Single Hit Single Target
In this particular case, one hit is required to inactivate the target and the cell is 
assumed to have one target. The survival fraction F , ,, of a cell population irradiated 
with radiation is given by F, exp (-h), where h is the mean number of hits per 
target.
2.2.1.2. Single Hit Multi-Target
For single hit multi-target action the cell is assumed to consist o f many targets and 
a single hit is required to inactivate a target. However many targets have to be 
inactivated in order to inactivate the cell. Survival fraction for single hit and multi­
target where m is the number of targets, is given by F, ,,= [!-(l-exp(-h))'"].
2.2.1.3. Multi-Hit Multi-Target
For multi-hit (n) and multi-target (m) the cell is assumed to consist o f many targets 
and each target requires several hits to inactivate the cell. The survival fraction of 
the irradiated cell population is given by: F^^^ 1-(1-F„
n - l
where  ^=exp i - h )  . 
r^ = o r  !
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n is the number o f hits;
m is the number of targets; and
h is the mean number of hits per target.
2.2.2. Two Component Models
In two component models, the radiation action is divided into two components 
namely low and high linear energy transfer (LET). For the liigh LET component, 
the response is assumed to follow single hit, single target characteristics. This is 
considered to be an irreversible mechanism. For the low LET component, the 
response is expected to follow single hit, multi-target characteristics. It is considered 
to be a reversible mechanism which could be influenced by various factors such as 
repair and oxygenation. Examples o f two component models are models by Todd 
[58], Wideroe [59] and Katz (see Section 2.4.3).
2.2.3. Dual Radiation Action Model
In the dual radiation action model, two separate modes o f radiation action are 
assumed to take place to produce primary lesions namely;
i. linear component of local energy concentration or dose;
It is due to intra-track action, which is attributable to the lesions produced 
along the individual particle track; and
ii. quadratic component o f dose;
It is due to inter-track action, which is attributable to the lesions produced 
by means o f separate charged particle tracks.
The overall effect o f radiation in this model is assumed to be dependent on linear 
dose and quadratic dose. Examples of dual radiation action model are models by 
Rossi-Kellerer [72], Neary [60] and Chadwick-Leenhouts [71].
2.3. Review of Biophysical Modelling
At the beginning (i.e. contemporary with Lea [62]), the central focus on biophysical 
modelling was on hit and target theory [61]. Then it was followed by dual 
radiation action (linear quadratic), two component and microdosimetric concepts. 
Recent developments in biophysical modelling deal with nanometre dimensions 
which are of the same order of magnitude as the dimensions of a DNA double
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stranded segment, and based on the hypothesis that the DNA double strand is the 
critical target for radiation effect. In the future it is expected that the challenge is 
to determine, from molecular biology, how many affected targets i.e. DNA dsb and 
indeed, possibly the type o f dsb, which relates directly to the effects.
Models of radiation action, proposed and formulated for various biological end­
points by different authors in the literature, employ different approaches and 
concepts. Some authors extend a combination of concepts proposed by earlier 
authors. Radiation is believed to incur in localised damage in sub-cellular sites. Such 
damage sites are sometimes called lesions or sub-lesions, depending on their 
categorization, in the critical site o f the irradiated cells. Various steps in the 
supposedly multi-stage process, starting from the physical process, through 
chemistry, biochemistry and biological processes, are systematically analyzed and 
modelled and are eventually formulated into a mathematical presentation. The 
processes which have been taken into account in the literature are;
i. Lesions or sub-lesions, their rate o f formation and total (integral) lesions;
ii. Interaction between lesions or sub-lesions induced by inter-track and intra­
track action; and
hi. Removal or repair o f lesions or sub-lesions mainly due to repair 
processes or cell division.
Among the first models reported in the literature is the hit and target model by Lea 
[62]. Conceptually a cell or the sensitive part of the cell, consists of a target (or 
targets) which must be hit by radiation before the cell is inactivated. The number 
o f hits for each target can be single (single-hit) or multiple (multi-hits). Generic 
variations of this model include single-hit single-target, single-hit multi-target, multi­
hit multi-target and multi-hit, single-target versions.
Lesion formation and its removal or repair has also been used as a basis for 
modelling o f radiation damage. For example the repair mis-repair model (RMR) by 
Tobias et-al [82], lethal and potentially lethal model by Curtis [78] and the 
cybernetic model by Kappos et-al [63]. The saturable model by Goodhead 
[64] also applies the same concept.
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Barendsen [65] [66] proposed that the surviving fraction (SF) of mammalian 
cells can be described adequately by a linear quadratic function o f the dose 
represented by SF=exp-(aD+pD”). The parameters a  and P can be interpreted as 
representing induction o f damage from single track and from two independent tracks 
of ionising particles. Curtis [67] derived his lethal and potentially lethal (LPL) 
model based on two types of lesions; reparable and irreparable, which are linked to 
DNA dsb o f different severity. Leenhouts and Chadwick [68] proposed, from 
a molecular theory o f radiation biology, that the dose response for the induction of 
DNA dsb is linear quadratic. The linear coefficient is dependent on the radiation 
type and the quadratic coefficient is dependent on the dose rate. The model predicts 
that there will be an interaction between two radiations when applied together or in 
immediate sequence. Zaider [69] elaborated on the concept of dual radiation 
action (DRA) in biophysical modelling. DRA refers to mechanisms of radiation 
effects which can be described in terms o f the pairwise interaction of sub-lesions 
produced from cellular alterations. Examples are the formation o f DNA dsb from 
two single strand breaks (ssb) or Exchange-type (ET) chromosome aberrations from 
simple chromosome breaks (CB).
Goodhead [70] has proposed that the models of radiation action may be broadly 
divided into two categories of model: phenomenological and mechanistic, although 
there is often overlap. Phenomenological models seek a parameterized mathematical 
description which fits the range of data of interest without the specific need to be 
related to the actual physical mechanism of radiation action. Mechanistic models 
seek a conceptual, parameterized description based on realistic assumptions related 
to basic mechanisms o f radiation action.
The structure o f charged particle tracks has also been intimately related to 
modelling. Katz [96] for example derived his two component model. In this thesis 
it is called the ’Cellular Track Structure’ model, based on the track structure of 
heavy ions and the effects of the delta-ray distribution in dose. The model has 
generalised factors as he applied it to radiation detectors, nuclear emulsion and 
cellular radiobiology. Watt et-al [114] developed a phenomenological model based
on observation o f the dependence o f effect cross-sections on the track core. In this 
thesis it is called the ’Track Core’ (TC) model. It includes direct and indirect effects 
(radical) along single tracks. Another approach is based on lesions or sub-lesions 
interaction such as the molecular model by Chadwick and Leenhouts [71], and 
its dual radiation action by Rossi and Kellerer [72] [73] .
Paretzke [74] classifies all radiation damage models into two namely Dosimetric 
and Track Related Biophysical Models. Dosimetric models basically incorporate 
explanations from dosimetric point of views such as macroscopic dose, microscopic 
dose, linear energy ti'ansfer, degradation spectrum and radial dose. Whereas track 
related models incorporate explanations based on various interaction patterns along 
the track structure o f radiation in the medium. Examples are nearest-neighbour 
analysis, activation-centred neighbourhood analysis, track entities, cluster formation 
and cluster association.
The microdosimetry approach, which basically takes the geometrical and spatial 
distribution o f energy dissipation into consideration to some extent, has played its 
role in the modelling of radiation damage. Bond and Varma's hit-size effectiveness 
(HSE) model [107] applies microdosimetry concepts to predict pink mutations in 
tradescantia. Although it has had only limited success, it offers a different approach 
to biophysical modelling and is one o f the few which specifically exploits 
microdosimetry per se.
Varma et-al [75] have proposed to classify models into two basic categories 
namely mechanistic models and phenomenological of empirical models. Models such 
as dual radiation action by Kellerer and Rossi; more generalised theory o f dual 
radiation action; Goodhead’s threshold model; Curtis LPL damage model; and 
Tobias’ repair mis-repair model (RMR), are examples of mechanistic models. 
Examples of phenomenological o f empirical models are gamma ray theory of RBE 
of Katz and hit size effectiveness approach (HSEA) o f Bond and Varma. In 
mechanistic models a certain mode of interaction of radiation with biological 
systems is postulated, on the basis o f which a biophysical model for prediction of 
biological effects is developed. The number of identifiable parameters to which a
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physical significance can be attached must be minimum. However if  the number of 
the parameters becomes too large, these approaches lose their significance as being 
mechanistic and become difficult to validate statistically. Phenomenological models 
which utilize sets o f existing data on biological end-points in one or more systems, 
are used to develop a methodology by which a predictive response function may be 
obtained.
In the DSB Model by Ostashevsky [76], DNA double strand breaks (dsb) are 
considered as the only important radiation induced lesions, and the recovery kinetics 
for split dose, multi-fractionated and continuous irradiations are considered with the 
assumption that a cooperative type of dsb repair takes place. In cooperative repair 
all dsb in the same DNA molecule are. repaired simultaneously whereas in non- 
cooperative repair each dsb is repaired independently. For the latter the repair 
process may take a different mean time.
Hall [77] noted the importance of the premature chromosome condensation 
(PCC) technique which can be used to assess the number of initial chromosome 
breaks without waiting until the next mitosis of the cell. The data may be used by 
the modellers to establish a relationship between the initial strand breaks and cell 
lethality.
In St. Andrews, the basic approach used in model development was first to extract 
effect cross-section from a wide range of available published survival data for 
inactivation and chromosome aberrations, for many different radiation types and to 
explore their correlation against various physical track sti'ucture parameters. By this 
means the importance of the mean free path for primary ionisation emerged and the 
role o f the 2 nm spacing in the DNA was identified. Thus the DNA dsb was 
identified as tlie fundamentally critical lesion for single tracks. Its induction 
efficiency is determined by X. Will the approaches and concepts used in modelling 
achieve the desired goals? Current thinking is that the process which gives rise to 
the various biological end points such as cellular inactivation, cell mutation, 
chi'omosome aberration, neoplastic transformation etc, is a multi-stage process 
initiated by the formation of lesions in the DNA and ameliorated by possible repair
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mechanisms (enzymatic) operating in the cell. The probability o f the subsequent 
biological end-point occurring may be determined by chance.
2.4. Evaluation and Critical Appraisal of Models
In this work the following five main biophysical models of radiation action will be 
evaluated in more detail and critically appraised;
i. Lethal and Potentially Lethal (LPL) Model (Curtis);
ii. Pairwise Lesion Interaction (PLl) Model (Harder);
iii. Cellular Track Structure (CTS) Model (Katz);
iv. Hit Size Effectiveness (HSE) Model (Bond and Varma); and
V . Track Core (TC) Model (Watt).
Evaluation and critical appraisal of a biophysical model, should be linked to the 
expected performance of a particular biophysical model. As a prerequisite, the model 
should be identified and be explained in brief. After understanding the basic 
principle and its survival equation, an overall appraisal on a particular model is 
carried out. If  available, the testing o f the model by the author is included in brief. 
A comparison o f the models will be shown to indicate similarities and differences 
in the results or prediction of the models. The following criteria if applicable, are 
used in the test and comparison of model;
i. Initial slope;
ii. Final slope;
iii. Number of parameters and their meaning; and
iv. Basis of the model.
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2.4.1. Lethal and Potentially Lethal (LPL) Model (Curtis)
2.4.1.1. Introduction
The Lethal and Potentially Lethal Damage (LPL) model by Curtis [78] identifies 
the main types o f radiation damage as lethal (L) and potentially lethal (PL) lesions. 
This model can be described under the heading o f lesion interaction [79] [80] 
and the model is derived by merging certain features o f the cybernetic model [63] 
and the repair misrepair model (RMR) [81]. L lesions cannot be repaired 
correctly whereas a potentially lethal (PL) lesion can be repaired correctly (viable). 
PL lesion can become lethal by interacting with another PL lesion (binary misrepair) 
or PL lesion can be fixed to become a L lesion. The rate o f production o f L lesions 
and their repair rates are taken into consideration in deducing the mathematical 
expression for this model: In deriving the survival curve, a Poisson distribution is 
assumed to apply and it is related with the number o f PL and L lesions.
2.4.1.2. Basic principles
The LPL model by Curtis, combines various concepts used in biophysical modelling 
o f radiation action which includes lesion interaction, irreparable lesions caused by 
single tracks, linear lesion fixation, lesion repair and binary mis-repair. LPL model 
identifies the lesions as DNA double strand breaks with different severity, which can 
be divided into two [82], namely;
i. Potentially Lethal Lesion (PL)
PL lesion is a potentially lethal lesion which is less severe and can be caused 
by less energy deposited locally. It has the possibility o f being correctly 
repaired presumably by cellular enzymatic process. A PL lesion can interact 
with another PL lesion to form a lethal lesion L and the interaction is called 
binary misrepair. A PL lesion may also be fixed to become a lethal lesion 
for example by the cell moving into or through some critical phase of its 
cycle. Curtis calls the process ’linear fixation’.
ii. Lethal Lesion (L)
L lesions are lethal and considered more severe than PL lesions. To produce 
an L lesion, a larger deposition of energy is required, locally. This type of 
lesion cannot be repaired correctly (irreparable).
36
Two processes compete for depletion o f the PL lesions namely correct repair process 
and mis-repair process. PL lesions can also be fixed to become L lesions by means 
of a fixation process. The role of PL repair rate and repair time are important in this 
model which are significant in the survival equation [83][84][85].
There are repair provisions for lethal (L) and PL lesions, namely;
a. for the production rate o f PL lesions;
d t
where jj = the dose rate
r]p.D = PL lesion production rate
^PL^pL = due to repair
^ 2 prd\pL -  due to the production of mis-repaired lesions (loss)
b. The rate of change of PL lesions is;
^ PI, ( ^ ~ Pf, (  ^)dr]pp{t) _ _  —2d t
where G p ^ r|p ^ ( t )  is due to repair of PL lesion; and
^ 2 pt'^pl is due to the mis-repaired lesions.
2.4.1.3. Survival equation
For cell survival (SF),
5 F = e x p  [ -  ir\pD+r\ppD) + € I n  [ i  + y  [ 1 - e x p  ] ] ]
with s is equal to the ratio between rate per unit time of correct repair and rate per
unit time o f binary misrepair for PL lesions, given by: e -PL
■2FL
where
is the rate of production o f lethal lesion per unit Absorbed Dose;
Ppi is the rate of production o f potentially lethal lesions per unit Absorbed Dose; 
D is the Absorbed Dose;
Spi is the rate per unit time of correct repair for potentially lethal lesions;
S2PL is the rate per unit time o f binary misrepair for potentially lethal lesions; and
tr is the available repair time i.e. t =t-(irradiation time T).
2.4.1.4. Model Appraisal
Dose is used to quantify radiation in this model. The basis for Curtis’ model is the 
interaction between lesions and there are two categories of lesion introduced in the 
model to distinguish between reparable and irreparable lesions. Although a specific 
radiosensitive site is not specified, it is implicit that the lesions are in the DNA 
molecule. Different degrees of severity are used to indicate the type of damage by 
the radiation action such as single strand break or double strand break. Inter-track 
effects (binary misrepair) as well as intra-track (irreparable) effects are taken into 
account.
2.4.1.5. Testing Curtis’ model
Curtis tested his model [84], by using data listed in table 2.1, namely Ne ions, alpha 
particles at different LET and x-rays data from:
i. Barendsen et-al 1960 for kidney cells of human origin [86];
ii. Raju and Jett 1974 for human kidney cells (T-1) [87]; and
iii. Ngo et-al 1981 for asynclironous Chinese Hamster V79 cells [88].
The results are plotted (refer to figure 2.1) against the experimental data and are 
satisfactory.
Table 2.1: The parameters used in testing LPL (Curtis) Model.
Parameters Barendsen Raju and Jett Ngo et-al
Aerobic Hypoxic
Particles a a a neon ions
LET (keV/pm) 170 210 210 183
z*-/p- 3052 3980 3980 1549
a ,  (pm-) 45 27 27 45
FpL 0.1 0.1 0.1 0.1
11 12 12 12 12
K 2.5E-04 2.5E-04 1.7E-04 2.5E-04
X-rays radiation
nL(Gy') 0.2531 0.0767 0.0402 0.1313
ppL(Gy‘) 0.8792 1.0 0.4177 0.7711
8 10 10 10 10
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Fig. 2.1: Comparison o f experimental cell survival data with theoretical predictions 
o f LPL model by Curtis. Panel a; is using Barendsen et-al data, panel b; is using 
Raju and Jett data, and panel c; is using Ngo et-al data.
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2.4.2. Pairwise Lesion Interaction (FLI) Model (Harder)
2.4.2.1. Introduction
The Pairwise Lesion Interaction Model (PLI) by Harder [89] is based on the 
concept originated from Lea’s model [62], namely that lesions can interact pairwise 
(i.e. interaction can occur between two lesions). Interaction between primary lesions 
(i.e. molecular lesions not yet fully repaired and temporarily able to interact 
pairwise) formed by radiation, is assumed to occur in contact regions, namely the 
regions with contact between different chromatin fibres or between sections of the 
same fibres. Among the endpoints considered under the PLI model are exchange- 
type cliromosomes aberration and reproductive cell death (cellular survival). The 
dose-mean restricted linear energy transfer with cut-off energy A=100 eV (L |oo.d) is 
used as the fundamental track structure parameter o f the charged particle. According 
to Harder [90], it has been possible to demonstrate a lineai* dependence o f yield 
coefficient a  (per Gy) upon L,oo.d ioi* the production of dicentric cluomosome 
aberrations in human lymphocytes, for survival from reproductive death of V 79 
cells, and other cytological end-points as well.
2.4.2.2. Basic principles
In the nuclear chiomatin, it is assumed that there are some regions with contact 
between different chromatin fibres or between sections of the same fibre, which are 
in temporary existence, due to its conformation changes and thermal movement 
(refer to figure 2.2). Radiation-induced primary lesions such as molecular lesions 
which have not yet been fully repaired, are formed in the contact (interaction) 
regions as well as in other part o f the nuclear chromatin. In this model, the primary 
lesions in the contact region, are assumed to be able to interact pairwise.
Suppose that there are n reactive lesions in a contact region, there will be
pairwise contacts per unit time, where a is the proportionality factor [91]. The 
probability per unit time o f pairwise interaction in a contact point is given by
a .  k . \  , where k is the interaction efficiency. For an irradiated cell nucleus.
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the mean interaction rate at time t is given by: e{t)=aic/^J , where
Suppose that the passage o f an ionizing particle contributes to the region a stochastic 
number o f lesions, o f which n, are reactive at time t. For passage o f u particles, the
cumulants are , and ■
So that n ' ^ - n - v  { n l - n ^ - n ^ )  +v^
If  u follows a Poisson distribution with —= = + i  , then averaging
over I) and substituting into e(t), the mean interaction rate at time t for each contact 
region in a cell nucleus is given by: e ( t) [rn +m^ .
However m is proportional to absorbed dose D. So s(t) exhibits a linear quadratic 
dose dependence. The first term is due to intra-track and the second term, due to 
inter-track interactions. Harder derived mathematically the expression for s(t) and
obtained the following result: e ( t) [ ( Af  - i )  cD+c^D^]2 7
where p(t-x) is the probability for an ionization, produced at time t, to result in a 
primary lesion at time t; 
m is proportional to absorbed dose D; 
i is the number of ionizations per particle traversal; and
-1 is the microdosimetric factor.
The result shows the linear-quadratic dose dependence regularly observed in 
chi'omosome aberration induction experiments.
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The contact region has nanometre dimensions in Harder model and can be simulated 
in microdosimetry. The linear term in s(t) is proportional to the microdosimetric
factor ^ - 1  . Harder et-al [91] have studied the properties o f this factor forT
interaction regions o f nanometre dimensions, for which a linear dependence of
-4 - -1 on Ljood has been established as shown in figure 2.3. The experimental2
result on the L,oo.d dependence of yield coefficient a  (Gy ') for dicentric 
chromosomes in human lymphocytes, as shown in figure 2.4, has strongly supported 
the expression for s(t), which is mathematically derived.
The complete expression for s(t) obtained by Harder is given as follows:
C t
€ ( t )  = [ ( 4=- - 1 )  ( t - x)  cD{x)  d x +  ( J pi  t - z )  cL>(z) dzp]
^  o  o
where c is the factor for region size;
p is the factor for repair kinetics: and
jj is the dose rate in time dx.
In the PLI model, the important number is the average production rate of pairwise 
lesion interaction products per cell, r(t), which is the product o f e(t) and the number 
N o f the interaction regions, i.e. r(t)=N. s(t). The pairwise lesion interaction is in 
competition with lesion repair. The amount of intra-track interaction (i.e. 
proportional to dose) between radiation-induced primary lesions in chromatin, will 
depend on the balance between interaction distance and particle track structure (LET 
effect). The amount of inter-track interaction (i.e. proportional to dose squared) 
reflects the balance between the lifetime of repairable lesions and their production 
rate (i.e. effects of fractionation and protraction).
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2.4.23. Survival equation
The survival fraction (SF) according to this model is given by:
S F = e x p  [- {Ln n) ( e x p  ( - 1  ) ]
O' 9
where
n is the extrapolation number; and
Dq is the shoulder dose.
2.4.2.4. Model Appraisal
L,oo,d is used as the physical parameter for radiation in this model. The PLI model 
by Harder utilizes ’pairwise o f lesion interaction’ as a basis to derive the model. The 
model takes care o f the following:
i. Intra-track interaction (i.e. proportional to dose) in the contact regions in 
nanometre region [92];
ii. Inter-track interaction which is proportional to dose squared in the nanometre 
region;
iii. Repair process which competes with the lesion interaction [93]; and
iv. The 0-rays exceeding 100 eV by taking L ^ o d as the fundamental track structure 
parameter.
However from the equation for the survival curve (SF) for the model, given by: 
FF=exp [- (Lzz zz) (exp ( - — ) + — -1) ] ;
i. It is common that not all survival curves possess extrapolation number n; and
ii. Not all survival curves have especially for high LET radiation.
2.4.2.5. Testing Harder s model
Harder has used data for the production of dicentric chromosome aberrations in 
human lymphocytes, and data from the reproductive death of V 79 cells, to test his 
model [94].
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Fig. 2.2: Pairwise Lesion Interaction in Chromatin (scheme)
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46
0.8
0.6die
0 , 4
0.2
4 0  k e V / f j .m  6 0200
o x: C Î . 5  kV
o x: AI 3  kV
Û x: A g  5  kV
o x: Cr  10  kV
0 x: Mo 3 0  kV
o x: W 1 5 0  k V
X 5 . 7  k e V
♦ §■ 0 . 7  M e V
V r ® ° C o  LI
A 7 ; ® ° C o  D o
X e : 2 . 9  M e V
+ e : 13  M e V
# n: fi 0 . 7  M eV
A n: fi 0 . 9  M e V
■ n: 2.1  MeV
1 00 ,0
Fig. 2.4: Restricted LET dependence o f yield coefficient a  for dicentric 
chromosomes in human lymphocytes.
47
2.4.3. Cellular Track Structure (CTS) Model (Katz)
2.4.3.1. Introduction
The model by Katz [95] for cellular survival after heavy ion irradiation, is based 
on his track structure model developed earlier for various ionizing radiation 
detectors which include observable tracks in nuclear emulsion, dry enzyme and 
viruses, scintillation counters, TLD and Fricke dosimeter. Katz claims the model is 
applicable to gamma and heavy ion irradiations. Inactivation o f cells by a beam of 
particles is assumed to proceed independently by two modes o f damage namely ion- 
kill mode with exponential survival characteristic, and gamma-kill mode (multi­
target, single hit) with sigmoid survival characteristic. Four parameters are required 
in the model to represent biological cells, under a specific ambient condition: a 
critical dose E^, the target multiplicity m to describe their response to y rays, and 
two additional parameters ic and to describe their response to heavy ions. The 
model is sometimes called a Two Component Model due to the fact that radiation 
can be considered to consist o f low (gamma kill) and high LET (ion kill) 
components.
2.4.3.2. Basic Principle
In principle Katz deduces the mean number o f hits due to 5-rays, per target located 
in a thin cylindrical shell with thickness dt at distance t from the ion path. The 5- 
rays are assumed to be emitted at right angles to the ion path and to have a simple 
range energy relationship given by t=KT, where t is the range and T is its kinetic 
energy. The fraction of targets inactivated in the thin shell is determined by using 
the Poisson probability laws of conventional target theory. In the cellular track 
model by Katz, zVp“ is used as an important quality parameter which is proportional 
to the yield o f delta rays per unit distance along a fast ion track. The model 
distinguishes between the track width regime and the grain count regime 
[96] [97]. The grain count regime is where the inactivation occurs randomly 
along the particle’s path, like ’beads on a string’. The cells within the gap i.e. 
between the activated cells, may be damaged sub-lethally because of fluctuations in 
the production of 5-rays. Cells which are not killed in the ion-kill mode by the 
passage of a single ion, may be damaged further and killed by 5-rays from the 
adjacent ion at high fluence i.e. inter-track effect. 5-rays are only able to inactivate
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a fraction (P), of the cells intersected by the ion. The range and number of 5-rays 
are limited and cannot activate remote targets giving the appearance o f 'hairy rope’ 
as in the track width regime. The result in the grain count regime is that the track 
has the appearance of a random string o f beads. P is the fraction of cells that are 
killed (inactivated) by ion-kill. P also represents the fraction of energy deposited by 
the ion that contributes to killing in the ion-kill mode. (1-P) represents the fraction 
o f cells that are killed in the gamma-kill mode and also represents the fraction of 
energy deposited in the gamma-kill mode.
The track width regime is where the inactivations are distributed like a ’hairy rope’. 
For high Z (nuclear charge), 5-rays that are produced, have sufficient number and 
range to activate remote target giving the appearance of ’a hairy rope’. In the track 
width regime P is greater than 0.95 and as a/<j„ increases, the dose deposited in 
gamma-kill mode is approximated as zero. The transition from the grain count to 
the track width regime takes place in a plateau, in the neighbourhood o f z*^/kP" of 
about 4, which corresponds to cr=1.47ia/. K(or a,J represents the size o f internal 
cellular targets. At lower values is the grain count regime, and at higher values is 
the track width regime. After the plateau, the cross-section rises in the track width 
regime then falls down in the thindown region. Thindown is due to a kinematic limit 
on the energy and hence the range o f 5-rays produced, which occur at the end o f the 
track. The effective charge z* is given by: z*=Z[l-exp-125pZ‘“''^ ]
There are two modes of inactivation in the cell survival model by Katz, namely ion 
kill mode and gamma kill mode. ’Ion-kill’ is defined as a response produced by the 
passage of a single ion tlu'ough or adjacent to a target. It fully describes a low 
fluence irradiation where it is unlikely that 5-rays from different ions in a beam will 
intersect in a single cell. ’Gamma-kill’ is defined as a response to 5-rays from 
different ions, overlap i.e. inter-track effect, which can be described by the same 
equation used for cell survival (SF) after y-irradiation given by formula SF=1-(1- 
exp(-h))"’ where m is the target number and h is the mean number o f hits in each 
target. The radiation effect is based on the dose deposited (by 5-rays) in, rather than 
the number of electron (or 5-rays) passing tlu'ough, the nucleus (i.e. the sensitive 
site). Cells inactivated by the passage of a single heavy ion are said to be inactivated
49
in ion-kill mode in the grain count regime with the inactivation cross section (a) 
less than the saturation inactivation cross section ( o j .  In the track width regime the 
inactivation cross-section (or) may be greater than cr„.
2.4.3.3. Ion-kill Inactivation Cross-section a
Katz calculates the ion-kill inactivation cross-section a , by integrating the 
probability P, for inactivation which is given by the expression suitable to multi­
target single hit statistics, over all space about the ion’s path. P is given by the 
following formula:
where
È is the mean dose due to 8-rays in a sensitive element o f radius a ;^
E„ is the critical dose after y-ray irradiation;
m is the target number;
t is the distance between the sensitive element centre and the ion’s path; and
a  ^ is the radius o f the sensitive element.
The ion-kill inactivation cross-section a , is given by: 
a = f2 Tt t  [ 1 - e x p  ( -  —  ) ] ’^d t
where x is the maximum range of the 8-rays.
The numerical integration of a , for different values of E^, a ,^ z, P, m and k, is 
shown in figure 2.5.
2.4.3 4. Survival Fraction SF
The total survival fraction (SF) of the irradiated cells is given by multiplying the 
ion-kill mode survival probability (TIJ with the gamma-kill mode survival 
probability (fly) (i.e.SF^rTj.riy ). The survivors of the ion-kill mode of damage is 
the initial population for the gamma-kill mode.
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When a thin specimen of the medium is irradiated with a beam of particles of 
fluence cj), and LET L. a dose D=(j)L will be deposited of which an amount PD is 
deposited in the ion-kill mode and an amount (l-P)D  is deposited in the gamma kill 
mode. The inactivation of cells by a beam of particles is assumed to proceed 
independently by these two modes, namely ion-kill mode with exponential survival 
characteristic and gamma-kill mode with sigmoid survival characteristic. The 
radiosensitivity parameters for CTS model are m, E„, and k .
There are two possible regimes where the cell inactivation will take place namely 
the grain count regime and the track width regime. From the value of it is
possible to determine whether a particular track segment irradiation is in the grain 
count regime or in the track width regime.
2.4.3.41. SF in the Grain Count Regime
The cell survival fraction (SF) in this regime is given by:
SF = n ,f i^
The ion-kill survival probability is given by:
= exp (-<?(()); or 
rij = exp (-aD/L). 
where a  can be derived from: a/a,,=P=[l-exp-(z*V Kp~ )]"\
The gamma-kill mode survival probability is by: 
n.  ^ = 1- [ 1-exp -(1-P)D/E, 1"
The survival fraction in the grain count regime is given by:
SF= exp(-a(|)){ 1 -[ 1 -exp-( 1 -P)D/E J"'}
2.4.3.4.2. SF in the Track Width Regime
The survival fraction (SF) is given by:
S F = nj.n ,
The value of P is bigger than 0.95 i.e. P>0.95 and the value for the gamma-kill 
mode survival probability is approximated to be equal to one i.e. =1.
The ion-kill mode survival probability is given by:
H i  =  e x p  ( - ( 3 ( |) )
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a  can be deduced from the figure 2.5; c/ay, against z *"/k (3L in the track width
regime.
The survival fraction in the track width regime is given by:
SF= e x p (-C (j)) .
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Fig. 2.5: The numerical integration o f a  for different values o f a„, z,p, m and 
K, versus zVkP^ .
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Table 2.2: Characteristics of the grain count and track width regimes, for multi­
target single hit calculation
In the grain count regime In the track width regime
i. The slope o f the envelope is equal to m, 
the target number.
i. The slope o f the envelope is equal to 
one (i.e. m =l)
ii. At low the following 
approximation for a/a^ is valid; 
a/ao=[l-exp-(z*VKp“ )]'".
ii. The value for a/a,, is greater than one.
iii. The plateau exists at the upper end of 
z*Vk P” at values of;
(a) z*-/K P“ =4; and
(b) a=cj^j ;the saturation ion-kill 
inactivation cross-section.
The w idth and flatness of the plateau 
increases with increasing m.
iii. The plateau exists at the lower end of 
z*Vk P“ at values of
(a) z*7k P" =4; and
(b) a=a„ the saturation ion-kill 
inactivation cross-section, and occurring at 
such a value o f z*~/p  ^ that every sensitive 
element through which the ion passes is 
sensitized.
iv. In the grain count regime
the fraction of dose P, deposited in the ion
kill mode is less than one.
i.e. P= a/a„ < 1
iv. In the track width regime the fraction 
of dose P, deposited in the ion-kill mode 
is one
i.e. a/a„ > 1 and P=1
V. There is no thindown phenomena in the 
grain count regime.
V. Thindown phenomena exists due to the 
decreasing radial distance t to which the 
ô-rays penetrate.
vi. Gamma-kill mode can occur only in 
the grain count regime. The damage 
mechanism can be ion-kill mode and 
gamma kill mode.
The fraction of intersected cells inactivated 
by a single passing ion (i.e. ion-kill) in the 
grain count regime is given by P, which is 
equal to
(j/(To=[ 1 -exp-(z'-/Kp- )]"\
vi. The damage mechanism is one hundred 
percent ion-kill mode. The value of H., is 
equal to one.
(i.e. n = ( l- ( l-e x p (-E /E J )l ).
a  initially rises and finally decreases 
rapidly due to the ’thindown’ [98].
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Ill the grain count regime In the track width regime
vii. The cross-section in the grain count 
regime is given by; 
a/cr„=[ 1 -exp-(z*"/KP“)]”\
vii. The cross-section in the track width 
regime is derived as follows;
a. find Target cross-section’ for a target of 
radius a„ from the equation:
K=Eoa"„ x5xlO*
E„ and m must be found from the cell 
survival response after y-rays irradiation; 
and
b. by using the standard figure i.e. figure 
2.6: cr/a„" versus z*VkP", assume that 
a/ap=l at z*VkP‘ =4. Find the value of 
z'-/Kp^ from the experimental set-up, then 
find (j from the graph.
Note: K  (or a^) represents the size of 
internal cellular target.
viii. This is unsaturated region. viii.This is saturation region (i.e. P >0.95)
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2.4.3.5. Model Appraisal
According to Katz [13] the model is purely physical (i.e. statistical and parametric 
rather than mechanistic) and rests on its fit to data rather than on its relationship to 
a presumed mechanism . A eucaryotic cell is assumed as a bean bag: the bag 
represents the cell nucleus and the beans represent the internal targets.
The model:
i. is able to fit many experimental data such as by Young, Underbrink and 
Skarsgard (see section 2.4.3.6) tlu'ough four radiosensitive parameters (m, E„, 
K and a j  [99];
ii. is applicable to nuclear emulsions, enzymes, viruses, bacteria, scintillation 
counters and eucaryotic cells;
iii. take cares o f the cumulative effect (gamma kill mode, the sigmoid survival 
characteristic) due to the low LET component, as well as non-cumulative 
effect (ion-kill mode, the exponential survival characteristic) due to the high 
LET component;
iv. appropriately, has used cross-sections to indicate the interaction probability
in both the grain count regime and the track with regime and has
successfully explained the increasing cross-section with increasing zVp~, and
the thindown phenomena;
However the model:
i. is not applicable to electron irradiation; and to neutron data as discussed by 
Waligorski [100] because z“/P“ is invalid for low energy protons;
ii. basically uses dose (i.e. due to ô-rays) to quantify the radiation, which is
argued against by a few authors including Katz himself;
iii. does not take care of:
a. repair phenomena of the damage, lesion or sub-lesion;
b. effects of cell cycle which can alter the sensitivity of the cells toward 
radiation;
c. effect of dose rate, dose fractionation or protraction;
d. inverse dose rate effect, and internal emitters etc.
Furthermore the splitting of dose into gamma kill mode and ion kill mode is 
artificial. The parameter zV(3“ used as a physical parameter of radiation in the model
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has a two-fold physical interpretation. zYp" can be interpreted either as the yield of
ô-rays per unit track or as the primary ionisation along the track (the inverse of the 
mean free path X). The model does not explicitly identify the energy requirement 
to inactivate a biological target. The model assumes that the effect produced by 
secondary electrons from y-rays and secondary electrons from heavy ions at the 
same dose, are comparable, which is a very crude approximation as the effect can 
vary considerably. For example the D„’s for carbon K„ X-rays and ^"Co y-rays differ 
by a factor o f two [10].
2.4.3.6. Testing Katz’s model
Katz has used very extensive sets o f data obtained by other researchers to test his 
model. This includes data by:
i. Skarsgard et-al [101] CFIZB? Chinese Hamster Cells irradiation;
ii. Yang et-al [102] C3H10T1/2 Mouse Cells irradiation; and
iii. Underbrinlc et-al [103] Tradescantia irradiation.
The values o f m, k,Eq and extracted from data used in the test are listed in table
2.3. According to Katz’s model the survival fraction is given by the following 
equations:
F = e x p  { - - ^ )  . [ 1 -  [ 1 - e x p  -  [ ( 1 - F r )  —^  ] ] U
i i 3 F = - . ^  + l n [ l - [ l - e x p - [  ( l -P , ,)  ~ ]  ]"]
Using D=(j).L and assuming that: ]
1
[ 1 -  [ 1 - e x p -  [ - ^ ]  ]
y  ,o
So I n F ^ - o ^ + l n A
di l nF)  ^ ^ d l n A _  d 0  -  -  0 + = -  0 +dO d 0  A
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dp
d o  d p  ' d 0
. [ ( - 1 )  ( - A ^  ^ |  e x p - [ ( 1 - P ,  dD P y , o )
or: - ^  = -j7?/ L ^ ^ e x p -  ( 1 - P- )  —^  ■ [ 1 - e x p - ( 1 - P . )
Then: dP 1d 0  L
The final expression for the effective cross section is given as follows:
d i n F ,  > ^ e x p - ( l - P J ^ [ l - e x p - ( l - P , ) ^
^ [ 1 - [ 1 - e x p - ( 1 - P ^ ) - ^ ]
Y'O
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Table 2 . 3 :  Values of m , K , E „  and extracted from survival data used by Katz.
Authors Cell types m K Eo
(erg
cm'^
(cm-)
Notes
Skarsgard et-al CH2B2 Chinese 
Hamster Cells
3 1100 1.82 4 .3x10 '
Yang et-al C3H1 O Tl/2 
Mouse cells
3 750 1.7 5x10^
Underbrink et- 
al
Tradescantia 2
or
1.5
1000
1900
2.1
2.6
3.5x10 '
4 .0x10 '
59
2.4.4. Hit Size Effectiveness (HSE) Model (Bond and Varma)
2.4.4.1. Introduction
In this model, the hit size effectiveness function (HSEF) is deduced to indicate the 
induction probability o f all-or-none effect with respect to the magnitude of energy 
imparted in a single event i.e. lineal energy [104]. This is an application of 
microdosimetry in the biophysical modelling of radiation action. The theory of 
microdosimetry requires detailed laiowledge o f the energy deposition in sensitive 
sites as a pre-requisite to estimate survival curves. When a population of cells is 
irradiated with ionizing radiation, various magnitudes o f energy will be imparted in 
the critical volume o f each cell [105]. Subsequently the hit effectiveness ratio 
(8), namely the fraction o f hits which result in the all-or-none effect, and the 
incidence (I), of the all-or-none effect will be deduced [106]. From this the 
survival fraction o f a specified biological end-point can be determined. The term 
quantal cell response or all-or-none effect [106], denotes responses which are not 
usually reversible spontaneously, e.g. Clii'omosome abnormalities, mutations, 
neoplastic cell transformations or cell death. Such responses are scored either by 
noting their presence in the individual cell, or by scoring abnormalities presumably 
derived from a single quantally altered cell.
2.4.4.2. Basic Principle
When a population of cells is placed or exposed in a charged particle field (i.e. due 
to indirectly or directly ionising radiations) of dose D, no matter how small, there 
is a chance of a stochastic encounter involving the charged particle(s) and the cell(s) 
[107]. Such stochastic encounters result in a wide spectrum of:
i. possible sizes of (single) hits (i.e.magnitude of energy imparted) on;
ii. possible sizes o f microdosimetric events (i.e. different magnitude of 
events for each track) in; or
iii. possible sizes o f cell doses to;
the critical volume of the cells or the critical effective target volume.
Absorbed dose expresses the average energy deposited per unit mass of the 
irradiated medium. At extremely low doses, absorbed dose loses its significance as 
a good indicator o f biological damage, due to its fluctuation. At lower doses the
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spatial energy deposition becomes important, and for this reason Bond and Varma 
[75] apply microdosimetry in developing this model.
To expose a population of cells means one or more charged particles, moving in the 
vicinity of the cells, quantifiable in terms of fluence 0 .  Stochastic transfer of energy 
to a critical volume o f cross section a . can cause injury to the cell, the severity of 
which depends on the event size. Usually quantal cell response denotes irreversible 
changes . All sub-effective cell injuries such as single strand breaks, are not 
considered as quantal cell response because they are not observable in individual 
cells and are usually repairable. High level radiation (HLR) is a strong field in 
which each cell is hit at least once. Any further increase o f O, can result only in 
additional (multiple) hits per cell. In low level radiation (LLR), only a small fraction 
of the exposed cells are hit, so the frequency of multiple hits on the same cell is 
negligibly-small (effectively all hit cells are singly hit). HLR and LLR refer to low 
and high probability o f interaction, and not necessarily to large or small energy 
deposits in the cell critical volume. The hit size on a cell is defined as the amount 
o f energy transferred to and deposited in the cell critical volume.
Gin - Gout-
The energy transfer causes injury to that cell critical volume, the severity o f which 
depends on magnitude of the transfer. Above some minimal level of severity 
(threshold), the cell will show a quantal response.
The incidence of hit cell I,.,, is given by :
I[_,= 0 a ;  
or Ih= 4)t,a 
where
a  is the average cross section of the cell critical volume;
0  is the integral fluence;
(j) is the fluence rate; and 
tg is the exposure time.
The total I„ is proportional to, or has a linear (no tlireshold) relationship with 0 .  I^ 
is also an expression of risk of a hit on an individual cell in the exposed population. 
However it provides only the average value for all cells in the exposed population, 
from which the true risk for any given cell can not be determined. The cell critical
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volume is a iion-anatomical volume within the ce ll the apparent mean diameter or 
'cross-section' cr o f which can be calculated, and within which the macromolecular 
target(s) must reside. The tissue content o f critical volume must be hit in order for 
the chance o f a quantal response to be other than zero.
The actual total incidence o f hit cells cannot be determined in living cells. However 
this incidence of hit cells. I,.,, can be indirectly estimated by using a microdosimetric 
proportional counter (mpc). The mpc is viewed as a phantom of cell critical volume 
which is filled with tissue equivalent gas and at reduced pressure, so that the number 
of interactions per charged particle is the same as that for the cell critical volume. 
A very large number of single events and their size can be recorded in a relatively 
short time in a low strength field because of the large diameter o f the chamber, 
relative to the that o f the cell critical volume. When adjusted or ’scaled’ to the 
dimension o f a cell critical volume and to the LLR field o f interest, which may 
involve a factor well in excess of 10 ,^ the converted reading does provide the small 
number of hit cells per cell. The mpc can record very large numbers of single events 
and their sizes. If I,, is known, 0  can be found by; 0 =  I , /a  .
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P A N E L  0
.0
P A N E L  b
0
P A N E L  c
P A N E L  d
Fig. 2.6: Schematic functions to illustrate the calculation o f the expected incidence 
of the single cell, stochastic effect. In panel a is shown v, the hit incidence density 
(or the number o f cell doses for unit cell dose size), versus z, the cell dose size (or 
the specific energy). The different letters (A and B) refer to spectra for two different 
radiation qualities. The subscripts 1 and 2 for each radiation quality refer to doses 
D, and D2 shown also in figure 2.7. corresponds to the ionization threshold, z^ 
and Zq are mean z values, and Ég refer to maximum z values, for the 
corresponding spectra, and is the value o f z above which the hit probability is 
effectively 1.0. In panel b is shown p, the probability o f an all-or-none single cell 
effect per dosed cell , versus the cell dose z. In panel c is shown w, the expected 
all-or-none single cell effect incidence density (or the incidence per unit cell dose 
o f size z), as a function o f z, for the low LET radiation A. The subscripts for 
distributions E, and E2 correspond to the same subscripts for spectra A and B in 
panel a. In panel d is shown the same plot as in panel c, but for the high LET 
radiation B (reference [108]).
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In figure 2.6, D, and are absorbed doses of low and high LET radiation. The 
horizontal axes for all four panels in figure 2.6, are the specific energy for single 
hits (or events) to the critical volume. The vertical axes for all four panels are:
i. v, the hit incidence density dp,/dz:
ii. p the probability o f the all-or-none effect;
iii. for panel c and d, w is the effect incidence density dpj^/dz, under the 
assumption that when D, and are sufficiently small, equal to dlg/dz.
Panel a: A, is the microdosimetric, specific energy spectrum for quality A of dose 
Dj. Ai, B] and Bj are the m icrodosimetric, specific energy spectra for quality A of 
dose Do, quality B of dose D, and quality B of dose Do, respectively.
If  gi-, is the hit incidence density function, so:
v=g[.iA(z:Di) for A,; the hit incidence (i.e.area under the curve) corresponds
t o  M h . a ( D , ) ;
v=gH.A(z:Do) for Ao: the hit incidence Ph.aCD^ );
'^=^§H.B(z:D,) for B,; the hit incidence Ph.bC^i); and
^^Sr.bCz’Do) for Bo; the hit incidence Pm.bCD.).
If  the corresponding normalised microdosimetric spectra i.e. the probability density
functions (or probability distributions) from the two qualities are f%(z) and fg(z), 
then the hit incidence density functions are given as follows:
g i - i .A ( z : D , )  = p„ A ( D , ) . f A ( z ) ;  
gH.A(z:Do) = PH.A(Do).fA(z);
gH.B(z:D,) = pH.B(D,).fg(z); and
gl-lA(Z-D2) ^bLB(Do).fB(z)'
The mean hit sizes are given by:
d z
64
and Zg=J z f g ( z )  d z
D is the specific energy averaged over the entire population of critical volumes both 
hit and unhit, whereas the values o f and Zg apply only to critical volumes which 
are hit.
D= Ph.a(D).Za ;and
PH.B(D).Zg.
If dose D for radiation quality A is the same for radiation quality B, for any value 
of D:
^ h ,a ( D ) /  P H .o (D ) =  Z g/ Za
i.e. the ratio o f hit incidence for the two qualities with the same dose for any value 
of dose (D), and is in the single-hit range for both, is equal to the inverse of mean 
hit size.
Panel b; The cell dose-cell response function P - ti(z).
P is the probability that a cell with a given hit size z, will manifest the all-or-none 
effect. Its value is zero (p=0) for z < Z j and rises from 0 to 1 in the range of Z j  to 
Zm and p=l for z > Z^
Panel c: The curves E, and E  ^are plots of the effect incidence density functions for 
quality A; which are the products o f the functions represented by curve A, and A  ^
in panel a; and the cell dose - cell response function P plotted in panel b.
For curve E,
w=gH,A(z:D,).7i(z) and the area under E, is Pe.a(D|) or Ie,a(D|)
For curve E,
w=gH,A(z:D2).Tt(z) and the area under E  ^ is PE.A(D:) or Ie,a(D2)
Panel d: Corresponds to panel c but for radiation of quality B.
Curve F I and F, represent the effect incidence density functions
w=gH.B(z:D,).Ti:(z) and the area under Fj is Pe.b(D]) or 1e,b(D i);
w=gH.g(z:D2).'n:(z) and the area under F2 is Pe.b(D2) oi' Ie.b(D2)
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The fraction o f hits which result in the all-or-none effect will be termed The hit 
effectiveness ratio' and designated as s with subscript to indicate the quality it 
refers.
Thus
-A
and -B
z
j f ^ i z )  . 1 1  {z)  d z
From the definition o f e,
where Ie,a(D) is the fraction of hit cell which result in all-or-none effect.
Ph,a(D) is given by:
Fh.a(D)==D/(Za)
So Ig a(D)=D. £a/(Za); and 
lH_g(D)= D.Sg / (Z g )
where Za and Zg are the mean hit size for radiation quality A and B respectively. 
The incidence of the all-or-none effect can be expressed in a very simple form, 
namely:
Ie.a(D)=D- Sa/(Za); and
Ig _ g (D )=  D .G g  /(Z g )
The relative biological effectiveness (RBE) of quality B relative to A, according to 
the definition o f RBE, is given by:
I lIT E ;(B //\.)= = [S g  /(Z g ) ]  /  [GA/(ZA)]
= [S g  /  8 a ]-[Z a  /  ZbI
6 6
w0 0 D i2
D,  r o d s
Fig. 2.7: Schematic plots o f the expected incidence o f the all-or-none effect vs. 
the amount o f radiation, D for qualities A and B. The amounts D, and are shown 
as being in the linear range for both curves. The ordinates o f the points L, and 
are equal to the areas under curves E, and in panel c o f figure 2.6, and the 
ordinates o f points H, and H2 are equal to the areas under curves F, and F  ^ in panel 
d o f figure 2.6. The incidence Ig equals the risk per undosed cell (as opposed to the 
ordinate p in panel b of figure 2.6, which is the risk per dosed cell).
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LU
(%)
Fig. 2.8; The expected incidence Ig vs. the amount of radiation measured as effective 
fluence c|)g, i.e. the number o f charged particles per unit area capable o f producing 
the all-or-none effect. Curve A is for a high- and curve B for a low fluence rate.
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2.4.4.3. Survival Equation
If Ig A(D)=D.E,\/(z^) is the mean number o f cells hit (i.e. incidence), after given dose 
D o f radiation with quality A. then the Survival Fraction (SF) for this model is 
given by:
SF=exp(-Ig) = exp(-D.s^/(z^)) or lnSF=-Ig = -D.6^/(2^)
where
Ig is the fraction of hit cells which result in all-or-none effect or the 
incidence o f the all-or-none effect after given dose D, can be expressed by 
the following term;
Ie.a(D)=D. E^/(z^)
For radiation o f quality A, the survival equation is;
lnSF=- D.G^/(z^)
The general form for Ig is given by:
Ig = aD  + pD“ + yD^ + .....
For low level radiation exposure (LLE) only the linear term is significant due to the 
fact that there is a complete repair of sub-effect damage before a second cell dose 
is delivered. It is expected that even with high level radiation (FILR) exposure, terms 
higher than the square would rarely ever be detected.
The survival equation for the HSE model is given by:
Ln SF = -niD
where
m is the gradient which depends on the LET o f the radiation, which is also 
equal to m=e^/(Zy^) for radiation quality A.
2 4.4.4. Model Appraisal
i. If hit size z, is the most important parameter, irrespective of radiation type, the 
same hit size from figure 2.6 (page 63), could give rise to different effects. Both z, 
are the same. Suppose that the critical volume is DNA double strand. In the first 
case, four DNA segments are affected by z, whereas in the second case, three DNA 
segments ai'e affected by z. What matters most is the spacing and correlation 
(orientation) of energy deposition events. If it is correlated with a DNA dsb 
(sensitive segment), the effect would be more than if it is not correlated with a DNA 
segment.
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ii. The derivation o f the hit size effectiveness function (HSEF) is complicated and 
requires the availability o f accurate data on a number of radiations o f different LET. 
How can we test the HSEF independently? May be independent testing is not 
feasible due to the fact that the hit sizes received by the exposed cells are governed 
by stochastic processes and in order to compare the probabilities, a lot of accurate 
data on all-or-none effects are required.
iii. The definitions of LLR (i.e. average ! % < < ! )  and HLR (1^ »  1 ) are not very 
critical because when every single track counts, the A. (spacing between primary 
ionizations) is important.
It is stated by Weber [108] that the HSE approach is a direct application of 
microdosimetry to low exposure irradiation, in which only a small proportion o f the 
exposed cells are hit predominantly by single tracks, in a cell population. The HSE 
approach can be regarded as a microdosimetric version o f hit-theory by using a 
continuous function (HSEF) instead o f a step function (i.e. 0 and 1) for the
response. The term ’h if  denotes the total amount of energy transferred to the
proposed sensitive structure. At low doses the ’hit’ varies widely from zero to a 
maximum value, depending on hit size (radiation quality). In classical hit-theory, a 
hit size effectiveness (Sj) is equal to:
i. zero ; for all hit multiplicities smaller than n; and
ii. one ; for all hit multiplicities equal to or bigger than n.
The survival fraction (SF), when fixed hit sizes are assumed, is expressed by the 
following equation:
SF = exp(~/ l£>)Y'  ( 1 - 6  .)
j
where D is the radiation dose.
From hit-target theory, it is given that:
( iD )?
{ID)
j !
p { j )  = ex p ( -A D) J
and survival fraction (SF) is given by:
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S F =  # = E P ( i
n - 1
N.
In the HSE model by Bond and Varma. a probability distribution of hit sizes for a 
given dose replaces the Poisson distribution of hit theory.
2.4.4.5. Testing Bond and Varma s model
To test his model, Bond used various data which includes the following:
i. Data for induced pinlc mutations in Tradescantia produced by x-ray 
irradiation, which have a slope of unity and are in good agreement with 
e x p e rim e n ta l d a ta  up to  a dose o f  ab o u t 0.1 Gy 
[108][109][110][111];
ii. The production of chromatid exchanges in CH2B2 cells after exposure to 
various heavy ions and x-rays [108][112].
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2.4.5. Track Core (TC) Model (Watt)
2.4.5.1. Introduction
A track core model o f radiation action by Watt [113] has been evolved directly 
from experimental observation of biological irradiations. It uses the interaction 
spacing concept, namely the mean free path of primary ionization along the primary 
track X. as a basis. It is known that the radiation damage is initiated by the charged 
particle tracks [114] and the single-valued parameter which determines quality 
is the linear primary ionisation of the charged particles. It is important to realise that 
the X emerges from the study o f the cellular data, based on laboratory experimental 
radiobiology; it is the parameter which best unifies the data for a wide range of 
radiation types and end-points. In deriving the model, the following assumptions and 
deductions are made:
i. Single track direct action is dominant at medium and low doses. Indirect (radical) 
action is deduced to be relatively small;
ii. There is no temperature dependence on the effect cross-section; and
iii. Results are for asynchi'onous cells: there is no specific allowance for variations 
in radiosensitivity during the cell cycle.
A mammalian cell contains DNA in its nucleus and double-strand breaks in the 
DNA are identified from the experimental analyses as the critical lesion. The 
traversal of a charged particle along a mean chord through the cell nucleus will 
activate the number o f overlapping DNA segments at risk, subject to the range of 
the particle. What matters most, is the number of induced DNA dsb due to the 
charged particle traversal. Absolute biological effectiveness (ABE) is obtained and 
expressed as an effect cross-section in this model to indicate the effectiveness of a 
particular radiation to induce DNA dsb in any specified biological cellular system.
2.4.5.2. Basic principle
In a population of cells irradiated by either directly or indirectly ionising radiation, 
the relevant charged particles will interact with the cells. The critical lesions 
considered in this model is the DNA double strand break (dsb). The yield of DNA 
double strand breaks (dsb) is derived from the following processes [114]:
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2.4.5.2.I. Direct Action
The cross section for DNA dsb production is given by: 
where
çjj, the projected geometrical area of the DNA pnT); 
i\, the number of overlapping segments at risk along a mean chord
through the cell nucleus; and 
s the probability that at least a single interaction will occur in each of
the two strands, each of thiclcness x, spaced at a mean chord distance.
The probable values o f e are:
i. For two ionisations occurring anywhere in the 2 nm distance i.e. e= [l-(l 
+;uyA.)exp(-iyA.)];
ii. For one ionisation occurring in the first strand and the second, within the next 2 
nm distance i.e. £=[l-exp(-x/X)][l-exp(-L„/?t)]; and
iii. For non-saturating tracks, one hit in each of the two strands and nothing in 
between
i.e. g=exp(-A.yA.)[l-exp(-x/l)]\
The mean number of DNA dsb induced per cell by direct action is given by:
^D.dsb“ *^ d^
where
(j) is the integral equilibrium charged particle fluence in the cell nucleus; and
a,4=a.,.m.e
2.4.S.2.2. Indirect Action
The mean number of DNA dsb produced per cell by radical action is given by: 
N],dsb" l^k-^ dsb-^
and
where
is the production cross section o f single strand breaks in DNA. the general 
form is given by: as,i~a,.exp(-a2.CJ[l-exp(-a3.Ly/CDNA)] 
a, is a geometrical interaction cross section;
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Sij. a. are constants;
is the intranuclear scavenging concentration;
C^ NA is the molecular density of single strands of DNA present in the cell nucleus: 
and
Lj is the track average LET for the equilibrium of the charged particles in the
cell nucleus; and
iij is the total number of DNA segments in the whole cell nucleus which differs
with Og.
2.4.S.2.3. Mixed Radiation
For mixed radiation the combined effects o f indirect and direct actions on individual
strands gives:
[ 1 - e x p  ( - X / À ) ]
g
^M.dsb ^M.dsb'^
and ^D.dsb I^.dsb “^ ^M.dsb
The repair of indirect and direct damage is assumed to occur at the same rate with 
a mean repair time t^ ep. A simple time-dependent damage factor can be derived as 
follows:
j  e x p [ - ] dt
The overall survival fraction (SF) for an irradiation of a population o f cells is given 
by:
SF=exp[-N i-^.K(ti)].
If the repair factor is considered to be 100 percent, the SF is given by: 
SF=exp[-N-,.^J.
SF can also be expressed in terms of the absolute biological effectiveness (ABE) as 
follows:
SF=exp(-ABE.(t))
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where
ABE is the mean number o f double strand breaks per unit incident fluence of 
primary radiation; and 
(j) is the incident fluence o f primary radiation.
2.4.5.8. Model Appraisal
The approach used in deriving the model is to correlate on a single curve the 
reported information on cellular effects observed in a variety o f irradiation 
circumstances, for many radiation types and for a variety o f biological end-points 
(refer to figure 4.1). The model is classified as a phenomenological model.
O f the five main biophysical models which have been explained in brief so far, this 
is the only model which uses interaction (event) spacing X, as the physical parameter 
to specify Tadiation. This is a significant development conceptually and can be used 
as an effective means of specifying radiation quality. The following explanation on 
the signal to background ratio of effectiveness if  dose is used, provides justification 
on using A. as radiation specifier:
Double strand break (dsb) is considered as the most important lesion induced 
by the radiation in the cellular DNA. From radiochemistry it is Icnown that 
only about 8 eV is required to rupture sufficient chemical bonds to produce 
a dsb. The distance between DNA strands is about 2 nm. If energy 
deposition parameter is used in this case take for example at just below the 
maximum RBE-LET curve, for any typical end-points, in the energy region 
generally considered to be unsaturated, a  particle expends about 110 
kev/pm, whereas a proton expends only about 60 kev/pm to produce the 
same effect. For a 2 nm distance (equivalence to 2x10'^ pm), the mean 
energy expended by alpha and proton are respectively 220 ev and 120 ev. 
The signal to noise ratio for alpha and proton are respectively 7% and 4%. 
For low LET, the corresponding ratio is in the order o f 0.003% . Therefore 
it seems inappropriate to use energy deposition parameters o f any kind for 
the interpretation of radiation effect because the small changes can not be 
accurately quantified against the large signal to noise ratio.
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2.4.5.9. Testing W att’s model
Extensive data of cell survival were used [115][116] to test the model, 
which include the following:
i. The ^"Co y irradiations o f HeLa cells by Hall and Bedford 1964 [117]:
ii. The dose survival data for irradiations o f mouse embryo fibroblasts with fission 
neutron E,=0.85 MeV by Hill et-al in 1982 and 1984 [118][119]; and
iii. The irradiation with alpha particles (2.7 MeV) by Hieber et-al in 1987 [120]. 
The overall result is satisfactory and detail discussion is given by Watt [135].
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2.5. Test and Inter-comparison of Models
There are a few ways to inter-compare biophysical models which include the 
following:
First, from the survival fraction equations, separate the terms which consist o f Dose 
(D) or (j) at one side and the terms which do not consist o f D or (j) at the other side. 
Then plot the graph against D or <j> for each o f the models i.e. display on a unified 
plot. Any deviation in the unified plot, indicates differences. This procedure could 
be difficult to carry out if the model is a complex mathematical expression; 
Second, by using standard sets o f bench mark data, curve fit each model and 
determine the error. Inter-compare the errors for each model. However this exercise 
requires a lot o f data points for various types of radiation which are available (i.e. 
published data). Furthermore the modeller may have carried out this procedure in 
the development o f the model; or
Third, by applying mathematical treatments to emphasise model characteristics, such 
as comparing the values o f the first derivative against dose (D) or fluence (([)). This 
procedure can be repeated for each model and for inter-comparison puiposes, the 
results could be displayed in a same graph.
In this thesis the first and the third methods are carried out on the five main 
biophysical models of radiation action and the results are shown in table 2.4. Inter­
comparison of the five main biophysical models is carried out by:
(i) determining for each model the initial slope (i.e.dlnS/dcj) when (|)-»0), the 
final slope (i.e. dlnS/d(|) when (j)-^ co), the number of parameters and their 
meanings, the basis of the model such as critical target, lesions types and the 
principle used; and
(ii) determining the first derivative of each In survival curve against D and 
(j), and display the results on the same graph.
2.5.1. LPL Model (Curtis)
The survival equation is given by:
( r | ^+r j p^)  D+ e I n  [ l  + ^ ^ D [ l - e x p  ( ]  ] ]
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l n S = -  (rip+ripp) <l>Lp+ e I n  [ 1 - t - - ^ O L p [ l - e x p  { -Cp^t^J ] ] ]
where;
P l is the rate o f L lesion production per unit absorbed dose;
rjpL is the rate of PL lesions production per unit absorbed dose; Gp^  is the rate of
correct repair for PL lesion per imit time;
S2P1 is the rate o f binary misrepair for PL lesion per imit time;
6 = -!fL
-2PL
and t^  is the repair time.
Assume that all parameters are not a function o f (|) or D.
[ l  + _ y ^ £ ) { l - e x p  ( - G p p .  t ^ )  ) ]€
'' " l 'Ipi,/
+ - e x p  ( -Gpp. t , )  )e
i.e. Using equation D=L(j); and 
d/d(|)=(d/dD).(dD/d(|)) or d/d(j)=L.(d/dD);
i. The initial slope
When D->0 :
When (j)->0 :
ii. The final slope
= [ l + e x p ( - Ep ^ C^ ) ]
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When D-^cc:
(Tli+Tl Pp)L,
- ( r | ^ + T ) p ^ )
d(|)When (j)-3-oo:
iii. Number o f parameters and their meanings
Five independent parameters are used in the LPL model. pi and ppL indicate the 
production rate of L lesions and PL lesions respectively per unit absorbed dose. L 
lesion is assumed irreparable and more severe than PL lesion which can be either 
repaired correctly or binary mis-repaired to become an L lesion. Sp^  and e^ p^  indicate 
the rate o f correct repair for PL lesions and the rate of binary misrepair for PL 
lesions respectively per unit time. The fifth parameter is t^  which is the repair time.
iv. Basis of the model
Dose is used to specify radiation quantity and the critical target is not specified but 
it is implicit that the lesions are in the DNA molecule; L and PL lesions. Interaction 
between PL lesions and repair o f PL lesions are assumed to take place in this model.
2.5.2. PLI Model (Harder)
The survival equation is given by:
l nS=- ln{n )  [ e x p  - 1 ]
where
n is the extrapolation number (i.e. note that not all survival curves have an 
extrapolation number)
D is the Dose; and 
Dq is the shoulder dose
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dD  D ,
d i ln S )  _ _ l n [ n )  $
d d  0 ,  0 ,
i. The initial slope
When (j)-»0:
When (})->0:
ii. The final slope
When (j)-^oo:
d ln S
dD
d l nS
dà
d ln S  I n n
dD
d ln S  _ I n n  —
dd) D^
iii. Number of parameters and their meanings
Two parameters are used in the PLI model, n and indicate the extrapolation 
number (corresponding to the number o f targets in the multi-target single hit model) 
and the shoulder dose D^, (the quasithiesliold dose) which corresponds to the width 
o f the shoulder, respectively.
iv. Basis o f the model
The basis o f the PLI is pairwise interaction between primary lesions. The critical 
target is assiuned to be at contact regions, namely the regions with contact between 
different chromatin fibres or between sections of the same fibres. Radiation induced 
primary (i.e. molecular) lesions are assumed to occur in the contact regions which 
are able to interact pairwise. Dose is used to specify radiation quantity.
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2.5.3. The CTS M odel (Katz)
The survival equation is given by:
l n S = - ~ + l n { l -  [ 1 - e x p -  { ( i -p )
where
m is the target multiplicity or the extrapolation number;
E„ is the critical Dose or the extrapolated 
Qq is the saturation cross-section found at a value of 
zVkP“=4;
K  relates to the size of the sensitive container which corresponds to the value 
of (jq at zVkP”=4.
A set o f parameters of Katz’s model for cell inactivation is given by cj„, E„, k , m. 
dins
m-1
^  ( 1 - [ l - e x p - { ( l - P )  ^
^ e x p - ( [i-exp- ( (1-P)d l n S _ _ o ^  -gp_____________ ^ _______________________ gp
^  ^  ( 1 - [ 1 - e x p - ( ( 1 - P )  ™ )  ] ^)
mL e x p  -  (  ^ ) [ 1 - e x p -  ( ( 1 - P )  L - ^ )  ]d l n S __^_ gp______________^
(1- [1-exp- ( (1-P) p A )  ]m)
i. The initial slope
When D-»0:
d ln S  o
dD P
8 1
d l n S ^ _ ^
When (j)-^ 0: 
ii. The final slope
When D -> o o ;
d({)
d l n S_ _ G  ( 1 - P )
(1-P)
d(j) P,
iii. Number o f parameters and their meanings
There are four parameters used in the CTS model by Katz, namely E„, k  and m. 
m is the target multiplicity, E„ is the critical dose, represents the size o f the 
container and k  represents the critical target size in the container. Katz suggests that 
the targets in the container can be considered as beans in a bean bag. E^ and m are 
parameters for multi-target statistics to describe the response from gamma kill at low 
LET, whereas g^ and k  are parameters for one hit statistics of ion kill at high LET.
iv. Basis o f the model
The basis of the CTS model is the dose deposited by 6-rays, which inactivates 
sensitive sites along and around the particle tracks. The concept used is that the 
response to 6-rays (secondary electrons) follows the same functional form for y-rays 
and for the 6-rays surrounding an ion’s path. zVp- is used to indicate the 6-ray yield 
per unit track length. No specific biological structure or damage type are inferred 
as the critical target or lesion in this model.
2.5.4. HSE Model (Bond and Varma)
In low level radiation exposure, the survival equation is given by:
lnPP=- /7?P
The first derivative of InSF against Dose D, is given by:
djLnSF)
dD
8 2
The first derivative o f InSF against fluence (())), is given by: 
dUnSF)
d(j) 
where
in is the linear coefficient which depends on the LET o f the radiations, 
which is also equal to m=s^/(zA) for radiation quality A. : and 
D is the absorbed dose.
i. The initial slope:
When D-^0: the slope -in, which is determined by the LET (L) o f the radiation.
When ({)-^ 0: the slope -mL .
ii. The final slope
When D->oo: the slope -> -m i.e the same as the initial slope.
When (j)-^ co: the slope -> -mL i.e. the same as the initial slope.
iii. Number o f parameters and their meanings
The product inD is equal to the expected incidence of a single cell effect, given
by the following equation:
J ^ = 4 . £ i
where
8 is the hit effectiveness ratio i.e. the fraction of hits which result in the all- 
or-none effect; 
z is the mean hit size.
iv. Basis of the model
The basis of this model is the amount of energy deposited in the critical volume of 
the irradiated cell, measured as a single event spectra in microdosimetry. However 
the spectra needs to be multiplied by a function (HSEF) which provides the 
probability that a cell with a certain hit size (cell dose) will manifest the all-or-none 
effect. The product, Ig is the incidence o f the all-or-none effect. Poisson statistics 
are assumed and consequently the survival fraction (SF) is calculated according to 
the formula SF= exp(-Ip). The critical target, within the cell nucleus, must be hit by 
a charged particle in order to have a non-zero probability of causing the all-or-none 
effect.
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2.5.5. TC M odel (W att)
The survival equation is given by:
lnS=-ABE.  (|)^^
<f>cp=-W-.o „.<(),
and
where ABE is the probability to induce DNA double-strand breaks per unit incident 
fluence; (j)^  is the incident fluence; (|)gp, (j)^  ^ is the charged particle fluence and the 
charged particle equilibrium fluence respectively; and is the average range of the 
charged particles. ABE values are calculated according to the following equation:
ABE^ ia^ .nJ  (4>s.e) {No k  {t  ^ ) + i n d i r e c t  component  .
where
CTg.n^  is the projected cross-sectional area of DNA and is the number of DNA 
double strands at risk;
{j)^ .s is the weighted integral equilibrium fluence of charged particle per unit 
incident fluence, and s is the efficiency for the charged particles to induce 
DNA dsb;
N.Œjr is the mass transfer coefficient; and
k(tj) is the repair term which for simplification is assumed as one. 
d l n S ^ _ ^  j^ B E)
d^cp  d<l>cp
i. The initial slope
Whe„<^^0;
Only single track effect is considered, at lower dose range;
= -ABE= - {o . n ) { ^ )  . ( l - e x p ( - — d(|)cp ^ d
8 4
with the following assumptions;
i. At low dose, only single track effect and less:
ii. no repair is assumed to take place: repair factor K(tr)=l ; and
iii. indirect contribution is assumed to be negligible.
ii. The final slope
When ( |)-^ ; = -ABE
There is no final slope due to the fact that:
i. The repair factor K(tr) is continuously acting;
ii. In the high dose region, (|)^ p^  becomes significant;
iii. the curve keeps on curving with no final slope.
iii. Number o f parameters and their meanings
In this model only ABE and fluence are used. However ABE is derived and 
calculated by using the following six parameters:
CTg is the projected geometrical area of the DNA;
is the number of overlapping segments at risk;
R is the mean range o f charged particle track:
d is the mean chord length, o f the cell nucleus;
A.„ is approximately equal to 2 nm; and
A. is the mean free path between the primary ionizations.
iv. Basis of the model
In the TC model only one type of lesion is assumed namely DNA dsb, which is 
induced by the radiation and acts as the precursor for various end-points such as cell 
inactivation, cluomosome aberrations or mutations. The latter have different 
probabilities o f occurence. The mean free path between the primary ionizations 
along the charged particle track is used as a basis for the model.
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The summaiy for equations of survival fraction (SF) of each biophysical models of 
radiation action are given as follows:
i. For LPL Model (Curtis):
InSF^-{7]^+r]pj D+ e I n  [ 1 + [ 1 - e x p  ( ]  ] ]
ii. For PLI Model (Flarder):
l nS F^ - ln {n )  {exp { - — )+— -1) ]
d( lnSF)  _ l n { n )
d#
iii. For CTS Model (Katz):
Survival Fraction (SF) is given by: SF= flj.n^ where flj is the ion-kill mode 
survival probability; and fl^ is the gamma-kill mode survival probability. 
In the Grain Count Regime: FIj=exp(-a(j)) or TIi=exp(-aD/L), where a  can 
be derived from a/a„=P=[l-exp-(z*VKP“)]"\ 
n ,= l-[l-exp-(l-P )D /E J'L
Survival Fraction SF in the grain count regime is given by: 
SF=exp(-(j(|)){l-[l-exp-(l-P)D/EJ'"}.
In the Track W idth Regime: the gamma-kill mode survival probability is 
equal to one; 11^  =1; and the ion-kill mode survival probability is given by; 
ITi=exp(-a(j));
Survival Fraction SF in the track width regime is given by:
SF==exp(-a(j)).
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iv. For FISE Model (Bond & Varma):
The survival fraction (SF). is given by the following equation: 
SF=exp(~mD)
where m is the gradient which depends on the LET o f the radiation, which 
is also equal to m=s^/(z^) for radiation quality A; and D is radiation dose:
and
V . For TC Model (Watt):
S F = e x p  ( -ABE . <p )
lnSF=-ABE.(j)
where ABE is the Absolute Biological Effectiveness; and (j) is the relevant charged 
particle fluence. The first derivative o f SF against ({) is given by:
dlnSF
d<p
2.6. Conclusions
2.6.1. Intercomparison Based on Theoretical Approach
The results o f the inter-comparison between the five main biophysical models are 
listed in table 2.4. The graphical illustrations for each model; its first derivative 
against dose D and Fluence (|). are given in:
i. Figures 2.9(a) and 2.9(b), for LPL model (Curtis);
ii. Figures 2.10(a) and 2.10(b). for PLI model (Harder);
iii. Figures 2.11(a) and 2.11(b). for CTS model (Katz);
iv. Figures 2.12(a) and 2.12(b), for HSE model (Bond and Varma); and 
V. Figures 2.13(a) and 2.13(b), for TC model (Watt).
The overall graphical illustration for all models is given in figure 2.14. The 
parameters o f the models in figure 2.14 are listed in table 2.5.
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Fig. 2.9(a): LPL Model by Curtis: Log Survival Fraction (SF) against Dose, D
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Fig. 2.10(a): PLI Model (Harder); Log Survival Fraction (SF) against Dose, D
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Fig. 2.11(a): CTS Model (Katz); Log Survival Fraction (SF) against Dose, D
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Table 2.5: Parameters used for the overall graphical illustration for all models
Models Parameters values Remarks
LPL model by 
Curtis
p,=1000, Ppl=100,
8pL=20, 82pl= 10, t=500, 
p^lO , 8=2
PLI model by 
Harder
n=5, Dq=200 The curve shows slight 
deviation compared with the 
other model but has the 
same general trend. The 
deviation is lessen if  
appropriate values of the 
parameters are chosen in 
the display.
CTS model by Katz L=100, a=4e-7, P=0.25, 
Eq=20, m=3
HSE model by Bond 
and Varma
111=4
TC model by Watt ABE=50, L=100 The model for y and 
neutron will differ due to 
the range R o f the charged 
particles generated (see 
page 84).
105
... j
2.6.2. Intercomparison Based on Experimental Data.
Three sets o f experimental data [121] are used for this purpose. The general 
characteristics of the data sets are:
i. Set 1: data which indicate that there is an initial slope and final slope 
(table 2.6);
ii. Set 2: data which indicate that it is a continuously changing with the 
amount o f radiation (table 2.7); and
iii. Set 3: data which is purely exponential in nature (table 2.8).
In this exercise the equation which corresponds to each o f the models is used to 
curve fit the data. The results are shown in figures l(a,b,c), 2(a,b,c), 3(a,b,c), 
4(a,b,c) and 5(a,b,c). The overall qualitative result o f this exercise is shown in 
table 2.9.
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Table 2.6: Survival Data with an Initial Slope and Final Slope Characteristics
No Dose X 
(Gy)
Survival Fraction
1 0 1.0
2 1.0 6.0E-1
3 2.0 2.513-1
4 2.9 l.OE-1
5 4.0 5.0E-2
6 5.0 1.4E-2
7 6.0 5.6E-3
Table 2.7: Survival Data with Continuously Changing Survival Fraction
No Dose X
(Gy)
Survival Fraction
1 0 1.0
2 1 7.0E-1
3 2 5.213-1
4 4 2.0E-1
5 6 6.0E-2
6 8 1.8E-2
7 10 2.4E-3
Table 2.8: Survival Data with Purely Exponential Survival Fraction
No Dose X 
(Gy)
Survival Fraction
I 0 1.0
2 0.5 3.513-1
3 0.9 1.213-1
4 2.0 1.6E-2
5 2.9 2.8E-3
6 4.0 4.2E-4
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Fig. 1a; Curtis Model with Data Set 1
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Fig. 1b; Curtis Model with Data S et 2
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Fig. 2.15: Curtis Model based on experimental data
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Fig. 2a:Harder Model using data set 1.
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Fig. 2c: Harder Model with Data Set 3.
c.9G2u_ 0.01>£
CO 0.001 eqn: y=exp(-in(a)(exp(-x/b)+x/b-1)), error^9.533E-005. 
a=+1.307E+000, b=+1,G16E-001 \ .
0.0001
Dose in Gray
Fig. 2.16; Harder Model based on experimental data
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Fig. 3a: Katz Model with Data Set 1
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Fig, 3b: Katz Model with Data S et 2
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Fig. 2.17; Katz Model based on experimental data
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Fig 4a: Bond and Varma Model with Data Set 1
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Fig. 2.18: Bond & Varma Model based on experimental data
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Fig. 5a: W att Model with Data Set 1
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Fig. 2.19: Watt Model based on experimental data
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Table 2.9: Overall Qualitative Model Intercomparison Based on the Experimental 
Data Sets
Model Curtis Flarder Katz Bond & 
Varma
Watt
1 Initial
slope
Yes Yes Yes Yes Yes
2 Final Slope No No No No No
3 Values of 
the
Parameters
Yes (i.e.
within
range)
Yes Yes Yes Yes
4 Basis of 
the model
Dose L ioO.D Dose Hit Size 
(microdo­
simetry)
A
\)ote:
Yes indicates that the model is responsive to the criteria; and 
No indicates that the model is not responsive to the criteria.
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2.6.3. Overall Conclusions
The ability of a particular biophysical model to predict the response o f a particular 
end-point, cannot be judged only by its ability to curve fit the experimental data. 
For an empirical biophysical model, i.e. one which employs sets o f empirical data 
in its development, the uncertainty in predicting the response is further increased, 
if the model is used to extrapolate the response in the range outside o f the empirical 
data used. The uncertainty may somewhat be reduced if the model is used to predict 
the response by interpolation.
Among the problems of using an empirical biophysical model are:
i. Most biophysical models can fit any reasonable experimental data by 
adopting a suitable set of values for the parameters used in the model;
ii. Most empirical models are suitable for interpolative purposes. Often other 
possible equations may be used to interpolate the data points in a specified 
range. However it is less defensible if the model is used to extrapolate data 
outside the range of the empirical data used.
In radiological protection one of the main objectives of a biophysical model is to 
predict the response at lower doses, by using the model to extrapolate response from 
high doses to lower doses. It is believed that a biophysical model which is 
developed based on only empirical data, is not complete and suitable for the 
radiological protection purpose. A practical and realistic model must be conceptually 
sound and the basis used in the development of the model can be justified and 
supported by theoretical as well as practical knowledge of the underlying 
mechanisms. This type o f model is then suitable to be used to predict the response 
by extrapolation from high doses to lower doses. This concludes that the basis of 
the model and the meaning of the parameters supported by current knowledge, 
theoretically and practically, are more important. However the chosen model must 
also show to some extent that it is capable to fit the empirical data.
Based on the arguments presented in this section, among the five main biophysical 
models o f radiation action appraised and intercompared. Track Core (TC) model is 
chosen due to the following points o f merit:
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i. fluence is a superior parameter to quantify the radiation (which is believed 
to be better than dose). Indeed radiation effect depends on the number of 
particle tracks which actually pass and activate with certain probability (cross 
section), the sensitive sites o f the system i.e. DNA double strand;
ii. ABE is used to quantify the cross section of the effect i.e. response, 
which is relatable to the induction of DNA dsb which is believed to be the 
precursor to cellular inactivation, mutation and neoplastic transformation; and
iii. The model derived is based on experimental observation and well 
supported theoretically.
Validity o f any biophysical model o f radiation action could be further tested by not 
only external radiation but also internal irradiation from incorporated radionuclides. 
It should be able to explain unusual phenomena, such as the reverse dose-rate-effect 
for transformations [122] and high inactivation probabilities o f internal auger 
electron cascades.
In this exercise five main biophysical models have been evaluated, appraised and 
inter-compared. To proceed with this work, the TC model by Watt has been chosen. 
This model has been derived directly from experimental data (see section 2.4.5.9). 
It can offer an interpretation o f the auger electron cascades of internally incorporated 
radionuclides and predicted the reverse dose rate effect. The basis used in the model, 
is used to investigate an alternate dosimetry system for radiological protection (see 
chapter four).
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CHAPTER THREE 
CANCER RISK COEFFICIENTS 
FOR RADIOLOGICAL PROTECTION
3.1. General
Cancer risk has received utmost consideration in radiological protection mainly 
because it is likely to be the only significant stochastic effect for individuals exposed 
to ionizing radiation [123]. How can one ensure that all reasonable steps are 
taken to reduce the induction o f stochastic effects which is in compliance with the 
present system o f dose limitation? Two stochastic effects which have been identified 
are cancer and hereditary effects. Stochastic effects can be reduced in frequency by 
lowering the dose but cannot be avoided entirely because there is still a finite 
probability o f occurrence with low frequency, at lower doses. The risk o f these 
effects has to be reduced to a value, not exceeding the risk in other safe industries. 
Cancer induction by radiation which has become the primary effect of concern at 
low doses, is given more emphasis due to the current progress achieved on the 
subject and due to the accumulation of recent data from the epidemiological as well 
as laboratory studies relevant to cancer. A prudent judgement has to be made by the 
various national authorities responsible for radiological protection, to incorporate the 
appropriate level of risk, in the legal system of radiological protection.
ICRP has incorporated the most recent cancer risk coefficients for radiological 
protection purposes, in ICRP Report no. 60 [34], which is discussed under the 
probability of cancer induction. There are two projections of risk models, which can 
be used to derive the cancer risk coefficients. The projected risk models are termed 
the absolute (risk) or additive projection model; and the relative (risk) or 
multiplicative projection model.
The dosimetry system currently applied in radiological protection uses dose and the 
relative biological effectiveness (RBE) as the basis of the system. Dose is defined 
as the amount o f energy imparted in a unit of mass of the irradiated material. The 
RBE is used to indicate the relative effectiveness of a particular type o f radiation 
with respect to x-rays or y-rays for a specified biological end-point. Quality factors
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(Q) and radiation weighting factors (w^) are allocated safety factors based on a 
study of RBE and used in operational radiological protection to take care o f various 
radiation qualities in order to derive the dose equivalent and equivalent dose 
respectively. The meaning of the quantities and terms commonly used in the system 
will be given in brief in this chapter.
3.1.1. Cancer Induction by Radiation
Ionizing radiation has been identified as a carcinogenic agent [124][125].
The exact mechanism o f cancer induction by radiation and other agents, has not 
been firmly established yet but evidence is mounting to indicate that it is a multi- 
step process [126]. The general concept of the origin o f cancer is that o f "an 
event or events in one or more cellular mechanisms leading to autonomous cell 
division and finally expressed as complete or partial cellular escape from local or 
general control by the surveillance system, homoral or cell mediated" [127].
There may be many different initial events to initiate the series o f changes which 
result in malignancy. However the transformed cells may be neutralized by 
spontaneous reversion or repair by excretion or by various control mechanisms or 
such processes as differentiation or cell death. The development of a cancer is 
believed to occur in multiple changes and to proceed in sequential stages. At least
thi'ee processes are involved in the cancer induction namely initiation, promotion and |1
progression. The initial events in the genome and the production o f a cell or cells |
Iwith the potential to develop into a cancer are known as initiation. In the promotion j
process the initiated cells must undergo further changes, after stimulation by a {
1promoting substance to become a cell with malignant potential. Sometimes the j
promoted cell is called a precancerous cell. Progression is the stage where the |
division and multiplication o f the promoted cell (i.e. precancerous cell) gives rise |
to an occult tumour. !
I
IThe carcinogenic process, includes the growth of a primary cancer to a detectable J
size, about 1 cm in diameter with billions o f cells. Changes in the genome i.e. total |
chromosome content o f a germ cell, may take place in the germinal cells of the ;
reproductive tissue, which may be manifest as hereditary disorders in succeeding I
generations. Modifications in a single cell such as neoplastic transformation leading i
I
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to malignancy, may have serious consequences. Death of one or a small number of 
cells, in most cases, have no consequences in tissue. Alterations in normal cells 
caused by ionising radiation, can give rise to cancer occurrence. The probability of 
such a change is proportional to dose, at very low doses. On average less than one 
event per sensitive target in a cell occurs. For example, 1 niGy o f 1 MeV gamma 
rays, result on average 1 (or occasionally more than 2) tracks per cell nucleus; and 
1 mGy of 1 MeV neutrons, result about 10'“ tracks per cell nucleus. In a DNA 
molecule, there are about 2x10^ o f 2 nm segments. Assuming the contribution o f 5- 
rays is negligible, the probability o f energy being deposited in a particular 2 nm 
segment is small, in the order of 10'^ per track.
Initial event may involve more than one step in which radiation interaction is not 
necessarily the first. A clone o f cells with malignant potential may arise and 
eventually a cancer may develop. The probability of cancer induction is far lower 
than that of the initial events, because of host defence and the failure of succeeding 
changes required by the initiated cells.
3.1.1.1. Latency Period
On the average the latency period for all cancers is 10 years. The shortest latency 
period is for acute myeloid leukaemia which is equal to 2 years [34].
3.1.1.2. Generalization of cancer induction by radiation
For high LET, low dose rate or fractionation, may have;
a. similar effect to that of high dose rate single exposure in some cancers: 
or
b. others, more effective than high dose rate, single exposure.
Certain chemicals can increase the rate of tumour induction by synergistic effects, 
for example 12-o-tetradecanoyl phorbol-13 acetate and asbestos. However some 
chemicals can decrease the rate of tumour induction such as Vitamin A analogue. 
For a given organ or tissue the risk of cancer induction is assumed proportional to 
the number of irradiated cells at risk.
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3.1.1.3. For low LET (cancer induction)
There is little direct data available for low dose low LET cancer induction. 
Exposures are often at high dose rates. Therefore in order to establish a dose 
response relationship the following are taken into consideration:
i. theoretical considerations; and
ii. experimental data and limited human exposure (Japanese survivors from atomic 
bomb attacks, 1945).
Initiation of cancer is associated with the induction of lesions in genomic DNA that 
result in specific gene loses and/ or changes in gene structure. However the DNA 
repair system which involves an enzyme system, is able to recognise and remove 
lesions from the DNA. The repair system is apparently more effective after low dose 
rate exposure than that o f high dose rate exposures, which will introduce the dose 
and dose rate effectiveness factor (DDREF) between high and low dose rates. The 
general conclusions by the NCRP (1980) on the dose-response relationship are as 
follows:
i. for high doses, at high dose rate rates, the relationship is likely to be linear- 
quadratic in form; and
ii. for low doses at low dose rate, the relationship is expected to be linear at 
low doses.
NCRP defines the dose rate effectiveness factor (DREF) as the ratio between the 
slope o f the linear no-threshold fit to high dose , and the slope o f the linear no- 
tlneshold fit to low dose data. NCRP also assumes that the value o f DREF varies 
between 2 and 10, whereas UNSCEAR 88 recommends DDREF values between 2 
and 10. UjNSCEAR 93 recommends DDREF values about 2 and may not be more 
than 3.
3.1.1.4. Dose and Dose Rate Effectiveness Factor (DDREF) for low LET
Cancer induction at low doses and low dose rates should be less than observed after 
high dose and dose rates. The ICRP recommends for radiation protection purposes, 
to use the value of DDREF equal to 2 [34].
3.1.1.5. Cancer induction after exposure to high LET radiation
Penetrating and short range high LET radiations are more damaging than low LET
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radiations per unit absorbed dose. For cell killing RBE values are about 2 or 3 and 
rise as the doses decrease. For deterministic effects RBE values do not exceed 10.
For stochastic effects the RBE of high LET is a function o f dose determined by the 
shape o f the dose response relationship. The maximum value, i.e. RBE„, (a constant 
value), at low doses where both the low LET and high LET dose-response curves 
become linear. Figure 3.1 shows that for high LET, fractionation is more effective 
than for low LET. Reverse dose-rate effect is the increase of the effectiveness with 
decreasing dose rate and or fractionation (in some cases for high LET radiation) at 
low doses.
3.1.1.6. Estimates of Probability for Carcinogenic Effects
New information on the risk of radiation induced cancer has emerged from human 
populations and from experimental data in both laboratory animals and cultured 
cells, which include the following:
i. About 90,000 survivors of the atomic bombs in Japan, are continually 
assessed, initially by using the official Tentative Dosimetry System 1985 
(T65D) and recently 76,000 o f them are assessed by using Dosimetry System 
1986 (DS86). The estimates o f the probability of cancer death from 1950 - 
1985 are increased over earlier estimates because of:
a. The increase in the number of cases (excess solid cancer)
about 135 in 1975, and about 260 in 1985: Leukaemia, about
I70 in 1950-1975, and about 80 in 1950-1985; j
b. The new dosimetry system (DS86), apparently increases the 1
probability values by about 30 percent only. However i
I
according to Thiessen et-al [128] there are two more I
important factors related to the increase namely: I
i. There are indications that those who were exposed j
while very young are now beginning to demonstrate |
an increased risk of radiogenic cancer; and ;
1ii. The relative risk projection model is better to i
represent the atomic bomb survivors data than the |
constant absolute risk projection model; I
c. Small changes in methods used to calculate the age specific j
1 2 0
probability o f cancer; and
d. Preference for the multiplicative model rather than the 
additive model for projection of the solid cancers to lifetime 
values (section 3.3);
ii. Solid cancer data from about 14,106 patients suffering anlcylosing spondylitis 
followed up after undergoing radiotherapy treatment.
The main basis for ionizing radiation risk estimate is the data from the atomic bomb 
survivors. The bombs were dropped in Hiroshima and Nagasaki on the sixth of 
August and the ninth of August 1945, respectively. A list o f the total number of 
malignancies in the survivor population by site of cancer as well as an estimate of 
the excess number of malignancies by site for all dose categories, all ages at 
exposure and both sexes, is shown in table 3.1. Other data are also available as 
reported in the literature which includes accidental exposures, occupational 
exposures (mining, dial painters), medical therapeutic (ankylosing spondylitis) and 
diagnostic exposures.
From the molecular biology point o f view, radiation can inactivate oncogenes which 
will be expressed somatically to produce malignant tumours. An oncogene [129] is 
a particular type of gene in the DNA which, if affected by radiation (e.g dsb), will 
lead to malignancy. The first oncogene discovered was sic  gene which can induce 
tumours in chickens [131] and over 25 additional oncogenes have subsequently been 
discovered.
1 2 1
High LET
Fractionated/ Low LET
Single Single
H-H-UJ Fractionated
Dose
Fig. 3.1: Shapes o f dose responses for low LET and high LET radiations plotted on 
linear axes (Sinclair 1982)
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Table 3.1: Atomic Bomb Survivor Data for the Period o f 1950 to 1985.
Site o f cancer Total cancer cases" Number o f excess cancer 
cases '^"^
Leukaemia 202 78
All cancer except 
leukaemia
5 J3 4 266
Oesophagus 176 11
Stomach 2,007 72
Colon 232 19
Lung 638 44
Female breast 155 22
Ovary 82 10
Urinary tract 133 19
Multiple myeloma 36 8
Remainder 2,275 61
Total for all sites 5,936 344
Assumes an average shielded kerma o f 0.162 Gy.
 ^The number of cases are for all exposure categories up to and including the 4+ Gy 
category.
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3.1.2. Risk Assessment
Radiation risk assessments have been carried out by various competent national as 
well as international authorities, dealing with radiological protection. In the 
following sections o f the chapter the risk assessment carried out by the ICRP will 
be presented in brief. However the induction of cancer is given more emphasis than 
the other effects due to current progress and the availability o f recent data in this 
field. Epidemiological study on the survivors of the atomic bombs in Japan, 
population o f more than 90,000, is the most important single source o f information 
for estimating the relationship between cancer risk and radiation dose.
Lambert [130] has noted that a full assessment of radiation risk at low levels 
have to include genetic and somatic effects. However the carcinogenic effect 
(somatic) is considered more important because cancer are often lethal and cancer 
is the only statistically verifiable cause of life shortening at low and intermediate 
doses. Its assessment at occupational or environmental doses (i.e. mSv per year or 
a few tens o f mSv) is difficult by direct observation. Only the epidemiological 
studies such as on the Japanese survivors of the atomic bombs, will likely resolve 
uncertainties in our estimates of cancer risk.
One of the developments in risk assessment is to take the quality o f life into 
consideration. Dennis [131] has pointed out that the input from social scientists 
may add other weighting factors in radiological protection which reflect the public 
evaluation o f the hazards from different sources. For examples why, in the public 
view is a sievert from the discharges o f nuclear power processing plant not the same 
as the sieveit from radon at home or from medical diagnosis? In the public view 
also there are fates that may be worse than death such as permanent paralysis below 
the neck or protracted terminal cancer.
3.2. Cancer Risk Coefficients
3.2.1. Cancer Risk Assessment by ICRP
3.2.1.1. Introduction
ICRP has clarified the term risk and decided to abandon its practice of always 
strictly using ’risk’ with the specific meaning of ’probability’ and to attempt to use, 
where practicable, the more direct term probability. Risk is a concept rather than
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a quantity. It may be seen as a multi-attribute quantity. Therefore according to 
ICRP. risk assessment is not necessarily synonymous with probability assessment 
but may include assessment of other aspects of risk: the nature and severity of the 
harmful consequences.
The Comm ission is concerned with two quantifiable risk quantities, namely:
i. The probability of each harmful effect (i), Pj
The effect will have to be specified eg. lethal cancer or curable cancer, 
severe hereditary harm, etc.; and
ii. The consequence if the effect occurs, W;
The consequence can be described in a variety of ways, indicating the 
severity o f the effect and its distribution in time.
The mathematical expectation of consequence, identical to the average consequence, 
is given by:
TV,.
when averaging is relevant, where;
Pj the probability o f each harmful effect (i); and 
Wj the consequence if the effect occurs.
It is a quantity which is sometimes used in the effort to express the magnitude of 
the risk by one single measure. In the individual case, the mathematical expectation 
(W=P.w) is not an expected result, because the only possible outcomes are zero or 
w measure o f harm.
Example:
Given that, the probability of losing, on average 20 years of life because of 
cancer, is equal to ID'*’ (i.e. P=10"^). The expectation of loss of life i.e. 
W=P.w, is equal to 10'^x20 years =2x1 O’" years (i.e. about 10 minutes). The 
real loss of life is either zero with probability P, equal to P=(l-10‘‘^) or about 
20 years with probability equal to P=10 '’.
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So the use o f the expectation, in this case masks the fact that it is composed of the 
two components P and w. The probability of death is the major factor in the multi­
attribute concept of risk. Other attributes should also be considered, such as illness, 
hereditary disease, risk to any fetus, economic losses, anxiety and other societal 
impacts.
The dose limits recommended in the ICRP publication 26 [35], were put forward 
with the implied assumption that an annual occupational death probability of about 
10‘^  to the most exposed individuals would be at the border o f being unacceptable. 
The corresponding death probability for members of the public at the annual limit 
o f 1 mSv would be about 10'\
3.2.1.2. The Risk of Death
Radiation induced cancers are indistinguishable from cancers induced by other 
agents. Radiation risk has been expressed as the percentage probability of death 
per Sievert. The introduction o f a new risk source will only change the distribution 
of the probable causes o f death, but will not change the lifetime probability of death. 
The total probability of death is 100% and it can not be increased. The introduction 
of a new risk source will only change the distribution of the probable causes of 
death. So, any increment that a new risk source causes, is an increment to the death 
probability rate at any given age, provided that the person is alive at that age (i.e. 
conditional probability rate).
The total conditional death probability rate from all causes can usually be described 
by the Gompertz-Makeham expression:
where
Go(U) is the total conditional death probability rate from all causes, for an 
average person given that the individual is alive at every age U ;
U is the age in years; and
A,B,C are parameters derived from demographic tables.
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A constant dose rate from age 18 to 65, may add a conditional source related 
increment o f probability rate. dP/dU. to the background rate:
G([/) = GALT) + dU
where,
G(U) is the total conditional death probability rate from all causes including 
radiation, for an average person;
Go(U) is the background rate; and
dP/dU is the conditional source related increment of probability rate.
3.2.1.3. The Background Conditional Death Probability Rate [G„(U)]
Gg(U) (excluding radiation) according to Gompert-Makeham is given by the 
following expression:
G,(U)= A e + C.
Usually Gq(U), the lowest when U=10 years and the annual probability o f death is 
about 1-2 in 10,000 in industrialised countries and 1 in 1,000 in developing 
countries. For choosing a dose limit, it is necessary to examine the overall risk 
picture and the Commission prefers a multi-attribute approach to the choice o f dose 
limits.
3.2.1.4. Primary Risk Coefficients Kd.ao Cp
A radiation dose, if received by an individual at a given age. will involve a risk 
commitment, namely a commitment of an increased cancer death probability rate in 
the future, after a minimum latent period for specific types of cancer. The 
occurrence o f cancer requires a minimum latent period of time elapsed since the 
radiation exposure. The risk committed by a radiation dose at a given age therefore 
cannot be added to the background risk at the same age. An increased cancer death 
probability rate (dp/du) will occur only after a minimum latent period of time since 
the radiation exposure. In the case of internal exposure, the committed effective dose 
may be delivered to a specified organ long after the intake o f the radioactive 
substance, which further delays the expression of harm. Two models have been used 
for risk projection with time:
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i. Additive or absolute model
The excess probability rate is dose dependent but age independent; and
ii. Multiplicative or relative model
The excess rate increases with age at the same rate as the background cancer 
rate.
3.2.1.5. Methodology: Models for Projection of Probabilities
Two principle models for the estimation o f probability o f cancer induction have 
been used viz. the absolute (risk), or additive projection model; and the relative 
(risk), or multiplicative projection model. The absolute or additive model predicts, 
after a minimum latency period, the constant excess o f induced cancer thi'oughout 
life unrelated to the spontaneous rate of cancer. The relative or multiplicative model 
predicts, after a minimum latency period, the excess of induced cancer will increase 
with time as a constant multiple of the spontaneous or natural rate o f cancer, and 
consequently will increase with age in that population.
The total death rate (per year at age a) qoAo(a) is given by: 
qD.Ao(a)=qo(a) + ho^,(a)
where
q„(a) is due to natural causes; and
ho Ao( )^ is the excess death rate due to dose D at age A„.
The probability of surviving ao(^) until age a after a given dose D at age A  ^ is: 
Ld,ao(u)=1 for a < Ao; and
LD.Ao(a)=LD.Ao(a-l)-(l-qD.Ao(a-l)} for a=A o+l..................
where
Ld.ao(u- 1) is the probability of survival until age (a-1); and
qD.Ao(U“l) is the death rate at age (a-1).
Survival to age a implies survival to age (a-1) and precludes death at age (a-1).
So the probability of survival until age a is the product of the probability of 
survival until age (a-1) and (1- (total death rate per year at age (a-1)}.
The amiual probability of death from any cause at age a is equal to Lo Ao( )^ qD.Ao(u). 
The annual probability of a radiation induced death at age a is equal to 
LD.Ao(u)-hQ_Ao(u)-
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The lifetime probability of a death due to radiation exposure D at age Ao is equal 
to U(Ao,D) given by:
m axageUiAo.D)  =
a=Ao
If in interval (A l. A2) where Ao < A1 < A2. the cumulative mortality Rq ao(A 1,A2) 
is given by:
Ao Ao (
a =A l
Note that the annual probability o f death from any cause at age a is equal to the |
product of the surviving probability to age a [L^ ^oCu)]; and the total death rate at 
age a [qo.AoCu)]- The annual probability o f death due to radiation exposure is equal 
to the product of the surviving probability to age a [L^ A o ( a ) ]  and the death rate due j
to cancer h^ .AoCa). I
i
The expression for the total death rate (per year at age a) qoAo(^) is given by: |
q D . A o ( a ) = q o ( a )  +  h ^  A o ( a )  I
where
q„(a) is due to natural causes; and ;
^D.AoCu) is the excess death rate due to dose D at age A^. I
In the simple additive model: j
hD.Ao(u)=0 for a< Ao +m ; and j
hD.Ao(u)=KD.Ao for a > Ao+m J
In the simple multiplicative model: I
ho.Ao(u)= 0 for a< Ao +m ; and |
I
h D .A o ( a ) = C D  Ao qo.(canccr)(a) f o r  ^  >  A o + m  j
where j
ÏKd Ac and Cd Ac depend on D and Ao, but not on a; j
qo(a)~qo.(cancer)(a)' q^o,(non-caiicer)(a)? and
qo.(caiiccr)(a) is the component o f q o ( a )  that pertains to the specified cancer being 
considered.
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Table 3.2; Primary risk coefficients for annual cancer death (UNSCEAR, 1988). 
These risk coefficients have been derived on the basis of observations on the cancer 
death rate among the survivors from the atomic bombing o f Hiroshima and 
Nagasaki. They relate to high doses and high dose rates and are strictly applicable 
to the Japanese survivors only. "ERR"=excess relative risk.
Age at 
exposure 
(years) Ao
Males Females
Additive lO '-Sv' 
and year K^ .Ao
Multiplie.
ERR/Sv
^D.Ao
Additive lO '-Sv' 
and year Ko
Multiplie.
ERR/Sv
^D,Ao
(a) Leukaem ia
0 - 9 0.0384 18.7 0.0300 19.5
10 - 19 0.0203 4.4 0.0104 4.6
20 - 29 . 0.0434 5.6 0.0249 5.8
30 - 39 0.0631 3.9 0.0196 4.1
40 + 0.0472 3.3 0.0318 3.4
(b) all cancer 
but leukaemia
0 - 9 0.0148 1.06 0.0407 2.06
10 - 19 0.0526 0.65 0.0707 1.27
20 - 29 0.126 0.57 0.137 1.11
30 - 39 0.114 0.24 0.137 0.48
40 + 0.164 0.18 0.186 0.34
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3.2.1.6. Convention on acceptable risks
Our daily activities, such as walking, motor-cycling, horse riding, driving etc. carry 
some risks. Some activities are accepted and some are not accepted even though the 
risks have been reduced as far as reasonably achievable. Society has accepted an 
unspoken convention on risk acceptance in order to enjoy the benefits of a modern 
society, provided that the risks are not unnecessary or easily avoided. But what 
levels of risk are acceptable?
Example:
From a report of a study group of the British Royal Society (1983); 
imposing a continuing annual occupational probability o f death of 1 in 100 
would be unacceptable. The situation imposing an annual probability of 
death o f 1 in 1000 is less clear, either acceptable or unacceptable. However 
the annual probability of death is only one attribute which is appropriate to 
take into account. The annual probability level of 1 death in 1000 could 
’hardly be called totally unacceptable provided the individual at risk Icnows 
of the situation, judged he had some commensurable benefit as a result, and 
understood that everything reasonable had already been done to reduce the 
risk’.
3.2.1.7. Assessment Based on the Additive and Multiplicative Models
The results o f assessment based on the additive and multiplicative models, carried 
out by the ICRP are as shown in figures 3.2, 3.3, 3.4, 3.5 and 3.6. The value of the 
parameters used in the assessment are as follows:
i. L= 2 years for Leukaemia;
ii. L=10 years for other cancer;
iii. P=40 years for Leukaemia;
iv. P=infinity for other cancers;
V. DDREF is assumed equal to 2;
vi. Exposure age A^= 5 years and 35 years;
vii. The conditional death probability rate (dP/du);
viii. The unconditional death probability rate (dr/du); and
ix. The attributable lifetime probability o f death (R).
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C o nd i t io n a l  p ro bab i l i ty  r a t e  
ADDITIVE MODEL
Minimum l a t e n c y
d p / d u  R r_ • D
AgeE x p o s u r e P l a t e a u  le n g th
(b)MULTIPLICATIVE MODEL
d p / d u  c r . d -B(u)
(c)
MULTIPLICATIVE .^........ . \
ADDITIVE .< \ I
\  \
T
Fig. 3.2: Illustration o f the two simple projection models. Figures (a) and (b) show 
the stylised models which have been used for the calculations; Figure (c) indicates 
possible curve shapes under more realistic assumptions, (a) The simple additive 
model: The excess conditional probability rate (of death from cancer) after a single 
radiation dose D,is assumed to be proportional to the dose, but first after a minimum 
latency period and over a plateau period o f time, (b) The simple multiplicative 
model: The excess probability rate is also assumed to be proportional to the 
background rate o f cancer death, B(u).
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A tt r ib u tab le  d e a t h  p ro b a b i l i ty  r a t e  
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E x p o s u r e  a t  a g e  5
l e u k a e m i a
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1 0 0  y e a r s5 0 a g e
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0 .3  -
d r / d u
0.2 .
l e u k a e m i a
1 0 0  y e a r sa g e5 0
Fig. 3.3; Variation with age of the attributable death probability rate dp/du 
(conditional) and dr/du (unconditional) after a single small dose at age 5 years, 
assuming a DDREF of 2. The discontinuities reflect the simplified assumptions on 
minimum latency periods and plateau shapes (refer to figure 3.2)
133
0 .0 9  _
0 . 0 6
0 . 0 3
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Fig. 3.4: Variation of age of the attributable death probability rates after a small 
single dose at age 35 years, assuming a DDREF of 2. The discontinuities reflect the 
simplified assumptions on minimum latency periods and plateau shapes (refer to 
figures 3.2 and 3.3).
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Fig. 3.5: The attributable lifetime risk from a single small dose at various ages at 
the time of exposure, assuming a DDREF of 2. The discontinuities are the result of 
the use of constant annual values for the primaiy risk coefficients within 10-year age 
interval. The higher risk for the youngest age group will not be expressed until late 
in life.
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Fig. 3.6; The unconditional death probability rate (the attributable probability densitv 
of the age of death, normalised for lifetime risk) for two exposure situations: (a) 
exposure from birth over lifetime, and (b) exposure from age 18 to age 65 years. 
The curves are for females, assuminu a DDRTF of 2.
3.2.1.8. Conclusion
The results o f the ICRP risk assessment are as follows:
i. For workers the risk which corresponds to a dose limit of 20 mSv per year 
is determined from the cancer risk coefficient of 4x10'- S v ’ (called the 
’nominal probability coefficient' by ICRP) to be equal to 20xl0'^x4xl0'"= 
8x10"’ per year; and
ii. Similarly, for the general population the dose limit is 1 mSv per year and 
the cancer risk coefficient is 5x10'- Sv'' which corresponds to a risk of 
Ixl0'^x5xl0'^= 5x10'- per year.
The nominal probability coefficients for stochastic effects are summarised in table
3.3, and the nominal probability coefficients for individual tissues and organs, are 
given in table 3.4.
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Table 3.3: Nom inal Probability Coefficients for Stochastic Effects
Exposed Detriment (10'- Sv'')
population Fatal Cancer^ Non-fatal
cancer
Severe
hereditary
effects
Total
Adult workers 4.0 0.8 0.8 5.6
Whole
population
5.0 1.0 1.3 7.3
Rounded values
For fatal cancer, the detriment coefficient is equal to the probability 
coefficient.
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Table 3.4: Nom inal Probability Coefficients for Individual Tissues and Organs®
Tissue or 
organ
Probability o f fatal cancer (10'- 
S v ')
Aggregated detriment 
(10'- Sv ')
Whole
Population
Workers Whole
Population
Workers
Bladder 0.30 0.24 0.29 0.24
Bone Marrow 0.50 0.40 1.04 0.83
Bone Surface 0.05 0.04 0.07 0.06
Breast 0.20 0.16 0.36 0.29
Colon 0.85 0.68 1.03 0.82
Liver 0.15 0.12 0.16 0.13
Lung 0.85 0.68 0.80 0.64
Oesophagus 0.30 0.24 0.24 0.19
Ovary 0.10 0.08 0.15 0.12
Skin 0.02 0.02 0.04 0.03
Stomach 1.10 0.88 1.00 0.80
Thyroid 0.08 0.06 0.15 0.12
Remainder 0.50 0.40 0.59 0.47
Total 5.00 4.00 5.92 4.74
Probability o f severe hereditary disorders
Gonads 1.00 0.6 1.33 0.80
Grand total 
(rounded)
7.3 5.6
The values relate to a population of equal numbers of both sexes and a wide 
range o f ages.
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CHAPTER FOUR 
PROPOSED NEW SYSTEM FOR RADIOLOGICAL PROTECTION
4.1. General
The proposed new system o f dosimetry is called a unified dosim etiy system which
is a system for the direct assessment of the absolute biological effectiveness of
ionising radiation without the need to know the radiation intensity and type,
therefore, it obviates the need for quality factors. From published data on damage
to yeast, plant and mammalian cells, the mean free path (X) for ionisation of the
charged particle tracks emerges as a physical parameter which best unifies data.
Damage is found to be optimum when the spacing of the ionization along the tracks
in the cell nucleus matches the mean strand spacing in the DNA segments (i.e. for
X-2  nm). This finding is common to the induction of mutations, chromosome 
aberrations and inactivation [132]. Bryant [133] has indicated that the
inter-strand distance between ends of a double strand break is 1.8061 mn. The
damage mechanism depends on the number of interactions via the interaction cross
section, and not on the amount of energy transferred (i.e. not on dose, LET, RBE
etc.). In the unified dosimetry system, the mean free path for ionisation X, o f the
charged particle is used as an important physical parameter of the radiation. For fast
particles X is directly proportional to zVf3“ and most particles are maximum
damaging at energies below X equal to ~2 nm. The parameter z“/P“, is proportional
to the yield o f delta rays per unit distance and also to the yield o f primary ionization
per unit distance, along a fast ion track. Absolute Biological Effectiveness (ABE)
is determined as the quantity which indicates the effectiveness of the radiation at
inducing DNA dsb as it penetrates thi'ough a cell nucleus. It is desirable that
radiation quality be defined absolutely in terms of appropriate physical and
biological parameters so that the fundamental requirements for designing radiation
measuring devices can be identified. In proposing the unified dosimetry system both
physical and biological parameters are taken into consideration.
The charged particle tracks are attributable to the incident fluence, whether it is of |
directly or indirectly ionising radiations. Radiations such as x-rays, y-rays or low j
energy electrons, produce a slowing down spectrum of secondary electrons with j
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different energy and spatial distribution. In the unified dosimetry system, the 
following parameters are used:
Â The mean free path for primary ionisation:
(j). The fluence o f the charged particles at equilibrium (or the charged
particle fluence);
rtg The effect (or action) cross section which is used to indicate the
induction of a specified biological end-point per unit fluence; and 
P The damage probability or intrinsic efficiency, defined as the quotient
o f the effect cross section ( a j  by the projected cross sectional area 
(cr ) o f the radiosensitive target i.e. P= c j/a  .
In conventional dosimetry quality and quantity of radiation are required to assess the 
biological effectiveness o f a particular radiation. ’Quality’ is usually expressed as 
relative biological effectiveness (RBE), in radiobiology or as quality factor (Q), in 
radiological protection whereas ’quantity' is usually expressed as absorbed dose. D. 
Instrumentation for measurement of radiation is designed in such a way that the 
response of the device which is a function o f particle energy, is related to specified 
biological effect, as a function of energy. For example a BF3 proportional counter 
can be fitted with a hydrogenous moderator to produce a long counter in which the 
count rate is proportional to neutron fluence rate independent of energy. In the 
unified dosimetry system, the signal from suitable instruments is related to the 
probability that exposure to the radiation field will induce cancer within a person’s 
lifetime [134].
4.1.1. Effect Cross-section (o j
The effect (or action) cross-section (cjJ measures the probability that the effect will 
occur in the target per incident track per unit area. The basic definition is 
’probability per unit fluence'. Hence for cell survival, the probability o f survival (F) 
is equal to the survival fraction (SF) i.e. F=SF. Therefore for exponential survival 
SF=exp(-ae,y.(|)), the effect cross-section ( a j  is equal to the first derivative o f F 
against fluence ({()) i.e. a=dF/d(j). For F=exp (-a((|)).(|)) with a  a function of (}). lnF=- 
a((|)).(j), therefore a((t))= -lnF/(|). In general, for exponential survival with cross
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section a function of fluence; o^(d>) d(|)
At 37 % survival lnF=-L therefore a  l/i))^  ^ or 1%  but note that the survival 
curve may not be a straight line on a In-linear plot. RBE o f radiation type 1 (LET 
track average L j ,) with respect to the reference radiation type 2 (LET track average 
L j .)  is given by:
RBE, = —2 = ^T,2
T , 1
with an assumption that the response can be expressed as a pure exponential.
The expression for the integral fluence, {j)^ , generated by the field radiation, takes 
different forms, according to whether the initial radiation field is directly or 
indirectly ionising and whether the experiments are performed in a track segment 
arrangement or under charged particle equilibrium conditions [135]. In case of:
i. External irradiation by charged particle beams in track-segment experiments;
where (|), is the fluence of charged particles incident on the whole sample;
ii. External irradiation in photon or neutron beams under charged particle
equilibrium conditions;
4), =4)v ' 4)i
where (|)^  is the equilibrium fluence of charged particles generated per 
interaction per unit volume, p..^; is the source density i.e. the product of the 
interaction coefficient for the indirectly ionising radiation in the medium 
(macroscopic interaction cross section or inverse interaction mean free path) 
and the incident fluence o f photons or neutrons; and
iii. Internal irradiations by alpha, beta, or gamma emitters homogenously
distributed in the target medium;
4>s =4>v - C  ; (j)v = R p .  F s  
where (j)^  is the equilibrium fluence of charged particles generated per unit
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source strength and C is the concentration of source activity in the sample. 
Rp is the range o f the frequency weighted average energy o f primary charged 
particles representing the decay spectrum emitted by the source activity of 
concentration C. is the build-up ratio of secondary to primary charged 
particle fluence.
The degree o f damage is determined predominantly by the number and correlation 
of physical interactions and not necessarily by the amount of energy transfer. The 
cross-section for radiation effect for the incident charged particles, is used to 
quantify the degree o f biological damage. Radiation effect is expressed in terms of 
the quantity ’intrinsic efficiency o f action’, P, for the charged particle track which 
actually enters a well defined geometric cross-section area of the irradiated 
specimen [136]. Thus P=a/o'g where a^ , is the whole molecule in the case of 
enzymes, the cross-sectional area within the protein coat for viruses, or the cross- 
sectional area o f the nucleus for cells. Most recent work indicates that could be 
best defined as the geometrically projected cross-sectional area o f the nuclear DNA.
4.1.2. Calculation of Effect Cross Section (o j
By assuming that cellular material has density p, the microscopic cross-section for 
induction o f the effect by individual charged particle radiations (effect cross section 
Og) can be extracted from the dose survival curves, by the following formula;
o „ = 1 . 6x l O~^  —^  cm^ ^ D .  p
where
Lp is the track average LET in kev.pm ' for the relevant charged particle 
energy spectrum;
D is dose in gray; and with an assumption that it is a pure exponential 
response; and
p is the density taken as unity in gcnf \
For fast charged particles (accelerated ions) in track segment experiments, L is 
calculated for the primary ion tracks and D is taken as the dose which corresponds 
to 37% survival fraction. For X and y irradiation, the effect is due to the slowing
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down recoil electron spectrum in transient equilibrium. L refers to the track average 
LET for the spectrum and D corresponds to the quoted by the original authors, 
or averaging the slope over the approximately linear portion of the survival curve 
[137].
The foregoing biophysical interpretation of the mechanism of radiation effects are 
to be applied to the currently accepted system of dosimetry for radiological 
protection. The method of risk assessment applied to the Japanese bomb survival 
data, will be reinterpreted within the new model (section 4.4.1).
4.2. Deduction of St. Andrews’ Model
The approach used for developing a model of radiation action in the University is 
first to correlate on a single curve the information reported on cellular effects 
observed in a variety of irradiation circumstances, for many radiation, types and for 
a variety o f biological end-points. Attempt has been made to quantify the observed 
survival data as effect per unit fluence o f track, in the relevant charged particle 
spectrum. For photons and neutrons, the respective equilibrium fluence spectra are 
o f recoil electrons and protons. For track segment irradiation, the fluence of incident 
particles has been taken as equal to the equilibrium fluence spectrum . The results 
are expressed as a ratio to the observed saturation effect cross section to yield the 
effect probability (P) per incident track [137] i.e
e f f e c t  c r o s s  s e c t i o n
^ s a t u r a t i o n  e f f e c t  c r o s s  s e c t i o n ^ ^ s a t ' ^
The saturation effect cross-section (cr^J is believed to be the projected area of the 
cellular DNA.
The advantages of this approach are several which include:
i. to improve The signal to noise ratio’, (i.e. only a very small percentage of 
dose D is efficient) as the net observed biological effect is attributed on 
probability grounds to the single track which penetrates the sensitive sites 
(see section 2.4.5.2);
1 4 4
ii. to provide a method of correlating data for different target types to reveal 
their similarities and differences: and
iii. it has high interpretive value as the radiation track is used essentially as a 
probe to explore the structure of the sensitive site within the biological 
target. For example by expressing the damage probability as a function of 
the mean free path for selected physical interactions, information is obtained 
on the presence o f significant sites and their critical linear dimensions.
The cross section ratio, or the intrinsic probability (P) represents the net intrinsic 
efficiency o f action of single tracks in the relevant charged particle spectrum, to 
which the sensitive sites are exposed. Plots of P against the mean free path for 
ionization by the tracks X, showed better correlation of data than that obtained for 
other parameters e.g. LET, and led to the following conclusions:
i. Structure is observed at a mean free path (X) o f between 1.5 and 2.0 nm and
occurs only in targets containing DNA. The most probable damage is when 
X=X^ f=2 nm. When X is different from the probability o f damage of the 
ionisations occurring at the appropriate spacing À, is given by s= (l- exp(-
ii. An analysis o f chromosome aberrations indicates the same basic mechanism 
is involved but the probability o f aberration is lower by a factor o f four 
compared with cell inactivation. It suggests that one in four double strand 
breaks (dsb) leads to chromatid breaks or that two simultaneous dsb are 
required-pairwise lesions;
iii. The ô-rays must have relatively small effect as the extrinsic efficiency of a 
delta ray track is found to be less than 10“’;
iv. At the same mean free path (À,), the equilibrium electrons from irradiations 
by electrons, x-rays and y-rays, are found to act with an intrinsic efficiency 
(P) of about one order of magnitude smaller than that for heavy particles, or
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charged particle recoils from neutrons. In other words the absolute quality
of an electron is about ten times smaller than the absolute quality o f a heavy
charged particle at the same mean free path X. Electrons are effective at
track ends where X for ionisation is in the neighbourhood of 2 nm which
corresponds to electron energy about 100 eV. However 100 eV electrons
have penetration depths o f a few nanometres and therefore they can never
penetrate more than one DNA segment. Whereas heavy particles can have
X less than 2 nm in portions o f their tracks, sustained for considerable 
distance, and thereby can penetrate 10 to 20 DNA segments; and
V.  It is expected that electrons will have a saturation inactivation cross-section 
equal to the geometrical projected cross-sectional area presented to the 
incoming electron track by the DNA in the cell nucleus (i.e. about 4 pm- 
depending on the cell type). Heavy particles have a saturation effect cross- 
sectional area equal to 10 to 20 times this value, due to the overlap of 
segments of DNA at risk along a mean chord traversal of the cell nucleus. 
Therefore the saturation inactivation cross-section for heavy particles (A.< 2 
nm) and for neutrons is 40 to 80 pm-, depending on the number o f DNA 
segments at risk, which in turn, depends on the cell type and their exposure 
conditions. Neutrons probably cannot quite achieve the maximum cross- 
section because the proton ranges at optimum damage are less than the cell 
nuclear diameter.
Although no preliminary assumption is made about DNA, the critical lesion 
emerging from the model is the DNA double strand break (dsb). It is an obvious 
conclusion from direct experimental measurement and the new analysis. The yield 
o f DNA double strand breaks (dsb) is derived from direct action, indirect action and 
mixed or combined effects of direct and indirect actions (see also page 72).
4.2.1. Direct Action
The cross section for dsb production by direct action ( a j  is given by:
Cd=(T .^n .^E
where
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a , is the projected geometrical area of the DNA (a„ %4 pmQ;
is the number o f overlapping segments at risk along a mean chord 
through the cell nucleus: and 
E is the probability that at least a single interaction will occur in each
of the two strands, each of thickness x, spaced at a mean chord 
distance of 2 nm.
The probable values of s are:
i. For two ionisations occurring anywhere in the 2 nm distance i.e. e = l- ( l 
+XJX) exp (-XJX)-, e ~ 0.3;
ii. For one ionisation occurring in the first strand and the second within the 
next 2 mn distance i.e. 1 -exp(-x /l)j[ 1 -exp(-Xyi)]; 6 ~ 0.4; and
iii. For non-saturating tracks, one hit in each of the two strands and nothing in 
between
i.e. e=exp(-XyX)[l-exp(-x/l)]-; e ~ 0.16.
The mean number o f dsb in DNA induced per cell by direct action is given by:
N d . dsb
where
(|) is the integral equilibrium charged particle fluence in the cell nucleus: and
CFd=a .^n .^E
4.2.2. Ind irec t Action j
The mean number of dsb produced per cell by radical action is given by:
Ni. d^sb- 4) 
and Cdsb==o-%,b/cFg
where
CTggb is the production cross section of single strand breaks in DNA, the general
form is given by: ct;gb=a,.exp(-a2. C 1 -exp(-a3.LyCDNA)] 
a, is a geometrical interaction cross section:
a .^ a. are constants:
Cgg is the intranuclear scavenging concentration;
147
is the molecular density o f single strands of DNA present in the cell nucleus; 
and
L J- is the track average LET for the equilibrium of the charged particles in the
cell nucleus; and
n, is the total number o f DNA segments in the whole cell nucleus which differs
with i\ .
4.2.3. M ixed Action
For mixed action the combined effects of indirect and direct actions on individual
strands gives:
=2.n . [ 1 - e x p ( - x / À ) ] .
F^ M.dsb ^M.dsb'^
and N-p Np> + N, +N^^
where Ny ^ gy is the total initial yield of double strand breaks in the absence of repair, 
produced by a single track in the cell nucleus.
The repair o f indirect and direct damage is assumed to occur at the same rate with 
a mean repair time t,.^ ,,. A simple damage factor can be derived as follows:
j  e x p  [ - (  t . - 1) /  ] d t
The overall survival fraction (SF) is given by:
SF=exp[-Npj,y.K(ti)].
The total yield o f dsb can be expressed in terms of absolute biological effectiveness 
(ABE) and the incident fluence (() and the overall survival fraction is given by: 
SF=exp(-ABE.(t)).
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4.3. Revised Dosimetry System
4.3.1. Conceptual and Principles
The foundations of the unified system o f dosimetry are as follows [138]:
i. The absolute specification of radiation quality is based on the probability of 
induction o f a specified end-point (e.g. inactivation or mutation) by single 
charged particle tracks which actually enter the biological target. The 
relevant charged particles are those in the equilibrium charged particle 
spectrum generated in the medium by indirectly or directly ionising radiation 
(see page 142). The probabilities for induction of the specified damage 
represents the intrinsic efficiencies o f action which are absolute measures of 
the radiation quality. The absolute biological effectiveness (ABE) can be 
defined in terms o f the product o f the geometrical cross-section o f the site 
and the intrinsic efficiency for unit incident fluence o f radiation;
ii. The important radiosensitive sites in the cell nucleus are the double stranded 
segments in the nuclear DNA;
iii. The dom inant crucial physical parameter of the charged particle radiation is 
the mean free path between ionization interactions;
iv. Damage is a stochastic process which occurs when the mean spacing 
between interactions along the charged particle track matches the mean chord 
distance tluough a DNA segment (~2nm);
V. Radiation effects depend mainly on the frequency and spatial correlation of
interactions, and not on the energy transferred in the interactions;
vi. Damage is predominantly due to intra-track, not inter-track, processes for all
radiations except at very large doses. The slope of the probability (P) against 
the mean free path (X) for X >  2 mn (i.e. the unsaturated region) is near 
unity (refer to figure 4.1). In other words there is a negligible ’dose rate 
effect’ which is contrary to the current thinking in many proposed models 
of repair.
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4.3.2, Calculation of Absolute Biological Effectiveness (ABE)
The Absolute Biological Effectiveness (ABE) [139], represents the 
effectiveness o f a particular radiation in term of its capability to induce a certain 
effect in a biological system. In the present work, ABE of a radiation is defined as 
the mean number o f double strand breaks (dsb) produced and remains um epaired in 
a pai'ticular biological system, per unit incident fluence o f primary radiation. The 
ABE of a radiation can be defined in terms of three biological parameters, namely:
i. the geometrical projected cross-sectional area of the DNA including an 
’overlap’ factor i.e. n^ .cTg ;
ii. the cell cycle time; and
iii. a mean recovery time for double strand breaks in the DNA; 
and two physical parameters, namely:
i. the charged particle equilibrium fluence; and
ii. the average mean free path for ionization for the energy spectrum of 
charged particles.
Here, only direct radiation action is assumed to apply. ABE values are calculated 
according to the following formula:
ABE e . 71^2) —  y  e x p  ( -  ( t ^ - t )  /  t^) d t
where
Gg = projected cross sectional area of the DNA;
= secondary charged particle equilibrium fluence per primary
interaction per unit volume;
Z = inverse mean free path for interaction by the incident radiation. (For
indirectly ionising radiation gamma and x-rays, Z =Na,j which is the 
mass energy transfer coefficient); 
i \  = mean number of double stranded DNA segments at risk along a 
random chord through the cell nucleus; 
s = the efficiency with which double strand breaks are induced by the
radiation.
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i.e. 8= [l-exp(-A.yX)] so that 
for XyX 0; 8 -> 
and XJX -> oo; 8 -» 1 (saturation): 
t, = cell cycle time:
t, = mean repair time for a dsb: and
tj = duration of irradiation.
For incident fluence of indirectly ionizing radiation, the ABE formula can be 
rearranged as follows:
 ^1
ABE^ { o ^ . n j  (iVo^^) ~  I e x p  [ -  ( 1) / 1^] d t
 ^ 0
The net integral fluence (equilibrium electrons) is given by :
$g= f(P gdE = f'(p (E )dE
0 0
The fluence weighted quality of the radiation field (equilibrium electrons) is given 
by:
(X) € (X) dX
If (j)f- is the incident fluence of indirectly ionising radiation, the survival fraction (SF) 
is given by:
SF=exp(-ABE.(j),-) 
or ln(SF)=-ABE.(|),-.
If  (j), =l/ABE, then SF=l/e, which corresponds to the survival fraction equal to 37%. 
ABE is in units o f area and its reciprocal represents the fluence o f incidence 
radiation which will produce 37 % survival fraction.
The fraction o f cells, surviving damage because of the direct component of action 
is given by:
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4.3.1. Conceptual and Principles
The foundations of the unified system o f dosimetry are as follows [138];
i. The absolute specification o f radiation quality is based on the probability of 
induction of a specified end-point (e.g. inactivation or mutation) by single 
charged particle tracks which actually enter the biological target. The 
relevant charged particles are those in the equilibrium charged particle 
spectrum generated in the medium by indirectly or directly ionising radiation 
(see page 142). The probabilities for induction of the specified damage 
represents the intrinsic efficiencies of action which are absolute measures of 
the radiation quality. The absolute biological effectiveness (ABE) can be 
defined in terms o f the product o f the geometrical cross-section o f the site 
and the intrinsic efficiency for unit incident fluence o f radiation;
ii. The important radiosensitive sites in the cell nucleus are the double stranded 
segments in the nuclear DNA:
iii. The dom inant crucial physical parameter of the charged particle radiation is 
the mean free path between ionization interactions;
iv. Damage is a stochastic process which occurs when the mean spacing 
between interactions along the charged particle track matches the mean chord 
distance through a DNA segment (~2nm);
V. Radiation effects depend mainly on the frequency and spatial correlation of
interactions, and not on the energy transferred in the interactions;
vi. Damage is predominantly due to intra-track, not inter-track, processes for all
radiations except at very large doses. The slope of the probability (P) against 
the mean free path (1) for 1 > 2 nm (i.e. the unsaturated region) is near 
unity (refer to figure 4.1). In other words there is a negligible ’dose rate 
effect’ which is contrary to the current thinldng in many proposed models 
of repair.
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4.3.2. Calculation of Absolute Biological Effectiveness (ABE)
The Absolute Biological Effectiveness (ABE) [139], represents the 
effectiveness o f a particular radiation in term of its capability to induce a certain 
effect in a biological system. In the present work, ABE of a radiation is defined as 
the mean number of double strand breaks (dsb) produced and remains unrepaired in 
a particular biological system, per unit incident fluence o f primary radiation. The 
ABE of a radiation can be defined in terms of three biological parameters, namely;
i. the geometrical projected cross-sectional area o f the DNA including an 
’overlap’ factor i.e. n^.a^ ;
ii. the cell cycle time; and
iii. a mean recovery time for double strand breaks in the DNA; 
and two physical parameters, namely;
i. the charged particle equilibrium fluence; and
ii. the average mean free path for ionization for the energy spectrum of 
charged particles.
Here, only direct radiation action is assumed to apply. ABE values are calculated 
according to the following formula;
ABE J e x p  ( -  ( t , -  t) /  t^) d t
where
CTj, = projected cross sectional area o f the DNA;
= secondary charged particle equilibrium fluence per primary
interaction per unit volume;
I  == inverse mean free path for interaction by the incident.radiation. (For
indirectly ionising radiation gamma and x-rays, E =NG,r which is the 
mass energy transfer coefficient);
n„ = mean number of double stranded DNA segments at risk along a 
random chord through the cell nucleus;
8 = the efficiency with which double strand breaks are induced by the
radiation.
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i.e. G= [l-exp(-À.yA.)] so that 
for E/zi -> 0; 8 -> XJX 
and XJX -* oc: 8 ^  1 (saturation);
I, = cell cycle time:
t^  = mean repair time for a dsb: and
tj = duration o f irradiation.
For incident fluence of indirectly ionizing radiation, the ABE formula can be 
rearranged as follows:
t ,
ABE^ (Og. rtg) ( ( j ig.e) {No f  e x p  [ -  ( t ^ - t ) / p j  d t
 ^ 0
The net integral fluence (equilibrium electrons) is given by ;
^ f  ^ sdE=j (p (E) dE
0 0
The fluence weighted quality of the radiation field (equilibrium electrons) is given 
by:
. £=J'(p (X) € (X) dX
0
If {j),-is the incident fluence of indirectly ionising radiation, the survival fraction (SF) 
is given by:
SF=exp(-ABE. (}),■) 
or In(SF)—ABE.(j)f.
If (j),-=l/ABE, then SF=^l/e, which corresponds to the survival fraction equal to 37%. 
ABE is in units of area and its reciprocal represents the fluence of incidence 
radiation which will produce 37 % survival fraction.
The fraction o f cells, surviving damage because of the direct component of action 
is given by:
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In (SF)= -Gg .(f)s.k(ti)
where:
Gg the biological effect cross-section, represents an absolute quality cross-section 
(unmodified by repair) o f the field radiation that generates an integral 
fluence o f charged particle (j), in an irradiation time f;
(j), is the integral fluence o f charged particles in an irradiation time f; and
k(tj) is a repair term. It represents the probability that the induced double strand
breaks in the cell will be repaired before a stated fixation time f.
The biological effect cross-section Gg is a function o f well-defined physical and 
biological parameters given by;
Gg= Gg.n„.(R/d).c
where
Gg «4.0x10'^ cm" ; the projected cross-sectional area of intracellular DNA;
iig is the average number of DNA segments at risk (-15) on penetration of a
mean chord traversal o f the cell nucleus by a charged particle track;
R/d is the ratio of the mean range R, o f the relevant charged particle tracks to
the mean chord length d, o f the cell nucleus. If R > d, R/d is limited to 1 ; 
and
s is the efficiency with which the charged particle radiation induces double
strand breaks.
Inactivation probability (P) is defined as the ratio of the effect cross-section to the 
geometrical cross-sectional area o f the sensitive sites. When P is plotted as a 
function of the mean free path {X) for primary ionisation of the relevant charged 
particle tracks, a unified representation o f data can be obtained for all cell types and 
all heavy particle types (refer to figure 4.1). For indirectly ionising radiation the 
relevant particles are those in the secondary charged particle equilibrium spectrum.
In the ABE calculation, the integral fluence generated by the incident radiation 
fluence at the point o f irradiation o f samples e.g. cells, has to be determined.
4.3.2.1. Calculation of ABE for Photons I
For photon ABE calculation, it is assumed that the projected geometrical cross- j
sectional area o f the DNA (Gg) is equal to 4.0x 10'  ^ cm", and the number of double j
stranded DNA segments at risk along a random chord through the cell nucleus (n^) 1
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is equal to 15. Calculation is carried out according to the following formula: 
ABE=[ag.(R/d).nJ((j),.s)(N.air)xl.
Assume that the repair term is equal to 1 (i.e. only the initial damage is considered) 
and the other values are obtained from computer calculation (i.e. result from 'pelsld' 
computer programme). ABE values for various photon energies are calculated b\ 
using a computer programme as in appendix one (i.e. photonabef.for) and the values 
are given in table 4.1 and the graphical illustrations are given in figures 4.2 and 4.4.
4.3.2.2. Calculation of ABE for Neutrons
The effectiveness o f neutron irradiation in tissue (i.e. approximated by water) is due 
to the hydrogen and oxygen recoils induced. The absolute biological effectiveness 
per unit incident neutron fluence "ABE^ ,^. is the total effectiveness of the recoils, 
obtained by direct summation and given by the following equation:
"ABE,,, = "ABE,; + "ABEg
where
"ABE,, is the total absolute biological effectiveness o f the hydrogen
recoils; and
"ABEq is the total absolute biological effectiveness of the oxygen
recoils.
i. For Hydrogen Recoils;
"ABE,, = [Gg.(R/d).nJ,,((j),.s)„(N.a„)„xl
where;
Gg is taken as equal to -4x10'* cnr;
(R/d) is 1 if  R /d>l; and R/d if R /d<l;
n, for hydrogen recoil is equal to about 15;
(j)j, is the equilibrium fluence o f hydrogen recoils;
8 8=(l-exp(-À,,/l)) is calculated by using l,=2m n and X mean free path for
primary ionization of H recoil;
is for hydrogen recoil which is obtained from the computer calculation. The 
value has been multiplied by two, in order to take into consideration two 
hydrogen atoms for each water molecule.
15:
ii. For Oxygen Recoils;
"ABEq = [Gg.(Ryd).nJo(<i>s-s)o(N.G„.)oXl
where;
Gg is 4x10"'  ^ cn r;
(R/d) is 1 if R/d>l : and R/d if  R/d<l ;
n, is equal to about 15;
(j), is the equilibrium fluence o f oxygen recoils, generated per unit incident
neutron fluence;
s G=( 1 -exp(-À,/À)) is calculated by using X,,=2nm and X mean free path for
primary ionization of oxygen recoils;
CN.Gjo
is the inverse mean free path for oxygen recoils and is obtained from the 
computer calculation.
For the neutron ABE calculation, a computer programme (i.e. neutronabe.for), as 
in appendix one is used to calculate ABE values from the outputs of the computer 
programme (i.e.neutlt.for), which calculates the hydrogen and oxygen recoil 
equilibrium spectra generated per unit incident neutron fluence and ABE of the 
recoils. The neutron cross section [140] used is as in appendix one. The ABE 
values for neutrons with various energies are given in table 4.2 and the graphical 
illustrations are given in figures 4.3 and 4.4.
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Fig. 4.1: Effect Cross Section (P) against Mean Free Path for Primary Ionisation (X)
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Table 4.1: The Absolute Biological Effectiveness (ABE) of Photons with Various
Energies.
Sources X or Gamma 
Energy (keV)
ABE for 
Gamma (cnr)
Mean Free 
Path (nm)
C 2.77E-01 1.31E-08 3.35E+00
N 3.92E-01 1.67E-08 3.41E+00
Ne 8.49E-01 3.04E-09 3.38E+00
Al 1.49E+00 2.65E-09 3.97E+00
K 3.31E+00 8.19E-10 5.81E+00
Cr 5.41E+00 3.32E-10 7.89E+00
Mn 5.90E+00 2.78E-10 8.00E+00
Fe 6.40E+00 2.37E-10 8.81E+00
Co 6.92E+00 2.03E-10 9.26E+00
Cu 8.04E+00 1.49E-10 l.OlE+01
Zn 8.63E+00 1.28E-10 1.05E+01
Ge 9.88E+00 9.57E-11 l.llE + 01
As 1.05E+01 8.33E-11 1.14E+01
Se 1.12E+01 7.23E-11 1.17E+01
Br 1.19E+01 6.35E-11 T19E+01
Sr 1.41E+01 4.21E-11 1.18E+01
Zr 1.58E+01 3.21E-11 1.16E+01
Mo 1.74E+01 2.44E-11 1.09E+01
Ag 2.21E+01 1.20E-11 9.09E+00
Cd 2.31E+01 1.05E-11 8.70E+00
Te 2.74E+01 5.88E-12 7.61E+00
Ba 3.21E+01 3.39E-12 6.94E+00
Sm 3.99E+01 1.62E-12 6.62E+00
Tm 5.04E+01 8.68E-13 6.94E+00
W 5.88E+01 6.72E-13 7.41 E+00
Am 5.96E+01 6.63E-13 7.51E+00
Au 6.81E+01 6.07E-13 8.12E+00
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Sources X or Gamma 
Energy (keV)
ABE fbr
Gamma (cm")
Mean Free 
Path (nm)
Bi 7.62E+01 6.09E-13 8.77E+00
U 9.70E+01 7.57E-13 1.06E+01
Cs 6.61E+02 1.74E-11 6.31E+01
Co 1.25E+03 5.68E-11 1.04E+02
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Table 4,2: The Absolute Biological Effectiveness (ABE^ o f Neutron with Various
Energies.
Neutron
Energy
(keV)
ABE for 
Neutrons 
(cm")
Mean free 
path for 
Hydrogen 
recoil(nm)
Mean free 
path for 
Oxygen recoil 
(nm)
l.OOE-01 6.43E-13 3.11E+01 9.83E-08
1.50E-01 9.44E-13 2.39E+01 1.26E-07
2.00E-01 1.23E-12 1.96E+01 1.40E-07
3.00E-01 1.77E-12 1.49E+01 1.54E-07
4.00E-01 2.28E-12 1.22E+01 1.60E-07
5.00E-01 2.77E-12 1.05E+01 1.64E-07
6.00E-01 3.23E-12 9.29E+00 1.67E-07
7.00E-01 3.69E-12 8.38E+00 1.69E-07
8.00E-01 4.11E-12 7.69E+00 1.70E-07
9.00E-01 4.53E-12 7.11 E+00 1.72E-07
l.OOE+00 4.93E-12 6.65E+00 1.73E-07
1.50E+00 6.77E-12 5.17E+00 1.79E-07
2.00E+00 8.37E-12 4.36E+00 1.84E-07
3.00E+00 1.12E-11 3.47E+00 1.92E-07
4.00E+00 1.36E-11 2.97E+00 2.01E-07
5.00E+00 1.57E-11 2.66E+00 2.10E-07
6.00E+00 1.75E-11 2.43E+00 2.18E-07
7.00E+00 1.92E-11 2.27E+00 2.26E-07
8.00E+00 2.06E-11 2.13E+00 2.34E-07
9.00E+00 2.19E-11 2.03E+00 2.43E-07
l.OOE+01 2.33E-11 1.94E+00 2.51E-07
1.50E+01 2.81E-11 1.67E+00 2.89E-07
2.00E+01 3.11E-11 1.52E+00 3.27E-07
3.00E+01 3.59E-11 1.37E+00 4.04E-07
Note for y-rays n~15 also, but X is much larger than for neutron induced 
recoils and R/d plays a role.
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Neutron
Energy
(keV)
ABE. for 
Neutrons 
(cnr)
Mean free 
path for 
Hydrogen 
recoil(nm)
Mean free 
path for 
Oxygen recoil 
(nm)
4.00E+01 3.84E-11 1.30E+00 4.81E-07
5.00E+01 4.06E-11 1.26E+00 5.59E-07
6.00E+01 4.17E-11 1.24E+00 6.39E-07
7.00E+01 4.23E-11 1.23E+00 7.18E-07
8.00E+01 4.22E-11 1.22E+00 7.97E-07
9.00E+01 4.23E-11 1.21 E+00 8.72E-07
l.OOE+02 4.21E-11 1.21 E+00 9.54E-07
1.50E+02 4.04E-11 1.22E+00 1.35E-06
2.00E+02 4.00E-11 1.26E+00 1.78E-06
3.00E+02 4.07E-11 1.37E+00 2.93E-06
4.00E+02 4.10E-11 1.51E+00 1.43E-05
4.40E+02 4.09E-11 1.57E+00 1.04E-05
5.00E+02 4.11E-11 1.67E+00 5.79E-06
6.00E+02 4.25E-11 1.83E+00 5.80E-06
7.00E+02 4.42E-11 2.00E+00 6.97E-06
8.00E+02 4.55E-11 2.17E+00 8.77E-06
9.00E+02 4.81E-11 2.34E+00 1.87E-05
l.OOE+03 5.01E-11 2.52E+00 2.20E-05
1.50E+03 5.83E-11 3.40E+00 1.58E-05
2.00E+03 6.61E-11 4.32E+00 1.74E-05
3.00E+03 8.17E-11 6 .14E+00 5.16E-05
3.75E+03 8.58E-11 7.54E+00 7.97E-05
4.00E+03 8.77E-11 8.01E+00 6.77E-05
5.00E+03 9.30E-11 9.85E+00 6.89E-05
6.00E+03 9.68E-11 1.17E+01 6.97E-05
7.00E+03 l.OOE-10 1.36E+01 7.69E-05
8.00E+03 l.OlE-10 1.55E+01 7.42E-05
9.00E+03 1.02E-10 1.74E+01 9.68E-05
1 5 9
Neutron
Energy
(keV)
ABE for 
Neutrons 
(cnf)
Mean free 
path for 
Hydrogen 
recoil(nm)
Mean free 
path fox 
Oxygen recoil 
(nm)
l.OOE+04 1.13E-10 1.93E+01 1.61E-04
1.50E+04 1.09E-10 2.88E+01 4.32E-04
2.00E+04 1.03E-10 3.84E+01 8.36E-04
3.00E+04 8.74E-U 5.80E+01 1.50E-03
4.00E+04 7.91E-11 7.75E+01 2.14E-03
5.00E+04 7.00E-11 9.59E+01 2.69E-03
6.00E+04 6.11E-11 1.14E+02 3.17E-03
7.00E+04 5.56E-11 L31E+02 3.67E-03
8.00E+04 6.65E-11 1.49E+02 4.17E-03
9.00E+04- 7.77E-11 1.66E+02 4.64E-03
l.OOE+05 8.87E-11 1.84E+02 5.17E-03
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Table 4.3: Irradiation Cases
Cases Mono-energetic 
or spectrum
Charged Particle Equilibrium 
(CPE) or Track Segment 
Experiment
Remarks
External 
Photons 
(j)i is the 
incident 
Fluence
External 
neutrons 
4), The 
incident 
Fluence
Mono-energetic Charged Particle Equilibrium
The integral fluence (|)g is equal 
to (|)v-P-4>i where c()^, is the 
equilibrium fluence o f charged 
particles generated per 
interaction per unit volume; p 
is the interaction coefficient for 
the indirectly ionising radiation 
in the medium; and (j); is the 
incident fluence
Complex 
incident photon 
spectrum 
(which includes 
x-rays, y- 
spectrum from 
radionuclides) 
can be written
Charged Particle Equilibrium
The integral fluence is the 
numerical integration of the 
spectrum;
4^sec.jPj 4 i^.j
as
hv=min
Mono-energetic Charged Particle Equilibrium
The integral fluence is equal to 
(j),.(NHa„H)(j)i where f  is the 
equilibrium fluence of charged 
particles generated per 
interaction per unit volume; 
(NhO^hh) is the interaction 
coefficient for the neutrons in 
the medium; and (j); is the 
incident fluence
i.The DNA double 
strand in the DNA 
segment is assumed 
to be the sensitive 
site.
ii. Spacing between 
the primary 
ionisations along 
the charged particle 
track in the 
medium or sample 
is shown to 
represent the 
quality o f the 
radiation track.
i and ii must match 
for the maximum 
effect i.e the effect 
probability 
coiTesponds to 
(l-exp(À(/A.))
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Cases Mono-energetic 
or spectrum
Spectrum
External 
Heavy Ions 
(HZE)
Mono-energetic
Charged Particle Equilibrium 
(CPE) or Track Segment 
Experiment
Charged Particle Equilibrium
The integral fluence is the 
numerical integration of the 
spectrum;
where f  is the fraction o f the 
jth  component.
Track segment experiment 
(instantaneous values)
Remarks
Internal
Radionuclide
s
a , p, and y 
emitters
Sufficiently 
homogeneously 
distributed 
(except special 
cases electron 
capture and 
auger electron) 
in the medium 
or samples
4)s = 4)\'C
4>v = Rp- Fs- 
where:
(j)v is the equilibrium fluence o f charged particles 
generated per unit source strength.
C is the concentration of source activity in the 
sample.
Rp is the range of the frequency weighted average 
energy of primary charged particles representing the 
decay spectrum emitted by the source activity of 
concentration C.
is the build up ratio of secondary to primary 
charged particle fluence. F, takes care o f the 
contribution from secondary, tertiary etc.
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4.4. Interpretation and Discussion
4.4.1. The expression of Risk in term of ABE
Risk is expressed per unit Sievert (Sv). namely 4x10'" S v ’ for persons 
occupationally exposed which corresponds to a dose limit of 20 mSv per year and 
5x10'" Sv'’ for members o f the general population which corresponds to a dose limit 
o f 1 mSv per year (see page 137). The Equivalent Dose H, in Sievert is the sum of 
absorbed dose D, multiplied by the radiation weighting factor w^, according to the 
following formula:
H= D.^.(w,0, + D„.(w,On 
(i.e. replacing the previous formula for the dose equivalent H, H=D.^Q  ^ + D„.Q„ 
where Q.=l and =10 are the quality factors for gamma-rays and neutrons 
respectively). For y rays w^=l irrespective of its energy and for neutrons, w^ varies.
It is equal to 5, 10, 20, 10 and 5 for neutron energies less than 10, 10-100, 100- 
2000, 2000-20000, and greater than 20000 keV respectively (see table 1.6). For 
neutron energies of 0.3 (for Hiroshima) and 1.6 MeV (for Nagasaki), Wr is equal 
to 20. The average gamma-ray energy for Hiroshima and Nagasaki is assumed to 
be equal to 1.0 MeV.
In order to express risk in terms of ABE (i.e.the unified system o f dosimetry) the 
following information is required:
i. the ratio between component doses (i.e. y and neutron) to the total doses; I
and ii
ii. the energy o f the radiation from which ABE and LET can be deduced. j
The Sievert can be resolved into its components such as gamma dose and neutron I
Îdose. The total effectiveness (BE,g, j^) of a radiation field (y and neutron) is given by: I
BEt^ t,, = (l)n.ABE„ + (ji^ .ABE^  |
where; j
!
is the neutron fluence; ;
ABE,, is the absolute biological effectiveness per unit incident neutron fluence; |
(|)^  is the gamma fluence; and '
ABE.  ^ is the absolute biological effectiveness per unit incident gamma fluence. !
II
From the epidemiological study of Japanese survivors, the ratios between gamma f
dose (fy) and neutron dose (f„) against total dose received by the survivors, vary j
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depending on many factors such as shielding, slant distance from explosion point, 
transmission factor etc. It is reasonable to assume that f^  varies subject to the general 
characteristics o f the radiation fields in Hiroshima and Nagasaki (refer to figure 4.5). 
In the following exercise, for simplification it is assumed that the total dose (i.e. 
gamma and neutron dose) is equal to 1 Sv. Also for simplification, only three values 
of fy are considered, namely 1.0, 0.90 and 0.75. The fluence (j) can be deduced from 
the expression D=(j).L, by using L values from the reference data 
[I41][142][143].
4.4.1.1. In Hiroshima
i. f^=1.0; D= 1.0 Sv; E^=1000 keV and E„=300 keV.
H,^=1.0 Sv and H„ =(1-1) = 0.0 Sv. By using Wr equal to 1 and 20 for gamma and 
neutron respectively, D,=1.0 Sv and D,=0.00 Sv. For the present purpose, 1 Sv must 
be expressed in terms o f BE, To do this, the energy and the flux must be known. 
For the gamma dose = (ji^ .L, from the table L= 0.378 keVpm'h For neutron D„ 
= (j)„.L, since D„=0.00 so (j>,=0.00 .
By using formula BE; ,^ j^=(|)y.ABE., +(j)„.ABE„ ;
(jiy.ABEy =(1.0/L) X ABE^(energy 1.0 MeV)
= (1.0/0.378) X 3.75xE-l 1=9.925-11 
(j)„.ABE„ =(0.0/L) X ABE„(energy 0.3 MeV)= 0.00 
BE,^^,=9.925-11.
i. For radiation workers (i.e. dose limit o f 20 mSv per year, which corresponds to 
the risk factor of 4x10'") the risk factor in terms of ABE is equal to Rabe-
RxBE = 4 x 1 0 - /9 .9 2 5 -1 1  
= 4.035+08 (BE) '
ii. For a member of the general public (i.e. dose limit 1 mSv per year, which 
corresponds to the risk factor of 5x10'") the risk factor in terms of ABE is equal to
R-ABE"
RABE = 5 x 1 0 -/9 .9 2 5 -1 1  
= 5.045+08 (BE) '.
The risk factor is equal to 4.035+08 (BE)'' and 5.04E+08 (BE)'' for a radiation 
worker and a member of the general public respectively.
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ii. fj,=0.9; D= 1.0 Sv; E^=1000 keV and E„=300 keV
H.=0.9 Sv and H„ =(1-0.9) = 0.1 Sv. By using Wr equal to 1 and 20 for gamma and 
neutron respectively, D.,=0.9 Sv and D, =0.1/20=0.005 Sv. For the present purpose. 
1 Sv must be expressed in terms of BE. To do this, the energy and the flux must 
be known. For gamma dose D,, = (j).,.L, from the table L= 0.378 keVpm''. For 
neutron D„ = (j)„.L, from the table for E„=300 keV, L=66.34 keV pm 'f 
By using formula BE,q(^ ,=(().^ .ABE.^  +(|)„.ABE„ ;
4),.ABE, =(0.9/0.378)x3.75E-ll = 8.93E-11.
(|),.ABE, =(0.005/66.34)x 3 .95E -ll=  2.98E-15.
= 8.93E-11 + 2.98E-15 = 8.93E-11.
i. For radiation workers (i.e. dose limit o f 20 mSv per year, which corresponds to 
the risk factor of 4x10'") the risk factor in terms of ABE is equal to R a b e -
RABE = 4x10 " / 8.93E-11.
= 4.48E+08 (BE)-'
ii. For a member o f the general public (i.e. dose limit 1 mSv per year, which 
corresponds to the risk factor of 5x10 ") the risk factor in terms o f ABE is equal to 
R - a b e -
RABE = 5x10'- / 8.93E-11.
= 5.60E+08 (BE)-'.
The risk factor is equal to 4.48E+08 (BE) ' and 5.60E+08 (BE) ' for a radiation 
worker and a member of the general public respectively.
iii. f.^=0.75; D= 1 Sv; E^=1000 keV and E„=300 keV.
Hy=0.75 Sv and =(1-0.75) = 0.25 Sv. By using Wr equal to 1 and 20 for gamma 
and neutron respectively, D,=0.75 Sv and D„=0.25/20=0.0125 Sv. For the present 
purpose, 1 Sv must be expressed in terms of BE. To do this, the energy and the flux 
must be known. For gamma = (|).^ .L, from the table L= 0.378 keVpm"'. For 
neutron D„ = (j)„.L, from the table L= 66.34 keVpm '.
By using BE,„„,,=()) .^ABE.  ^ +(|)„.ABE„
(|,^.ABE^ =(0.75/0.378)x3.75E-l 1=7.44E-11.
4),.ABE, =(0.0125/66.34)x3.95E-l 1=7.44E-15.
BE,,,,, = 7.44E-11.
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i. For radiation workers (i.e. dose limit o f 20 mSv per year, which corresponds to 
the risk factor o f 4x10'-) the risk factor in terms of ABE is equal to Rabe*
RABE = 4x10 - / 7.44E-11 =5.38E+08.
= 5.38E+08 (BE)-'
ii. For a member o f the general public (i.e. dose limit 1 mSv per year, which 
corresponds to the risk factor of 5x10'“) the risk factor in terms o f ABE is equal to
R -A B E *
R-ABE = 5x10-- / 7.44E-11 =6.72E+08.
The risk factor is equal to 5.38E+08 (BE) ' and 6.72E+08 (BE) ' for a radiation '
worker and a member o f the general public respectively.
4.4.I.2. In Nagasaki
By carrying out the same calculation, using data listed in table 4.4, for neutron 
energy equal to 1.6 MeV, the results are as shown in table 4.6. The parameters used 
in the calculations to express risk in the unified system o f dosimetry are listed in 
table 4.4.
The calculations are summaiised as follows:
i. t;=1.0; D= 1.0 Sv; E^=1000 keV and E„=1600 keV.
By using formula BER,,.„=(j).^ .ABE.^  +({)„.ABE,,;
(j).^ .ABEy =(1.0/L) X ABE.Xenergy 1.0 MeV)
= (1.0/0.378) X 3.75xE-Il=9.92E-ll 
(j),,.ABE„ =(0.0/L) X ABE„(energy 0.3 MeV)= 0.00 
BE,,,, =9.92E-11.
i. For radiation workers (i.e. dose limit of 20 mSv per year, which corresponds to 
the risk factor o f 4x10'“) the risk factor in terms of ABE is equal to Rabe*
R-ABE =4xl O- - / 9 . 92E- l l  
= 4.03E+08 (BE)-'
ii. For a member of the general public (i.e. dose limit 1 mSv per year, which 
corresponds to the risk factor of 5x10'“) the risk factor in terms of ABE is equal to 
R a b e *
R a b e  = 5x10-“ / 9 .92E-11 
= 5.04E+08 (BE)-'.
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The risk factor is equal to 4.03E+08 (BE) ' and 5.04E+08 (BE) ' for a radiation 
worker and a member of the general public respectively.
ii. t;=0.9; D= 1.0 Sv; E^=1000 keV and E,=1600 keV
By using formula BE,o,|=({)y.ABE, +(|)„.ABE„ ;
4).,.ABE  ^ =(0.9/0.378)x3.75E-ll = 8.93E-11.
(|),.ABE, =(0.005/40.47)x 6.06E-11= 7.49E-15.
BE,,; = 8.93E-11 + 7.49E-15 = 8.93E-11.
i. For radiation workers (i.e. dose limit o f 20 mSv per year, which corresponds to 
the risk factor of 4x10'^) the risk factor in terms o f ABE is equal to Rabe-
RABE = 4 x l O " / 8 . 9 3 E - l l .
= 4.48E+08 (BE)-'
ii. For a member of the general public (i.e. dose limit 1 mSv per year, which 
corresponds to the risk factor of 5x10'“) the risk factor in terms of ABE is equal to 
R a b e *
R.n:: = 5x10 “ / 8.93E-11.''A B E
—  c  c f w :  I A O  / n r %5.60E+08 (BE)-'
The risk factor is equal to 4.48E+08 (BE) ' and 5.60E+08 (BE) ' for a radiation 
worker and a member o f the general public respectively,
iii. f,=0.75; D= 1 Sv; E^=1000 keV and E„=1600 keV.
By using BE,„=(})^.ABE,^ +(()„.ABE,
(|)y.ABE, =(0.75/0.378)x3.75E-l 1=7.44E-11.
(|)„. ABE„ =(0.0125/40.47)x6.06E-11=1.87E-15.
RRiotai “  7.44E-11.
i. For radiation workers (i.e. dose limit of 20 mSv per year, which corresponds to 
the risk factor of 4x10'“) the risk factor in terms of ABE is equal to Rabe*
RABE = 4x10'- / 7.44E-11 =5.38E+08.
= 5.38E+08 (BE)-'
ii. For a member of the general public (i.e. dose limit 1 mSv per year, which 
corresponds to the risk factor o f 5x10'“) the risk factor in terms o f ABE is equal to 
R .^ABE*
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RABE = 5x10- / 7.44E-11 =6.72E+08.
The risk factor is equal to 5.38E+08 (BE) ' and 6.72E+08 (BE)'' for a radiation 
worker and a member of the general public respectively.
Information on the atomic bombs dropped at Hiroshima and Nagasaki [144] 
is listed in table 4.5.
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Table 4.4: The parameters used to express risk in the unified system o f dosimetry
Type Energy
(keV)
ABE (cnr) LET (keV pm '') Fluence (cm )
Lt.H'
hydrogen
recoil
F t.o
oxygen
recoil
Hydrogen
recoil
Oxygen
recoil
Recoils of 
neutron
300 64.11 200.50 1.287x10"' 2.135x10-''
1600 38.42 260.22 4.75x10"' 4.44x10-"
Neutrons"' 300 3.95E-11 66.34
1600 6.06E-11 40.47
Gamma' ' 1000 3.75E-11 0.378
The mean neutron energies in Hiroshima and Nagasaki are assumed equal 
to 300 keV and 1600 keV respectively.
The mean gamma energies in both Hiroshima and Nagasaki are assumed 
equal to 1000 keV.
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Fig. 4.5: Comparison of values for the radiation fields in the open at Hiroshima and 
Nagasaki
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Table 4.5: The Atom ic Bombs dropped in Hiroshima and Nagasaki
Information Hiroshima Nagasaki
Date o f bombing 6 th. August 1945 9 th. August 1945
Estimated yield 15 ± 3 ktons 22 + 2 ktons
Average Neutrons 
energy
0.3 MeV 1.6 MeV
Extrapolated at 
burst point (m^rad) 
Neutron
Gamma
8.7 x 10'" 
3.45 X 10'"
1.30 X 10'" 
2.75 X 10'"
H height o f burst 
(m)
570 500
Relaxation length 
(m)
Neutron 198 198
Gamma 250 350
Type Uranium (^^'U) bomb: 
a gun assembly weapon
Plutonium (“^ ^Pu) bomb: 
an implosive type weapon
General notes:
i. In H iroshima an explosive propellant is used to shoot one piece Uranium against 
another piece to create a critical mass; and
ii. In Nagasaki chemical explosive was used to compressed a subcritical mass to 
become a critical mass.
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Table 4.6: The Risk Factors expressed in terms of the unified system of dosimetrv 
ABE)
Data Fraction of 
Gamma Dose
Fraction of 
Neutron Dose
Risk Factors (BE) '
A radiation 
worker
A member of 
the public
Hiroshima data 1.00 0.00 4.03E+08 5.04E+08
0.90 0.10 4.48E+08 5.60E+08
0.75 0.25 5.38E+08 6.72E+08
Nagasaki data 1.00 0.00 4.03E+08 5.04E+08
0.90 0.10 4.48E+08 5.60E+08
0.75 &25 5.38E+08 6.72E+08
Average for 
both cities
1.00 4.03E+08 5.04E+08
0.9 4.48E+08 5.60E+08
&75 5J8E +08 6.72E+08
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4.4.1.3. Dose Estimation for Japanese Survivors
Dose received by each Japanese survivor was first estimated by using Tentative 
1965 Dosimetry System (T65D) and then was estimated by using Dosimetry system 
1986 (DS86). Two important parameters for dosimetry of individual survivor are 
distance and shielding.
In Tentative Dosimetry (T65D) System, gamma and neutron doses received by the 
survivors are calculated according to the following formula:
G^exp ( -  )
D ( # ) = - R ‘
where
D(R) is free in air (FIA) dose in rad;
R is slant distance i.e. between air zero to location at time o f explosion;
L is relaxation length in meters (m);
Go is the intensity in rad.im;
R=(H' + d')'- ;
FI is the distance between air zero to ground zero: and
d is the distance between ground zero to location at time of explosion.
In T65D the survivor’s shielding at the time of bombing (ATB) was taken into
account by the use of transmission factor (TF) (i.e. the ratio between the radiation 
dose inside and outside o f the house).
k(n)=TF(n)kq(n)
k(y)=TF(Y)k,(Y)
where kq(n) and k^(y) are radiation doses in the open (outside the house) for neutron 
and gamma respectively. TF was determ ined by the nine parameter method, the 
globe method and ad-hoc assignment method. T65D tissue-kerma estimates for the 
survivors, served only as an approximation to the maximum absorbed dose at the 
surface (or skin) o f the body.
In 1970 Absorbed Dose Factor (ADF) (i.e. the ratio between absorbed dose in a 
specific organ and tissue kerma in air) was calculated. The absorbed dose D of an
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organ o f interest:
Dto,ai =D(n) + d(y)
D(n)=ADF(n) k(n)
D(y)= ADF(y).k(y) +ADF(y^)k(n)
where
ADF(n)k(n) provides the high LET absorbed dose for neutron;
ADF(y).k(y) provides the low LET absorbed dose for external y ray;
ADF(y^)k(n) provides the low LET absorbed dose from yray produced by neutron 
interactions within the body (called autogammas)
For leukaemia the organ o f interest is active bone mirror. Other cancers, the organ 
of interest are the female breast, thyroid, lung etc.
The latest dose estimate received for each survivor in Hiroshima and Nagasaki 
epidemiological studies is carried out by using dosimetry system 1986 (DS86) 
[145]. The DS86 methods for dose estimation to individual survivors, are 
embodied in the modular code system as follows:
i. a data base for the radiation fields in the open, which specify the differential 
energy and angular fluence of neutrons and gamma rays at four different heights 
above the ground and at 25 m intervals from 100 to 2500 m ground range in both 
cities;
ii. a data base from home shielding which describes how the differential neutrons 
and gamma ray fluences are modified at over 50 sites inside, outside and either 
partially or totally shielded by a .lapanese house; and
iii. a data base for organ dosimetry which describes how the differential neutrons 
and gamma fluences are further modified at 15 organ sites within the body as 
functions of a survivor’s orientation and posture.
DS86 doesn’t employ transmission factors (TF) or absorbed dose factor (ADF). For 
survivors with shielding histories, organ dose and tissue kerma in air were computed 
directly for cases such as:
i. the survivor was exposed inside a Japanese home and nine parameter data were 
available;
ii. the survivor was exposed outside but shielded by a Japanese house and globe data 
were available;
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iii. the survivor was outside-unshielded and flash burns were reported on exposed 
portions of the skin (e.g. the face, neck and arm)
4.4.2. Discussion
ABE is energy dependent. From figure 4.2 the ABE values for photons vary from 
2x10^ cn r to 6x10''^ c n r  in the energy range from 0.1 keV to 10  ^ keV. It has a 
m inimum value about 6x10''^ cn r at an energy of about 70 keV. From figure 4.3 
the ABE values for neutrons vary from 2x10''" cm~ to 6x10 '^  c n r  for neutrons in 
the energy range from 0.1 to 10  ^keV. If measurement were carried out by using the 
proposed unified dosemeter, the measurement would be given in BE units which 
would be directly relatable to the probability of inducing cancer in the person’s life. 
Further study is required to validate this conclusion.
The numerical values for risk per year expressed in both systems, depend on the 
components of the radiation received. The conversion of risk per year expressed in 
the conventional dosimetry system into the unified dosimetry system is given in the 
following example:
A radiation worker has received the dose limit o f 20 mSv per year so the 
associated risk per year is equal to 20x10^x4x10^' = 8x10 'f The cancer risk 
coefficient is equal to 4x10'- Sv'‘. In the unified system, the 20 mSv has to 
be expressed in BE which depends on its fluence components (i.e. fraction 
of gamma and neutron doses) and, say it is equal to x, BE. Then, the risk 
per year in the unified system is equal to x, multiplied by the appropriate 
risk factor Rabe*
In the ESS study each individual dose is calculated according to the DS86 
(Dosimetry System 1986). The individual dose can be expressed in term of BE by 
carrying out the same procedure as in section 4.4.1. For the whole LSS study 
cohorts, reassessment of cancer risk in term of the new dosimetry system can be 
carried out and the result would be given in risk factor per BE. In the examples 
given to express risk factor in terms of BE, the results in both cities Fliroshima and 
Nagasaki are the same because the contribution of neutron components are 
insignificant.
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CHAPTER FIVE 
CONCLUSION, DISCUSSION AND RECOMMENDATIONS 
FOR FUTURE WORK 
5.1. Conclusions and Discussions
In Radiological Protection near environmental level, the effect of radiation on 
individual cells can be considered as due to a single track without any saturation 
effect or inter-track action. Direct data on human beings exposed to low level 
radiation cannot be obtained mainly due to statistical limitation and the uncertainty 
is very significant. Radiation risk o f significant important in this level is attributable 
to cancer and genetic effects. Data are obtained mainly from epidemiology studies, 
ankylosing spondylitis patients, occupational and accidental exposures and animal 
studies. The most important data is from epidemiological study of .lapanese 
survivors of atomic bombs dropped in Hiroshima and Nagasaki.
This thesis basically presents three main themes namely:
i. Biophysical models o f radiation action;
ii. Cancer risk coefficients; and
iii. A proposed new system of dosimetry in terms of ABE.
Five main biophysical models of radiation action have been evaluated and appraised 
as in chapter two. Cancer risk coefficients, basically from the ICRP assessment, 
have been presented in chapter three and the proposed new system o f dosimetry is 
explained in chapter four.
5.1.1. Biophysical Modelling
The success in biophysical modelling of radiation damage is believed to rely on the 
reliability o f the physical description o f the radiation field and the biological 
description of the system. As explained in chapter two Harder uses L,oo.d a quality 
parameter and Curtis uses local dose to induce lesions which are able to interact 
pairwise in the contact regions. Katz uses z"/j3" which is interpreted to be the yield 
of 5-rays per unit track length. Watt interprets zVp“ as the yield o f primary 
ionisations along the track concluding that the 5-ray effects are negligible for fast 
heavy ions. Bond and Varma use a microdosimetry concept (i.e. hit sizes) to
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determine the fraction o f cells which responds quantally. Each model has been tested 
against experimental data and to some extent has achieved its respective goal.
Biophysical modelling carried out in this university (i.e. the TC model) has distinct 
advantages which include:
i. À which is used as the quality parameter, has a clear physical interpretation
namely the mean free path o f the primary ionizations along the particle
track;
ii. Fluence o f the relevant charged particles (see table 4.3) which is found to be
a better field quantity than dose. The effect on cells is determined by the
actual number of charged particles traversing the cells multiplied by their 
probability (cross-section) to induce the effect; and
iii. ABE is used to incorporate the necessary relevant concepts important in
modelling, such as;
a. DNA double strands;
b. Number of segments at risk along the charged particle track;
c. Range i.e. R/d factor which indicate the physical capability of any 
charged particle to penetrate a cell nucleus;
d. The equilibrium charged particle fluence which is the fundamental 
cause of the effects;
e. The concept of cross section which is used to indicate the probability 
that a charged particle will induce a certain effect; and
f. The efficiency s, which indicates the efficiency o f the spatially 
correlated events with the structure of the DNA double strands, to 
induce DNA dsb.
These factors are deduced directly from the biological observations rather than by 
mechanistic modelling. The TC model has been applied for many cases such as 
irradiation by x-ray, y-ray, heavy ions and electrons. Jin et-al [146] take care 
o f Auger electron cascades as well as photo-electric and Compton electrons in the 
iluence generated and apply the TC model to yeast cells. Sykes et-al [147] 
provides interpretation on the reverse do se-rate effects, by using the TC model. In 
the future the new data obtained by using the latest technique and procedures may 
be applied in the TC model. An image cytometry device [148] has been
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reported to be able to determine with 98% accuracy by automated scanning 
procedures for cell survival measurements at low doses. The premature chromosome 
condensation tecluiique (refer to page 32). provides the initial number o f DNA dsb 
in an irradiated system. However it is more meaningful if the data used in modelling 
are standardized for example data obtained by using a standardised procedure, or 
better still, data obtained from experiments carried out in the same laboratory, to 
reduce systematic errors that would arise between different laboratories.
5.1.2. Cancer Risk Coefficient
An attempt has been made to express risk in terms of the new system of dosimetry 
i.e. by using ABE (see section 4.4.1). The ICRP results for risk (cancer) assessment 
are used for this purpose (see section 3.3.1.8). In the future for application in 
operational radiological protection, BE values which are considered as an upper limit 
in a certain period such as in a year, and the limit for a lifetime, have to be set.
5.1.3. The Proposed New Dosimetry System
5.1.3.1. General
The new dosimetry system as explained in chapter four is thought to be more 
rigorous and meaningful. It is superior in many aspects compared to the 
conventional system, such as:
i. The ABE values for various radiations are more consistent and provide 
smoother curves (refer to fig. 4.4) compared to Q (refer to table 1.5) or w^ 
values (refer to table 1.6) of radiation (i.e. less smooth curve and as a step 
function); and
ii. The derivation of ABE is based directly on experimental radiobiology 
interpreted in terms o f the basic radiation physics. Consequently it is more 
meaningful than the derivation of Q and w^.
There are many implications of having a better system of dosimetry. More precise 
dosimetry is desirable in operational plants such as a nuclear power plant or an 
irradiation facility, because it means:
a. precise allocation o f job in controlled or very high radiation areas. From 
economic point of view, this will save operational cost of the plant due to
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maximum utilisation of the available man-power;
b. radiation workers, management staff as well as regulator staff will know 
the amount of radiation received more precisely. From legal point of view, 
this will facilitate them in complying with the existing legal requirements i.e. 
rules and regulations.
5.I.3.2. Damage due to Neutrons, Heavy Ions, Photons and Electrons
In the conventional dosimetry system, neutrons are considered to be most damaging
i.e. Wr=20. in the energy range between 100 keV to 2 MeV (see table 1.6). For 
alpha particles and heavy ions, w^= 20 for all energies and for electrons Wr=1 for 
all energies. From the published data where the inactivation cross-section P is 
plotted against X [149], it has been found that neutrons are just able to reach 
the saturation region and the P decreases for lower A,. Alpha particles are 
comparable with neutrons. However heavy ions are capable to be in the saturation 
region with maximum P about up to three times the saturation inactivation cross- 
section. On the basis o f these facts, in the new system, neutrons can not be as 
damaging as heavy ions but the most damaging heavy ions and neutrons will differ 
by a factor o f three. The maximum damage o f alpha particles and neutrons are about 
the same. On the same basis electrons are found to be less damaging by at least an 
order of magnitude and hardly can reach the saturation region.
The damaging soft photon energy is considered to be due to the X o f the relevant 
chai'ged particle fluence being in the order of 2 nm. However its penetration is 
limited due to its range R. In this region the factor R/d, where d is the diameter of 
the cell nucleus, is playing a significant role, although X is about 2 nm but R/d is 
near to zero.
The inactivation cross section P, of gamma, is an order of magnitude lower than for 
heavy ions. The possible explanation for this is due to the penetration capability of 
the secondary charged particles produced by gamma (i.e. secondary electrons). At 
their most damaging, they are not able to penetrate through the cell nucleus whereas 
the heavy ions do, at the same A,.
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5.1.3.3. Incorporated Radionuclides
As pointed out by Younis et-al [53] the conventional system may not suitable lor 
assessing the hazard from incorporated radionuclides due to:
i. Many of radionuclides have complex decay schemes, accompanied by 
auger electron cascades, which have ranges localised in cellular or sub- 
cellular dimensions thereby producing a large degree o f damage; or
ii. If the radionuclide is incorporated into an especially sensitive site within 
the cell structure, excessive damage may be expected.
In the new system the concept of fluence is applicable. It takes care of the charged 
particles produced by the incorporated radionuclides.
Improved risk control presented in this thesis is given in terms o f the absolute 
biological effectiveness (ABE). Here, the term absolute means the ability to define 
the biological effect uniquely, in terms o f fundamental physical and biological 
quantities. The new dosimetry system proposed has distinct advantages over the 
existing system:
i. the calculation of ABE is based on the DNA dsb. which is directly related 
to various end-points o f prime importance in radiological protection;
ii. It is additive in nature, so that the BE of a radiation field is a direct mixture 
o f BE of the relevant charged particle fluence;
iii. Knowing the BE value for a given radiation field, the risk associated can be 
assessed without the need to know the radiation type and quantity;
iv. ABE is a unified measure of quality making other modifying factors such as 
Q or WR redundant;
V . The values reflect the probability of cancer induction in one lifetime after
receiving the radiation exposure; and 
vi. If an instrument which measures the BE directly can be designed and made
available, the BE values received by individuals during a specified period 
can be measured and the risks associated with the exposure can be 
determined.
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5.2. Recommendations For Future Work
For the new dosimetry system, the ABE values presented in this work may be 
further improved by:
i. Using the efficiency factor 8. against A. obtained from experimental data. By 
doing so all uncertainties in deriving the efficiency factor s. can be 
minimised (see section 4.2.1 and 4.3.2); and
ii. The factor R/d, (i.e. to correct for insider tracks having range R less than 
cell diameter, d) may be applied more accurately to the lower energy interval 
of the relevant (equilibrium) charged particle fluence generated in the 
medium.
The overall risk (cancer) assessment can be carried out in terms of ABE. Data from 
the Japanese epidemiological study may be used. In order to do that the following 
is required;
i. BE value for each individual, instead o f individual dose, can be evaluated;
ii. A complete set o f ABE values against energies for gamma and neutrons and 
their respective fluence;
iii. By using the same cohorts (see section 3.1.1.6), assess the risk in term o f BE 
by using the same methods and procedures i.e. apply multiplicative or 
relative projection models;
If the cancer risk is expressed in terms o f BE, a value o f risk can be set. as 
acceptable for radiological protection purpose. By assuming linear relationship 
between risk and BE. maximum value of BE can be set for radiation workers and 
members of the public annually.
In order to apply the new dosimetry system, instrumentation to measure BE is 
required. Basically in its design concept has to incorporate the sensitive sites 
separated in 2 nanometre distance (i.e. an array of sensitive sites). The inactivation 
(or events) of the pair o f sensitive sites spaced at 2 nm distance, is registered and 
the number recorded corresponds to the exposure received. Many possible types of 
detectors can be investigated in the future such as using organic macro-molecules 
and phosphors in solid phase. An active research programme to achieve such 
detectors is supported by the Commission of the European Communities.
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The role of a hormesis effect in low. near environmental levels of radiation, as 
reported in the literature has to be investigated not just because o f its intrinsic 
importance but because o f its relevance to test of models. The hormesis effect (or 
adaptation effect) [150] is defined as the induction of beneficial effects by low 
doses of an otherwise hamiful physical or chemical agent including radiation. 
Fremlin [151] has concluded that the most probable explanation for hormesis 
is in the education of the immune system, which is very complex and is capable of 
learning to deal with a variety of threats to living cells. It is however a controversial 
issue because it is not supported by statistical analysis. There is also evidence that 
low dose radiation increases metastasis o f some tumours. Fabrikant as mentioned by 
Sugahara et-al [152] made a case for a DDREF for humans in the range of 3 
to 4 rather than 2 which is used both by ICRP (No 60) and BEIR V committee 
(NAS). In future, when sufficient data is available this controversial issue may be 
resolved.
Finally, it is believed that the unified dosimetry system, which has been presented 
in this thesis, is able to provide an improved system o f damage limitation for better 
risk control in radiological protection near enviromnental level. Success in devising 
appropriate measuring instruments would ensure the application of the new 
dosimetry system in operational radiological protection.
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Appendix One
Programme photonabef.for, to calculate ABE for Photon
c Program 'photonabef.for* calculates ABE for various energy x and
c gamma in keV. ABE iscalculated by taking into account the
c electron spectra generated per unit incident x or gamma fluence,
c This program include mean free path for equilibrium electron spectrum,
implicit none
real* 8 eng(lOO), gsig(lOO), dsig,
Id, r(lOO), fl(lOO), abeg(lOO), mfp(lOO)
Integer n, le, ndp
open(unit=30,status=’old\access=’sequentiar,file=’gh2o2f.dat’)
open(unit=48,status=’unknown’,access=’sequentiaT,file=’photonabef.dat’)
1 1 = 1 5
dsig=4.0e-08
d=6.0e-04
c dsig is the DNA geometrical cross section given in cm2,
c d is the mean chord length o f the cell nucleus as 6 microns,
c but given in cm (6 micron= 6.0e-04 cm)
read(30,l0)
10 format(a)
read(30,*) ndp 
do 150 le=l,ndp
read(30,*) eng(le),gsig(le),fl(le),r(le).mfp(le)
150 continue
c fluence fl(le) has already incorperated efficiency factor
c =(l-exp(-2/lamda).
write(48,155)
155 form at(lh ,2x.'Gamma Energy\5x,'A BE for Gamma’,5x,’mean free path
nm ')
do 250 le=l,ndp 
abeg(le)=dsig*n*fl(le)*gsig(le) 
write(48.255) eng(le).abeg(le),mfp(le)
255 form at(lh ,5x ,lpel0 .2 ,5x ,lpel0 .2 ,5x ,lpel0 .2 )
250 continue
stop 
end
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Input Data for Program photonabef.for
File: gh2o2f.dat (ecfii.crs)
Number of data points: 31
Photon Cross 
Energy Section
Fluence Range mfp
A
0.277 3.200E+04 6.8302E-07 3.57E-07 3.35E+00
0.392 2.576E+04 1.0821E-06 4.75E-07 3.41E+00
0.849 6.107E+03 8.2969E-07 3.73E-07 3.38E+00
1.486 1.422E+03 3.1117E-06 1.54E-06 3.97E+00
3.310 1.421E+02 9.6100E-06 9.80E-05 5.81E+00
5.410 3.245E+01 1.7030E-05 5.93E-05 7.89E+00
5.900 2.489E+01 1.8620E-05 5.00E-05 8.00E+00
6.400 1.939E+01 2.0388E-05 4.17E-05 8.81E+00
6.925 1.520E+01 2.2223E-05 4.88E-05 9.26E+00
8.040 9.570E+00 2.5867E-05 6.48E-05 l.OlE+01
8.630 7.674E+00 2.7872E-05 7.57E-05 1.05E+01
9.880 5.026E+00 3.1747E-05 9.25E-05 l.llE + 0 1
10.53 4.107E+00 3.3801E-05 1.02E-04 1.14E+01
11.21 3.381E+00 3.5618E-05 1.17E-04 1.17E+01
11.900 2.808E+00 3.7673E-05 1.29E-04 1.19E+01
14.140 1.634E+00 4.2980E-05 1.72E-04 1.18E+01
15.750 1.159E+00 4.6183E-05 2.08E-04 1.16E+01
17.440 8.334E-01 4.8817E-05 2.30E-04 1.09E+01
22.100 3.870E-01 5.1890E-05 3.13E-04 9.09E+00
23.110 3.351E-01 5.2111E-05 3.17E-04 8.70E+00
27.380 1.961E-01 4.9986E-05 3.46E-04 7.61E+00
32.060 1.224E-01 4.6165E-05 3.49E-04 6.94E+00
39.910 6.832E-02 3.9421E-05 3.36E-04 6.62E+00
50.390 4.179E-02 3.4618E-05 2.89E-04 6.94E+00
58.830 3.295E-02 3.3967E-05 2.63E-04 7.41E+00
59.600 3.240E-02 3.4113E-05 2.63E-04 7.51E+00
68.130 2.816E-02 3.5919E-05 2.53E-04 8.12E+00
76.250 2.607E-02 3.8924E-05 2.65E-04 8.77E+00
97.000 2.469E-02 5.1089E-05 3.52E-04 1.06E+01
661.000 3.255E-02 8.9335E-04 3.59E-02 6.31E+01
1253.300 2.974E-02 3.1818E-03 1.20E-01 1.04E+02
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Programme neutronabe.for, to calculate ABE for Neutron
c Program 'neutronabe.for' calculates ABE for neutrons
c w ith various energies. ABE is calculated by adding the ABE of
c hydrogen recoils and ABE of oxygen recoils generated per unit
c incident neutron fluence.
implicit none 
real*8 eneut(lOO), flh(lOO), flo(lOO),
Imfph(lOO), mfpo(lOO), nsigh(lOO),
2nsigo(100), dsig, abeh(lOO), abeo(lOO). aben(lOO), d, rh(lOO),
3ro(100)
Integer nh, no, le, ndp
open(unit=30,status=’ old’ ,access=’ sequential ’ ,file=’ nli2o4.dat’ ) 
open(unit=48.status='unknown’,access=’sequentiar,file=’ 
lneutronabe.dat’) 
nli=15 
no=15
dsig=4.0e-08 
d=6.0e-04
c d is the mean chord length of the cell nucleus, taken as 6 micron,
c dsig is the DNA geometrical cross section. j
read(30,10) |
10 fbrmat(a) j
read(30,*) ndp |
do 150 le=l,ndp I
read(30,*) eneut(le),nsigh(le),nsigo(le),flh(le),flo(le), }
1 mfph(le),mfpo(le),rh(le),ro(le) |
I150 continue i
write(48,155) :
155 form at(lh ,2x,'Neutron Energy'.5x,’ABE Neutrons’,2x,’mfp H ’,5x,
rm fp  O ') I
do 250 le=l,ndp :
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c epsilh(le)=( l -exp(-2/mfph(le)))
c epsilo(le)=( 1 -exp(-2/mfpo(le)))
c rdh(ie)=rh(le)/d
c if (rdh(le).gt.l) rdh(le)=l
c abeh(le)=dsig*rdh(Ie)*nh*flh(ie)*epsilh(Ie)*nsigh(le)
abeh(le)=dsig*nh*flh(le)*nsigh(le) 
c rdo(le)=ro(le)/d
c if (rdo(le).gt.l) rdo(le)=l
c abeo(le)=dsig*rdo(ie)*no*flo(le)*epsilo(le)*nsigo(le)
abeo(le)=dsig*no*fio(le)*nsigo(le) 
aben(le)==abeh(le)+abeo(le) 
c nsigh lias incorporated the effect o f two hydrogen atom
c per water molecule, in its value.
c Note: in this calculation R/d factor is not applied to the
c average values for ABE calculation. It has to be applied
c to each fractions of the spectrum in the main programme.
write(48,255) eneut(le),aben(le),mfph(le),mfpo(le)
255 formate 111 .5x ,lpel0 .2 ,5x ,lpel0 .2 .5x ,lpel0 .2 ,5x ,lpel0 .2 )
250 continue
stop 
end
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Neutron Cross Section
Neutron Cross Sections are arranged according to Neutron Energy. Neutron Cross- 
section (hydrogen) (Nsig),, and Neutron Cross-section (oxygen) (Nsig)o- Number of
data points is 63.
Neutron Energy. (Nsig)„ . (Nsig)o
l.OOE-01, 20.470, 3.890
1.50E-01. 20.460, 3.890
2.00E-01, 20.450, 3.890
3.00E-01, 20.430, 3.890
4.00E-01, 20.410, 3.890
5.00E-01, 20.400, 3.890
6.00E-01, 20.370, 3.890
7.00E-01. 20.360, 3.890
8.00E-01. 20.340. 3.890
9.00E-01. 20.320, 3.890
l.OOE+00, 20.310. 3.890
1.50E+00, 20.210. 3.890
2.00E+00. 20.110, 3.890
3.00E+00, 20.000. 3.880
4.00E+00, 19.870. 3.880
5.00E+00, 19.780, 3.880
6.00E+00, 19.640, 3.880
7.00E+00, 19.540, 3.870
8.00E+00, 19.370, 3.870
9.00E+00, 19.190, 3.870
lO.OOE+00, 19.130, 3.870
15.00E+00, 18.500. 3.850
20.00E+00, 17.800, 3.840
30.00E+00, 16.900, 3.820
40.00E+00, 16.000, 3.800
50.00E+00, 15.350, 3.770
60.00E+00, 14.700, 3.750
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Neutron Energy, (Nsig),,, , (Nsig)o
70.00E+00, 14.100, 3.730
80.00E+00, 13.500, 3.710
90.00E+00, 13.000, 3.670
lOO.OOE+00, 12.510, 3.660
150.00E+00, 10.600, 3.560
200.00E+00, 9.400, 3.490
300.00E+00, 7.860, 3.630
400.00E+00, 6.600, 12.400
440.00E+00, 6.350, 7.940
500.00E+00, 5.960, 3.730
600.00E+00, 5.420, 2.900
700.00E+00, 5.000, 2.800
800.00E+00, 4.640, 2.900
900.00E+00, 4.370, 5.200
l.OOE+03, 4.130, 5.200
1.50E+03, 3.320, 2.000
2.00E+03, 2.820, 1.400
3.00E+03, 2.250, 2.180
3.75E+03, 1.910, 2.350
4.00E+03, 1.830, 1.800
5.00E+03, 1.560, 1.280
6.00E+03, 1.360, 0.966
7.00E+03, 1.210, 0.830
8.00E+03, 1.080, 0.645
9.00+03, 0.980, 0.696
l.OOE+04, 0.940, 0.980
1.50E+04, 0.640, 1.360
2.00E+04, 0.480, 1.650
3.00E+04, 0.305, 1.520
4.00E+04, 0.223, 1.340
1 9 4
Neutron Energy, (Nsig)^ , (Nsig)o
5.00E+04, 0.172, 1.170
6.00E+04, 0.137. 1.020
7.00E+04, 0.114. 0.910
8.00E+04. 0.111, 0.820
9.00E+04, 0.108. 0.740
1.00+05, 0.105. 0.680
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Appendix Two
Derivations of the Linear Energy Transfer (LET) values and the Absolute Biological 
Effectiveness (ABE) values (refer to table 4.4 page 172) used in expressing risk in 
terms of the unified dosimetry system are as follows:
A.I. For hydrogen recoil
(Refer to table 3(a) page 7-8 [144])
For neutron energy E„=300 keV, L=64 .11
E =1500 keV, L=3.961xlO""' 
E =2000 keV, L=3.365xlO'"' 
For E,=1600 keV. L=3.9661xl0""'+(33.65-39.61)xl00/500 = 38.42.
A.2. For oxygen recoil
(Refer to table 3(b) page 9-10 [144])
For neutron energy E,=300 keV, L=2.005x10""“
E =1500 keV, L=2.564xl 0'"- 
E =2000 keV. L=2.755xlO'"- 
For E =1600 keV, L=256.4+(275.5-256.4)xl00/500 = 260.22
A.3. Effective LET for neutron L^ ff IiEffective LET for neutron L^ff, is calculated by averaging L o f all recoils generated j
per unit incident neutron fluence, by using the following formula: I
kelT ^  + lo-^TX) {
where, j
f,[ is the fraction of hydrogen recoil fluence to the total fluence (i.e. ((),, 1
/ ^i-no )’ I
Lj|_, is track average LET due to hydrogen recoil; ‘
fo is the fraction of oxygen recoil fluence to the total fluence (i.e. (j)o / j
(|)H+o ); and j
L-po is track average LET due to oxygen recoil. j
For neutron energy £^=300 keV, |
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287X10""; and 
(j)o = 2.135X10"".
Therefore:
( 1.287X10""/( 1.287X10'""+2.135X10"")}x64.11 
+{2.135X10-""/(1.287X10-""+2.135X10-"")}x2.005xlO'"-
Lg(f=66.34 
For neutron energy E„=1600 keV,
(j)H=4.750x10'"": and
(1)^ =4.440x10-"".
Therefore: L,fr{4.750X10""/(4.750X10-""+4.440X10-"")}x38.42
+{4.440X10-""/(4.750X10""+4.440X10-"")}x260.22
Lg,-j-=40.47
A.4. LET For Gamma-rays
(Refer to table 3(a) [142])
For gamma energy E,=1253.3 keV, L=0.306 
E =661 keV. L=0.475 
For E.=1000 keV: L=0.475 + (0.306-0.475)X(1000-661)/(1253.3-661)= 0.378
B .l. Derivation of ABE for gamma
ABE values for gamma can be obtained fron the graph shown in figure 4.2.
For gamma energy E^=1000 keV. from the graph ABE,oo(3=3.75E-l 1. I
I
B.2. Derivation of ABE for Neutron
For neutron the ABE values can be obtained from the graph shown in figure 4.3 :j
(refer to page 162). From the graph; I
For neutron energy E,=300 keV, ABE.QQ=3.95E-11; and j
For neutron energy E,=1600 keV, ABE,6oo=h.06E-l 1. j
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